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ABSTRACT 
Bacterial communities (microbiota) of great diversity populate the large intestine of 
animals including humans and influence the physiology, biochemistry and immunology of 
the host. Microorganisms mainly bacteria that when administered in sufficient amounts 
promote a beneficial effect to the host are defined as probiotics. The positive clinical 
effects of probiotics, mainly belonging to the Bifidobacterium and Lactobacillus genera in 
treatments of irritable bowel syndrome, gut infections and lifestyle diseases are well 
documented. Compounds that selectively stimulate the beneficial effect of probiotics, 
primarily non-digestible carbohydrates, are termed prebiotics. The knowledge of prebiotic 
utilization and in particular the specificities of carbohydrate transport and metabolism are 
limited, hampering robust understanding for the basis of selective utilization of known 
prebiotics and the discovery and documentation of novel ones. In this project we set out to 
investigate the metabolism of carbohydrates that are prebiotic or potential prebiotic 
compounds utilized by the probiotic organisms Lactobacillus acidophilus NCFM (NCFM) 
and Bifidobacterium animalis subsp. lactis BL-04 (Bl-04).  
The aim of this Ph.D. thesis was the study of probiotic NCFM and Bl-04 interaction with 
prebiotic carbohydrates using differential proteomics and protein characterization. 
Proteomics is a potential omics tool to investigate probiotic bacteria and its response to 
prebiotic carbohydrates at the protein level. The reference proteome of NCFM and Bl-04 
was established using 2D based proteomics. The whole cell extract proteome of NCFM 
grown on glucose until late exponential phase was resolved by two-dimensional gel 
electrophoresis (2-DE) (pH 3−7 and 6−11). A total of 507 and 150 protein identifications 
were made from the CBB stained 2D-gel using MALDI-TOF MS and/or MS/MS in the pH 
3−7 and 6−11 respectively. While from the whole cell extract 2D proteome of Bl-04 (pH 
3−7 and pH 3−10), 870 protein identifications were made using MALDI-TOF MS and/or 
MS/MS. Differential 2-DE (DIGE) of NCFM and Bl-04 grown on established and 
potential prebiotics revealed several proteins with differential abundance including the 
glycoside hydrolases involved in primary breakdown of oligosaccharides and changes in 
carbohydrate metabolic pathways. 
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The potential carbohydrates transport systems involved in uptake of potential prebiotic 
carbohydrates, specifically the ABC-transporter associated solute binding protein BlXBP 
involved in the transport of XOS from Bl-04 was characterized. Surface plasmon 
resonance binding assays showed that BlXBP was specific for XOS with a degree of 
polymerization (DP) 2– 6 with optimal affinity (Kd ~50 nM) for xylotetraose followed by 
xylotriose. Differences in binding affinity was governed largely by the association rate 
(kon), while koff had a more modest contribution to binding affinities, except for xylobiose, 
which displayed the highest koff. The binding affinity and kinetics of arabinose decorated 
XOS were similar to undecorated counterparts, thus providing evidence that arabinoxylan 
fragments are efficiently captured by the ABC import system. The binding affinity towards 
xylotriose and xylotetraose was corroborated using fluorescence emission spectroscopy 
and isothermal titration. calorimetry that revealed that the binding free energy was 
dominated by a favourable enthalpy, which was off-set by a large unfavourable entropy 
change. The crystal structures of BlXBP in complex with xylotriose, xylotetraose and 
xylohexaose were determined and showed a binding cleft large enough to accommodate 
the preferred ligand xylotetraose. The helical structure of xylan fragments was recognized 
by aromatic stacking of xyloxyl rings 1, 3 and 4, in addition to several direct and solvent 
mediated hydrogen-bonds that contribute to the binding enthalpy. Binding of larger ligands 
requires conformational changes in a lid loop that contributes to the structural plasticity of 
BlXBP. This data bring novel insight into the molecular basis for XOS uptake by 
bifidobacteria, and xylan utilization by the gut microbiome. 
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DANSK RESUMÉ (SUMMARY IN DANISH) 
Tyktarmen hos mennesker og dyr indeholder en mangfoldig og divers population af 
bakterier, der kan påvirke værtens metabolisme og immunforsvar. Mikroorganismer som 
indtages i tilstrækkeligt antal udviser en positiv effekt på modtageren, er defineret som 
probiotika. Det er dokumenteret at probiotika, hovedsageligt fra genera Bifidobacterium og 
Lactobacillus kan anvendes i behandlingen af irriteret tyktarm, tarminfektioner og 
forskellige livsstilssygdomme. Levnedsmiddelskomponenter, der selektivt stimulerer de 
gavnlige effekter af probitika er defineret som præbiotika. Kendskab til hvordan 
probiotiske bakterier stimuleres af præbiotiske kulhydrater og i særdeleshed de probiotiske 
bakteriers kulhydrattransport og metabolisme er begrænset. Dette hindrer forståelsen af 
den selektive effekt af kendte præbiotika samt opdagelse og dokumentation af nye. Ph.D-
projektets målsætning er at undersøge kulhydrat metabolismen hos to probiotiske bakterier 
Lactobacillus acidophilus NCFM (NCFM) og Bifidobacterium animalis subsp. lactis BL-
04 (Bl-04) mens de fermenterer præbiotiske eller potentielt præbiotiske kulhydrater. 
Formålet med denne Ph.D-afhandling er at studere de probiotiske bakterier NCFM og Bl-
04´s interaktion med præbiotiske kulhydrater ved hjælp af differentiel proteomanalyse og 
proteinkarakterisering. Proteomics er et ´omics´-værktøj der på proteinniveau kan 
anvendes til at undersøge probiotiske bakterier og deres interaktion med præbiotiske 
kulhydrater. Referenceproteomer for NCFM og Bl-04 blev etableret ved hjælp af 2D gel-
baseret proteomics.  
Proteomet af NCFM dyrket på glukose blev etableret ved 2D- gelelektroforese (pH 3-7 og 
6-11). MALDI-TOF massespektromeri resulterede i 507 og 150 protein identifikationer fra 
coomassie farvede 2D-geler med pI intervallerne pH 3-7 og 6-11. For Bl-04 resulterede 
referenceproteomet (pH 3-7 og pH 3-10), i totalt 870 protein identifikationer. Differential 
2-DE (DIGE) af NCFM og Bl-04 dyrket på etablerede og potentielle præbiotika afslørede 
en række proteiner med differentieret ekspressions mønster herunder glykosidhydrolaser 
involveret i primær nedbrydning af oligosaccharider og dermed ændringer i kulhydrat 
stofskiftet. 
Et solute binding protein BlXBP tilhørende en ABC-transportør involveret i transport af 
XOS (Xylooligosaccharider) fra Bl-04 blev karakteriseret. ´Suface plasmon resonance´-
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bindingsanalyser viste, at BlXBP var specifik for XOS med en polymerisationsgrad (DP) 
fra 2 til 6 med optimal affinitet (Kd ~ 50 nM) for xylotetraose efterfulgt af xylotriose. 
Forskelle i bindingsaffiniteten for forskellige XOS var i vid udstrækning reguleret af 
associations parameteren kon, mens koff havde et minimalt bidrag til bindingsaffiniteten, 
bortset fra xylobiose, der viste den højeste koff. Bindings-affinitet og -kinetik for 
arabinoxylan fragmenter lignede de lineære XOS varianter, hvilket viser, at arabinoxylan 
fragmenter effektivt opfanges af ABC-transportøren. Bindingsaffiniteten for xylotriose og 
xylotetraose blev bekræftet ved hjælp af fluorescensemissionsspektroskopi og isotermisk 
titreringskalorimetri der viste, at den frie bindingsenergi var domineret af enthalpi bidrag, 
som blev opvejet af en tilsvarende forandring i entropi. Krystalstrukturer af BlXBP i 
kompleks med xylotriose, xylotetraose og xylohexaose blev løst og viste en bindingskløft 
der helt kan akkommodere den foretrukne ligand xylotetraose. Binding af større ligander 
kræver konformationsændringer af et ´loop´ der afgrænser bindings sitet mod solventsiden, 
denne strukturelle plasticitet af BlXBP er afspejlet i bindingsdata. Observationer giver en 
hidtil ukendt indsigt i det molekylære grundlag for bifidobacteriers optagelse af XOS samt 
tarmbakteries udnyttelse af xylan. 
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1    INTRODUCTION  
1.1    FUNCTIONAL FOODS 
Functional foods refer to food products and beverages, which can produce a positive health 
effect that surpasses the effect of the nutrients contained by the product and is intended to 
enhance not replace normal food. Functional food has been defined as “Functional Food is a 
natural or processed food that contains known biologically-active compounds which when in 
defined quantitative and qualitative amounts provides a clinically proven and documented 
health benefit, and thus, an important source in the prevention, management and treatment of 
chronic diseases of the modern age” [1]. The health benefit in this context means health 
promotion, disease prevention, relief of symptom or possibly even healing. The concept was 
originally developed in Japan in the 1980s and in the 1990s the development and availability 
of functional food products grew especially in the United States, simultaneously the concept of 
functional foods was specifically defined in Europe [2, 3]. Probiotics and prebiotics are classes 
of physiologically beneficial components used in functional foods. 
 
1.1.2    PROBIOTICS AND PREBIOTICS 
Probiotics meaning “pro life” are defined by the FAO/WHO as:  "Live microorganisms which 
when administered in adequate amounts confer a health benefit on the host".                                                            
The health claims of live microorganisms in food or fermented foods go long back in history 
primarily as folklore. The original scientific proposal of the positive role played by certain 
bacteria was first introduced by Élie Metchnikoff in 1907 [4], who suggested that it would be 
possible to modify the gut flora and to replace harmful microbes with useful microbes. This 
was at the beginning of the modern microbiology and probiotics were thought to beneficially 
affect the host by improving its intestinal microbial balance, by inhibiting pathogens and toxin 
producing bacteria [4]. The term probiotics was first used by Lilly and Stillwell [5] as the 
opposite of antibiotics “substances secreted by one microorganism which stimulates the 
growth of another”, later the term came to include the microorganisms in question. In recent 
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years specific health effects of probiotic microorganisms in combination with selectively 
metabolized compounds (prebiotics), mainly carbohydrates [6] have been investigated and 
documented, including alleviation of chronic intestinal inflammatory diseases [7], prevention 
and treatment of pathogen-induced diarrhea [8], urogenital infections, and atopic diseases [9]. 
Furthermore probiotics have been suggested to play a role in some cases of obesity [10] (see 
Table 1). Most attention has been given to the probiotic potential of bifidobacteria and LAB 
(Lactic acid bacteria) especially various lactobacillus species of the latter group. But other gut 
inhabiting microorganisms have also been shown to have probiotic effects. Probiotic 
organisms have been suggested in species of Bacteriodes, Bifidobacterium, Enterococcus, 
Escherichia, Lactobacillus, Lactococcus, Leuconostoc, Pediococcus, Ruminococcus, 
Saccharomyces and Streptococcus [11-13], in this context it is worth noting that Bacteriodes, 
Escherichia, Enterococcus, and Streptococcus double as both beneficial and detrimental 
genera. The determinants of beneficial or detrimental effect may be species specific and could 
also be dependent on the diversity and composition of the gut microbiota 
 
Table 1. Studies investigating human health benefits of consuming probiotics 
Effect on ailment References 
Common infections [14-18] 
Diarrheal illness [18-22] 
Inflammatory bowel disease [23-27] 
Age dependent effects [28-30] 
Allegies [31-33] 
Colonic cancer [34, 35] 
 
The term prebiotic has been defined twice by Gibson and Robberfroid [11, 14] and has ended 
up in the form: “A prebiotic is a selectively fermented ingredient that allows specific changes, 
both in the composition and/or activity in the gastrointestinal microflora that confers benefits 
upon host well-being and health”. The prebiotic definition does not emphasize a specific 
bacterial group. Generally, however, it is assumed that a prebiotic should increase the number 
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and/or activity of probiotic bifidobacteria or lactic acid bacteria. So far most attention has been 
given to bifidobacteria and lactic acid bacteria in the role of probiotic bacteria and as a 
consequence most evidence has been on the beneficial effects of these groups, especially in 
terms of improving digestion and the effectiveness and intrinsic strength of the immune 
system. Synbiotics is the less frequently used term for the combined use of probiotic 
organisms and prebiotic compounds to increase their effect. 
  
1.1.2.1    PREBIOTIC CARBOHYDRATES 
Intake of prebiotic non digestible dietary carbohydrates is another approach to obtain the 
health benefits of intestinal probiotic microbes already present in the gastrointestinal tract 
(GI). A healthy and balanced gut microbiota has been proposed to be one that is primarily 
saccharolytic with significant numbers of lactobacilli and bifidobacteria [15]. Accoding to the 
definition given earlier and [16] a food ingredient has to fulfill the following criteria in order 
to be classified as a prebiotic: 
1) Resist gastric acidity, hydrolysis by mammalian enzymes and gastrointestinal 
absorption 
2) Be fermented by the intestinal microbes 
3) Selectively stimulate the growth and/or activity of intestinal bacteria associated with 
the health benefit and well being    
So far only fructooligosaccharides (FOS), galactooligosaccharides (GOS) and lactulose have 
been classified as prebiotic carbohydrates [16]. Other carbohydrates that are being evaluated 
as promising emerging prebiotics are lactitol, isomaltooligosaccharides (IMO), 
xylooligosaccharides (XOS) and raffinose family oligosaccharides (RFO). One of the major 
aspects of the prebiotic concept is the selective stimulation of prebiotic bacteria such as 
lactobacilli  and bifidobacteria at the expense of other bacteria especially potential pathogenic 
bacterial groups [17]. Such selectivity may be conferred by carbohydrate characteristics such 
as the type of glycosidic linkage, degree and type of branching or added modifications and 
degree of polymerization (DP). The DP may influence where in the colon the carbohydrates 
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are fermented as longer polymers are supposed to travel longer into the colon before they are 
broken down [18].   
Recent studies have focused on investigate the potential of nondigestible carbohydrates (Table 
2) to act as a prebiotic. Lactitol (4-O-β-D-galactopyranosyl-D-glucitol) is a synthetic sugar 
alcohol obtained from lactose and is accessible to the microbiota in the colon [7]. It has been 
shown to stimulate growth and metabolism of intestinal Bifidobacterium and Lactobacillus 
species, thus creating unfavourable conditions for pathogens such as Clostridia and 
Enterobacteriaceae [8]. Daily consumption of the synbiotic combination of NCFM and 
lactitol by elderly volunteers increased stool frequency, fecal levels of NCFM and genus 
Bifidobacterium, and modulated fecal immune biomarkers, reflecting stimulation of intestinal 
mucosal functions [9]. RFO are an emerging class of prebiotic carbohydrates derived from 
soybean and lupins. Raffinose was been shown to modulate the human intestinal microbiota 
for beneficial effects [15] and the administration of raffinose has shown to increase the levels 
of bifidobacteria sp. in the gut from 12.5% to 37% [19]. GOS and FOS supplementation has 
shown a bifidogenic effect in infants and adults and results in increased amounts of 
bifidobacteria in the gut [20, 21]. IMO are known to be selectively fermented by bifidobacteria 
and increase their numbers in the presence of the human gut microflora [22].  
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Table 2. A list of various nondigestible carbohydrates with their chemical structure and 
potential sources 
Common names  Chemical Structure Source Ref. 
Fructo-oligosaccharides (FOS)  [β-D-Fruf-(1-2)]a -(β2,α1)-D-Glcp 
Hydrolysis of chicory inulin or 
enzymatic synthesis 
[23]  
Inulin  As FOS with a > 20 
Onion, banana, garlic,leek, 
chicory root 
[24]  
β-galacto-oligosaccharides (GOS)  [β-D-Galp-(1–4)]b-D-Glcp 
Milk or enzymatic synthesis 
from lactose 
[25]  
Lactitol  β-D-Galp-(1–4)-D-Glc-ol 
enzymatic sunthesis from milk 
sugar 
[26]  
Lactulose  β-D-Galp-(1–4)-D-Fruf 
Enzymatic isomerization of 
lactose 
[25]  
Raffinose family oligosaccharides  
(RFO)  
[α-D-Galp-(1–6)]c- D-Glcp-(α1,β2)-D-Fruf 
Soybean, beans, cabbage, 
brussels sprouts, broccoli and 
asparagus 
[27]  
Melibiose  α-D-Galp-(1–6)- D-Glcp Produced from RFOs 
 
Isomaltooligosaccharides (IMO)  [α-D-Glcp-(1–6)]d-D-Glcp 
Enzymatic degradation from 
starch. 
[28]  
Panose  α-D-Glcp(1–6)-α-D-Glcp-(1–4)-D-Glcp 
Enzymatic degradationfrom 
starch. 
[29]  
Gentio-oligosaccharides  [β-D-Glcp-(1–6)]e-D-Glcp 
Enzymatic synthesis by trans-
glycosylation 
[30]  
β-xylo-oligosaccharides (XOS)  [β- D-xylp-(1–4)]f-D-xylp 
Bamboo shoots, plant cell 
walls, produced comercially by 
enzymatic treatment of xylan 
rich material e.g. corncob 
[31]  
Arabinose-decorated XOS (AXOS) 
 α-D-Araf-(1–2) and/or α-D-Araf-(1–3) 
linked to XOS 
Bamboo shoots, plant cell 
walls, produced comercially by 
enzymatic treatment of xylan 
rich material e.g. corncob 
[31]  
Xylitol  β- D-xylp-(1–4)-D-xylp-ol Enzymatic synthesis 
 
Polydextrose mostly mixed α-
glucans, DP=2–30  
Chemical synthesis by random 
polymerization of glucose 
[31]  
Rhamnogalacturonan I (RG-I) 
fraction of pectin 
 [α-L-Rhap-(1,2)-α-D-GalAf-(1,4)]g 
Plant cell walls, commercially 
produced from citrus and apple 
solids 
[32]  
Manno-oligosaccharides  [α- D-Manp-(1–4)]-D-Manp yeast cell wall, Konjac (plant)  [33]  
a = [1–5]; b = [1–5]; c = [1=raffinose, 2=stachyose, 3=verbascose]; d = [1–5]; e = [1–5]; f = [1–7]; 
g = [1–4] 
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1.2    THE GUT MICROBIOME 
The continuum of microorganisms inhabiting the GI tract has a few collective names, 
including gut microflora, microbiota and gut microbiome. The big majority of the gut 
microbiome consists of bacteria, between 300–500 species per individual [34], but also yeasts 
and archaea inhabit the gut microbiome. The varied conditions along the GIT have led to 
development of niche specific microbial communities (Fig. 1). The small intestine has the 
lowest density of microbes, while the large intestine has the highest density of microbes (Fig. 
1) [35]. The density of bacteria in human feces is quite high 10
11
 - 10
12
 cells per gram which is 
equivalent to 50–60 % of fecal solids [36]. This makes the gut microbiome one of the most 
densely populated natural ecosystems. The combined genome of the gut microbiome is 
estimated to be over 100 times larger than the human genome and is often in popular terms 
referred to as our second genome or the genome within [37, 38]. The metabolic capabilities of 
the combined microbiome are beyond what is found in the human genome which corresponds 
to the role of the microbiome. It contains a wide array of activities for utilization of 
carbohydrates that would otherwise escape processing. Furthermore minerals are made more 
accessible to the host by the microbiomes activities [39] and helps to get rid of potential toxic 
components [40]. 
Given this relatively large and complex microbial community living in our digestive system it 
seems almost natural that both its composition and the products of its combined metabolism 
may have an impact on human health. The relationship is mutual, as our diet to a very large 
degree determines the composition of the gut microbiome. Digestion of food and absorption of 
nutrients is a complex process performed by the GI system. The small intestine is the part of 
the gastrointestinal tract, where most of the human digestion and absorption of nutrients take 
place. Carbohydrates that resist degradation in the small intestine reach the cecum and colon, 
where they are available for bacterial fermentation [41]. The major end-products of bacterial 
metabolism in the gut include short-chain fatty acids (SCFA), pyruvate, lactic acid, ethanol, 
and succinic acid [42]. 
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Fig. 1. The distribution of microbial flora in the human intestine. The schematic representation of the intestine 
indicates the different regions and the overall sizes of the residing bacterial populations (blue boxes) 
(modified from [43]). 
  
The highest density and diversity of bacteria is found in the large intestine (10
11–1012 CFU/g). 
The human GIT microbiota is a complex ecosystem that has co-evolved with its human host 
[44]. As mentioned above it contains three domains of life, bacteria, archaea and eukaryote, 
where the bacteria are the most abundant and diversely represented [34, 45]. The intestinal 
microflora is established at birth or shortly after and develops with the host through life. 
Breast-fed infants are colonized by high numbers of bifidobacteria opposed to formula-fed 
infants whose fecal samples contain high numbers of bacteriodes and clostridia [46-48]. The 
intestinal microbiota stabilizes after weaning and resembles the adult composition when the 
child is approximately 3 years old. Our GIT microbiome varies through our life, between 
geographical regions and with different diet. The diet seems to be major factor determining the 
composition of gut microflora and clear separations are observed between populations with the 
major food intake being of plant origin as opposed to western (US or European) diet [49-52]. 
There is much diversity in the gut microbiome even between individuals from the same 
geographical area that are supposed to have a more similar diet, but interestingly the combined 
metabolic capabilities of the gut microbiome is found to be a lot more stable [53]. The 
  
16 
 
combined metabolic function of the whole gut microbiome rather than the type of bacteria 
seems to plays a detrimental role of a healthy gut. (Fig. 2)  
 
 
Fig. 2. Biodiversity of the gut microbiome and their genome content divided into functional groups from 242 
healthy individuals (modified from [53]). 
 
The organisms of the gut microflora are thought to have 3 types of interactions with the host; 
commensalism where one organisms benefits without affecting the other, mutualism where 
both organisms benefits and parasitism where one benefits and the other is harmed. Probiotic 
bacteria belong to the mutualists and can in some cases inhibit colonization by pathogens [54, 
55]. A huge determinant of a well functioning gut microbiota in balance is the diversity and 
the exact composition. Imbalances have been observed with several gut diseases e.g. 
inflammatory bowel disease and irritable bowel disease [55, 56]. A huge effort has recently 
been established to characterize the GIT microbiome diversity and its gene contents through 
phylogenetic studies and sequencing of gut bacterial genomes [53]. This study involving stool 
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samples from 242 individuals, showed large differences in content of microbial taxa between 
individual but the little variance in the metabolic pathways present. This effort has added 
greatly to our understanding of the system, but is still in the early days of emergence. Some of 
the complicating factors are the differences between different species of the same genera and 
even at the strain level, crucial differences between choice of life style (commensal, mutualist 
or pathogen). In order to understand what a healthy balanced gut microbiome is, we need to 
investigate the differences between normal healthy gut microbiome and the composition found 
in different bowel diseases. It has been reported that individuals with inflammatory bowel 
disease and irritable bowel syndrome (IBS) have an over representation of bacteriodes in feces 
and in the intestinal mucosa combined with an under representation of bifidobaceria (Fig. 3) 
[56-58].   
 
 
Fig. 3. Phylogenetic tree representing the diversity of the human gut microbiome. Taxa are presented 
in bold when found to be significantly different between IBS patients and healthy subjects. The direction 
of the changes are indicated by the arrows (down arrow, higher in healthy; up arrow, higher in IBS). 
The reference bar indicates 10% sequence divergence [59]. 
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The main carbon source arriving in the colon are the so called recalcitrant insoluble 
carbohydrates deriving from insoluble plant fibers from plant cell wall structures and resistant 
or partly degraded storage polysaccharides like inulin and resistant starches. But also animal 
derived carbohydrates from e.g. cartilage will reach the colon. Of all the different species of 
bacteria in the gut only a few have the cellolytic activity associated with breakdown and 
growth on recalcitrant carbohydrates. In humans bacterial species capable of degrading 
recalcitrant carbohydrates have been identified within the genera bacteriodes, roseburia, 
ruminococcus, enterococcus and bifidobacteria [60]. Plant cell walls are composed of 
cellulose (polymer of glucose linked via α-1→4 glycosidic linkages) fibrils, held together by a 
matrix of hemicellulose (heteropolymers such as arabinoxylans) and pectin (polysaccharide 
rich in galacturonic acids). The degradation of cellulose is the first step in the breakdown of 
plant cell-wall derived structures, and this ability is primarily found in Gram-positive 
firmicutes of the genera ruminococcus and enterococcus and Gram-negative bacteriodes  and 
they are often termed primary degraders [61]. The cellulytic glycoside hydrolases are located 
on the cell surface of the primary degraders either in large functional units called cellulosomes 
that co-localizes different glycoside hydrolase activities on a common protein scaffold (in 
Gram-positives) or as lipid anchored proteins on the surface of Gram-negatives like 
bacteriodes [60]. Cellulytic gut bacteria have acquired the ability to degrade matrix 
polysaccharides like xylans and pectins in order to make the cellulose fibrils available, but 
they do not necessarily use the solubilized matrix polysaccharides which therefore can be 
available for other gut bacteria, a phenomenon known as cross-feeding [61]. The secondary 
degraders, cross feeders or scavengers are basically the rest of the non pathogenic species 
found in the colon. The substrates that the secondary degraders cross-feed on are end or by-
products from other species metabolic activity. First there is the cross-feeding on solubilized 
oligosaccharides (DP=2–10) and polysaccharides (DP > 10) of both branched and unbranched 
structure, then there is the cross feeding of anaerobic fermentation end-products; hydrogen, 
carbon dioxide, short chain fatty acids and lactate. Apart from being used as carbon source by 
colonic bacteria, the short chain fatty acids butyrate and acetate are also taken up by the host 
and used as energy source by the colonic epithelium (butyrate) and the heart and brain 
(acetate) [62].   
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The probiotic bacteria of the genera bifidobacteria and lactobacilli are saccharolytic and use 
oligosaccharides and monosaccharides as carbon source. They are also among the first 
colonizers of the infant gut and are found in especially high amounts in breast fed infants [63]. 
In the infant gut bifidobacteria and lactobacilli catabolize different carbohydrates, lactobacilli 
seem to prefer lactose and monosaccharide components while bifidobacteria are able to 
directly metabolize human milk oligosaccharides (HMO), suggesting that they cooperate 
synergistically to digest the human milk sugars [64-66]. In the mature gut the lactobacilli and 
bifidobacteria derive oligosaccharides from the activity of the primary degraders or from the 
partial breakdown of plant polysaccharides from other secondary degraders for instance 
xylooligosaccharides from the activity of roseburia and bacteroides on solubilized 
hemicelluloses [58]. The probiotic bifidobacteria and lactobacilli bacteria often have their own 
(often limited) set of secreted glycoside hydrolases in order to degrade polysaccharides into 
oligo or monosaccharides that can be transported to the inside of the cell for further utilization. 
Once inside the cell oligosaccharides are hydrolysed by glycoside hydrolases (GH) into 
monosaccharides that are ultimately metabolized via the glycolysis (Embden-Meyerhof 
pathway) for lactobacilli [67] or through the bifid shunt (Pentose phosphate pathway) for 
bifidobacteria, that also have a specialized pathway for HMO and mucin-derived 
carbohydrates [68]. 
1.3    LACTOBACILLUS AND BIFIDOBACTERIA 
Lactobacilli are low G+C gram positive firmicutes, and microaerophilic. They have been 
isolated from various habitats including milk plant and animal sources. The lactobacilli 
residing in the gut are characterized by their ability to adapt to bile stress [69] and utilize a 
diverse range of carbohydrates [70, 71]. The lactobacilli are either homofermentative in which 
lactic acid is the primary product or heterofermentative in which lactic acid, CO2, acetic acid, 
and/or ethanol are produced [67]. The lactobacilli isolated from gut include L. acidophilus, L. 
gasseri, L. crispatus, L. johnsonii, L. salivarius, L. casei, L. rhamnosus, L. reuteri [72]. 
Bifidobacteria are high G+C gram positive of the phylum actinobacteria. They are 
endosymbiotic inhabitants of the gastrointestinal tract. Bifidobacteria are known to colonize 
the GIT of infants during the first days to weeks of life, and B. bifidum, B. infantis, B. breve, 
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and B. parvulorum were isolated from infant feces [43]. The adult GIT hosts B. animalis, B. 
adolescentis, B. bifidum and B. longum. Bifidobacteria are heterofermentative resulting in 
production of acetate, lactate and formate when fermenting carbohydrates [54]. 
 
1.3.1    CARBOHYDRATE METABOLISM IN LACTOBACILLUS AND BIFIDOBACTERIA 
The carbohydrates are metabolized via the glycolysis (Embden-Meyerhof pathway) for 
lactobacilli [67] and through the bifid shunt (pentose phosphate pathway) for bifidobacteria 
[73]. In homofermentative lactobacilli, fructose 1,6-bisphosphate is converted to two  triose  
phosphate  moieties which are funneled into the end product metabolite lactate (Fig. 4). 
Bifidobacteria are heterofermentative, fructose 6-phosphate is converted to acetyl phosphate 
and erythrose-4-phosphate by phosphoketolase (Fig. 4). The end product metabolites of 
carbohydrate metabolism in bifidobacteria are acetate lactate and formate at changing molar 
ratios depending on the carbohydrate metabolized [74, 75]. 
 
Fig. 4. Hexose metabolism in lactobacilli via the glycolysis (Embden-Meyerhof pathway) and through the bifid 
shunt (Pentose phosphate pathway) for bifidobacteria.  
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The carbon flux in the metabolism of low G+C Gram-positive lactic acid bacteria is tightly 
regulated by carbon catabolite repression (CCR) (Fig. 5) [76], thus in the presence of glucose, 
genes not needed for growth with glucose are repressed. The regulation of the repression is 
brought upon by transcriptional control and regulation at the protein level by phosphorylation 
[76]. CCR is a global gene regulation system that ensures only one set of sugar utilization 
genes are expressed at a given time. This achieved through three known mechanisms; inducer 
exclusion, inducer expulsion, and control of the activity of transcriptional regulators through 
phosphorylation [77, 78]. CCR has been extensively studied for low G+C Gram-positive 
bacteria utilizing sugars transported by a phosphoenolpyruvate dependent carbohydrate 
phosphotransferase system (PTS) [79]. The regulation of carbohydrate utilization for high 
G+C bifidobacteria is by an uncharacterized CCR under the control of LacI-type repressors 
[75]. CCR plays an important role in the survival of lactobacilli and bifidobacteria in the GIT, 
where they compete with gut microbiota for scant carbohydrate sources. 
In lactobacilli and other low G+C Gram-positive bacteria, CCR involves negative regulation 
of genes encoding catabolic enzymes by the protein CcpA [80]. CcpA binds to DNA target 
sites called catabolite response elements (cre) and thereby inhibits transcription of the genes 
downstream from the cre site. The most important effector of CcpA is the phosphorylated 
form of HPr, the phosphocarrier protein of the PTS transporters. The phosphorylation state of 
HPr reflects the glycolytic activity of the cell. Hpr is phosphorylated at Ser-46 by the HPr-
kinase that in turn is allosterically regulated by the levels of fructose-1,6-bisphosphate and Pi. 
The phosphorylated form of HPr can mediate inducer exclusion by interaction with non-PTS 
transporters which blocks their transport activity [81, 82]. Phosphorylated HPr also interacts 
with CcpA and thereby stimulates binding to cre sites (Fig. 5) [83].  
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FIG. 5. Schematic representation of CcpA-dependent carbon catabolite repression in low G+C Gram-positive 
bacteria. A. Glucose is phosphorylated to glucose-6-phosphate during PTS mediated transport. 
Histidine-containing phosphocarrier protein (HPr) is phosphorylated by enzyme I (EI) at the histidine 
residue. The histidine phosphorylated phospho-carrier protein HPr transfers the phosphate group to 
glucose moiety via the EIIABC. B. Fructose-1,6-bisphosphate produced from glucose-6-phosphate 
activates  HPr kinase (HPrK) that phosphorylates HPr at the regulatory-site serine. Binding of HPr-
Ser-P to catabolite control protein A (CcpA) results in a complex that inhibits the transcription of 
target genes (negative regulation) (modified from [84]).  
 
 
Preference for specific carbohydrates has been demonstrated in bifidobacteria. Little is known 
about the exact mechanisms of CCR in bifidobacteria, but the system is surely different from 
that found in lactobacilli. In B. longum NCC2705 glucose transporter glcP was shown to be 
under lactose repression [85]. Bifidobacteria do not have an obvious CcpA homologue and no 
cre sites have been predicted in the generea as well [85]. Secondly carbohydrate transport in 
bifidobacteria does not seem to be primarily facilitated by PTS-type transport systems but 
rather by ABC-transporters or MFS or GPH permeases where no substrate phosporylation 
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occurs during the translocation event, which rules out a PTS-HPr circuit for most 
carbohydrates. In one case it has been indicated that B. lactis exhibited glucose repression of a 
sucrose and raffinose active sucrose phosphorylase gene scrP. When expressed in E. coli. 
induction of the scrP gene was mediated through a GalR-LacI type transcriptional regulator in 
the presence of sucrose or raffinose [86] . The exact mechanism of the glucose repression in 
this system is not known and elucidation is hampered by the lack of genetic tools like cloning 
vector and transformation techniques for bifidobacteria [86].  
  
1.3.2    CARBOHYDRATE TRANSPORT IN LACTOBACILLUS AND BIFIDOBACTERIA 
In general transport mechanisms in prokaryotes are classified as simple transport, group 
translocation and ABC systems. In simple transport, the substrate is carried across the cell 
membrane without being chemically altered. The transport is driven by energy from the 
proton-motive force. There are three different types of simple transport events, performed by 
uniporters, antiporters and symporters. In group translocation the transported molecule is 
altered during the transport sequence e.g. by adding a charge to the transported compound. A 
classic example is the prokaryotic sugar phospho-enol-pyruvate phosphostransferase system 
(PTS-transporters), where a high-energy phosphate group from phosphoenolpyruvate is 
transferred to the sugar. Energy for the transport process comes from the stepwise transfer of 
the phosporyl group from phosphoenolpyruvate to the sugar. ATP-binding cassette (ABC) 
transporters use the energy derived from ATP hydrolysis to drive the translocation event but 
do not chemically alter the transported substrate.  
There are four main classes of carbohydrate transporters identified within bacteria [87] major 
facilitator superfamily (MFS) permeases; and glycoside-pentoside-hexuronide permeases 
(GPH) that form a sub-group of MFS permeases, PTS-transporters and ABC-transporters. 
Classification and annotation of transporters have mainly been accomplished by sequence 
homology based classification [88-90]. The probiotic Lactobacillus acidophilus NCFM 
(NCFM) and Bifidobacterium animalis subsp lactis Bl-04 (Bl-04), which have been used for 
the present study, are known to possess transporters for utilizing several different 
carbohydrates [91, 92]. NCFM genome has of 17 PTS, two MFS/GPH permeases and three 
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ABC transporters predicted to be carbohydrate transporters (family 1 solute binding proteins, 
SBP_bac_1 (Pfam PF01547)). In Bl-04 carbohydrate transport is carried out by MFS/GPH 
permeases, and ABC-transporters [93] and the genome of Bl-04 has five MFS/GPH permeases 
and five ABC-transporters predicted to be involved in carbohydrate uptake [93]. A section of 
the thesis focuses on the solute binding domain of the ABC-transporters and has been 
described below. 
 
1.3.2.1    ABC TRANSPORTERS  
ABC-transporters are part of one of the largest protein-families epresentatives in 
all phyla from prokaryotes to mammals [94]. They facilitate uptake of vitamins, 
carbohydrates, oligo-peptides, amino acids, ions and a wide variety of other compounds [95]. 
The broad range of transported compounds is reflected by diversity in the oligomerization of 
the domains that constitute the transportes [96]. The classic architecture consists of two 
nucleotide binding (NBDs) and two transmembrane domains (TMDs) (Fig. 6). This 
configuration facilitates ATP-driven transport of a large variety of substrates in all known 
phyla. Among these; import and export systems are differentiated. Import systems are so far 
only found in prokaryotes and archaea and require an additional solute binding protein (SBP), 
which binds the substrate in the periplasmic space or extracellularly on the cell surface and 
delivers it to the transmembrane permease part of the transporter. SBPs have been classified 
using different approaches, sequence alignment [88], structural connectivity of the secondary 
elements [97] and most recently by structural alignment of 107 3D models from the PDB 
database (http://www.pdb.org/pdb/home/home.do) [98]. The reason for the different 
classification studies is that SBPs have relatively low sequence similarity, but share an overall 
similar tertiary structure [99] . Another interesting observation from these studies is that 
contrary to what might be expected, the different groupings did not correlate with ligand 
specificity of the SBPs. Crystal structures of SBP have shown two possible conformations; 
open without substrate and closed with substrate bound. In theory though four different states 
may exist; open-unliganded, closed-unliganded, open-liganded and closed-liganded. SBPs 
consist of two globular lobes of different size, creating a cleft between them where the 
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substrate binding-site is located. In the closed-liganded complex the two domains have rotated 
towards each other along a hinge region and closed around the substrate. This mechanism is 
named the Venus Fly-trap model and describes the SBP conformation change upon ligand 
binding and the burying of the substrate in the closed confirmation [100]. Bacterial 
carbohydrate ABC-importers are typically arranged as pentamers composed of an extracellular 
cell wall/cell membrane lipid anchored solute SBP in Gram-positive bacteria whereas Gram-
negative bacteria secrete the SBP into the periplasmic space. Two membrane-spanning 
domains forms the heterodimeric permease that recruits the closed-liganded SBP. The channel 
is formed between the two transmembrane domains as their transmembrane helices align on 
each side along a hypothetical axis perpendicular to the membrane. Two nucleotide (ATP) 
binding proteins dock with each its transmembrane domain on the cytoplasmic side of the 
membrane [96]. The mechanism of carbohydrate uptake by ABC transporters has been studied 
based on structural work [101, 102]. The transport sequence of events starts with the SBP, 
which upon substrate binding undergoes a conformational change capturing the substrate 
which allows docking onto the membrane embeded permease for release of the substrate into a 
transmembrane funnellike channel. ATP loading in the NBDs is thought to cause a 
perturbation of the SBP conformation destroying the highaffinity binding site and releasing the 
substrate into the funnel of the outward open conformation of the permease. Translocation is 
facilitated by an altering access mechanism where conformational change in the permease 
subunits driven by hydrolysis of ATP by the nucleotide binding proteins, changes the funnel 
shaped channel from outward open to inward open allowing the substrate to diffuse into the 
cytoplasm (Fig. 6). 
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FIG. 6. Schematic representation of carbohydrate ABC-importers in Gram-positive bacteria. A. The 
architecture of ABC-type importers in Gram-positive bacteria. B. The proposed alternating access 
mechanism of transport for ABC-importers.  
 
1.3.3.    THE PROBIOTIC LACTOBACILLUS ACIDOPHILUS NCFM 
Lactobacillus acidophilus NCFM was isolated and from a human source [103] and is a 
probiotic with benefits to human health [104]. The probiotic characteristics of NCFM include, 
i) its ability to survive the GIT, ii) modulate host immune response, ii) maintain GIT 
microflora balance and iv) alleviation of lactose intolerance [104].  A lot of effort has been put 
into understanding the basis of NCFM probiotic effects on human health. The 2.0 Mb genome 
of NCFM encodes for 1864 proteins, including 39 glycoside hydrolases for carbohydrate 
utilization [105]. The carbohydrate utilization [70, 91, 106] , acid stress [107], and bile stress 
[108, 109]  of NCFM have been studied by transcriptomics.  
Prebiotic carbohydrates in combination with NCFM have shown to beneficially effect human 
health. Daily consumption of the combination of NCFM and lactitol by elderly volunteers has 
shown to increase stool frequency, fecal levels of NCFM and genus Bifidobacterium, and 
modulated fecal immune biomarkers, reflecting stimulation of intestinal mucosal functions 
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[110, 111]. Complementary beneficial effects with this synbiotic were also observed in a semi-
continuous colon fermentation model [112]. 
Previous studies on NCFM have been focused on gene inactivation studies and 
transcriptomics. Proteomics is an omics tool to investigate NCFM and its response to prebiotic 
carbohydrates at the protein level. During the past years a number of proteome 2-DE profiles 
were described for lactic acid bacteria  mostly related to changes associated with growth [113-
115], growth medium [116], and adaptations to the gut [117, 118]. However, only very few 
proteome reference maps were reported [113, 119, 120]. For example using narrow range pH 
windows of 4–7 and 4.5–5.5 a reference map of Lactococcus lactis IL14103 contained 230 
proteins, corresponding to 25% coverage of the predicted acidic proteome [120]. Proteome 
analysis of cytosolic proteins of L. plantarum WCFS1 at pH range 3−10 covered 3.3% of all 
genes [113]. Studies however are lacking with regards to NCFM proteome and the proteome 
adaptation to different carbohydrates abundant in the gut. 
 
1.3.4    THE PROBIOTIC BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04 
Bifidobacterium animalis subsp. lactis Bl-04 (also known as DGCC2908 and RB 4825) was 
originally isolated from a fecal sample from a healthy adult and is a widely used commercial 
probiotic bacteria. Bl-04 has a 1.9 Mb genome with a ~60% GC content, encoding 1655 
predicted ORFs of which 1072 has been annotated with a function [93]. The Bl-04genome 
contains 38 glycoside hydrolases (GH) divided into 16 GH families 
(http://www.cazy.org/b982.html).  However this is somewhat fewer than what has been 
observed in strains of B. longum and B. adolescentis,  (~50-70 GHs in 20–25 families) which 
also have larger genomes (2.0-2.5 Mb) [121]. The relatively small size of the B. animalis 
subsp. lactis Bl-04 genome compared to those of other bifidobacteria could indicate a genome 
simplification process that reduces biosynthetic capabilities and favors the retention and 
acquisition of genes involved in the utilization of nutrient sources in a specific nutritionally 
rich ecological niche [122, 123]. This could also explain the smaller number of GHs in Bl-04 
than in B. longum and B. adolescentis. Notably, the genes involved in the catabolism of human 
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milk oligosaccharides in B. longum subsp. infantis and in the degradation and utilization of 
mucin (endo-α-N-acetylgalactosaminidase) are not present in Bl-04 [93].  
Probiotic treatment with Bifidobacteria animalis subsp. lactis has been reported to reduce 
symptoms associated with irritable bowel syndrome [124, 125], activate immune system by 
increase the proportions of total, helper (CD4
+
) and activated (CD25
+
) T lymphocytes and 
natural killer cells [126, 127] and inhibit infection rates of the pathogen E.coli  O157:H7 
[128]. Recent studies with colon simulator models have shown that potential prebiotic 
carbohydrates (xylobiose, melibiose, raffinose and maltotriose) increased the numbers of Bl-
04 in the colon simulator. As a result the concentrations of acetate and butyric acid increased 
and the ratio of bacteriodes/firmicutes decreased, suggesting direct link between the activity of 
bifidobacteria to the composition of the gut microbiota [129].  
 
1.4    EXPERIMENTAL WORK INCLUDED IN THE PRESENT THESIS 
In this thesis, I have used two fundamentally different approaches to study the uptake and 
utilization of potential prebiotic carbohydrates by the probiotic bacteria Lactobacillus 
acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bl-04. First, 2-DE based 
proteomics approach was used to establish the reference proteomes of Lactobacillus 
acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bl-04. Next 2DE-DIGE was 
used to study the changes in proteome profiles during growth on different prebiotic 
carbohydrate carbon sources. Secondly, the biochemical protein characterization was carried 
out for an ABC-transporter associated solute binding protein (SBP) from Bifidobacterium 
animalis subsp. lactis Bl-04, to evaluate the binding and recognition of different 
xyloligosaccharides. The work carried out has been described in the following chapters. 
 
1.4.1    CHAPTER 2 
— describes the reference proteome (pH 4−7) of Lactobacillus acidophilus NCFM established 
using 2-DE. A total of 275 unique proteins assigned to various physiological processes were 
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identified from 650 spots. Differential 2-DE (DIGE) (pH 4−7) with the prebiotic lactitol, 
revealed proteome changes of NCFM with lactitol. 
 
1.4.2    CHAPTER 3 
— describes the reference proteome (pH 6−11) of Lactobacillus acidophilus NCFM 
established using 2-DE. A total of 102 unique proteins assigned to various physiological 
processes were identified from 202 spots.  
 
1.4.3    CHAPTER 4 
— describes the differential proteome (pH 4−7) of Lactobacillus acidophilus NCFM with the 
potential prebiotic raffinose using 2D-DIGE. Various proteins involved in the metabolism of 
raffinose including -galactosidase, sucrose phophorylase, maltose phosphorylase and -
galactosidase were identified. 
 
1.4.4    CHAPTER 5 
— describes the reference proteome (pH 3−7 and 3−10) of Bifidobacterium animalis subsp. 
lactis Bl-04 established using 2-DE. A total of 328 unique proteins assigned to various 
physiological processes were identified from 960 spots. Differential 2-DE (DIGE) (pH 4−7) 
with various prebiotics including, galactooligosaccharides, melibiose, raffinose family 
oligosaccharides and isomaltooligosaccharides, revealed various proteins involved in prebiotic 
metabolism. 
 
1.4.5    CHAPTER 6  
— describes the characterization of the SBP of the ABC transport system from the XOS 
operon of Bifidobacterium animalis subsp. lactis Bl-04 (BlXBP). BlXBP was produced and 
purified, its ligand preference and affinity determined and optimal affinity (Kd ~100 nM) for 
xylotetraose was found. The crystal structure of BlXBP in complex with xylotriose, 
xylotetraose and xylohexaose was determined, thus providing a structural rationale to the 
binding data and highlighting structural elements responsible for XOS recognition and 
capture.  
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Abstract 
Lactobacillus acidophilus NCFM is a probiotic bacterium adapted to survive in the 
gastrointestinal tract and with potential health benefits to the host. Lactitol is a synthetic sugar 
alcohol used as a sugar replacement in low calorie foods and selectively stimulating growth of 
L. acidophilus NCFM. In the present study the whole cell extract proteome of L. acidophilus 
NCFM grown on glucose until late exponential phase was resolved by two-dimensional gel 
electrophoresis (2-DE) (pH 3−7). A total of 275 unique proteins assigned to various 
physiological processes were identified from 650 spots. Differential 2-DE (DIGE) (pH 4−7) of 
L. acidophilus NCFM grown on glucose and lactitol, revealed 68 spots with modified relative 
intensity. Thirty-two unique proteins were identified in 41 of these spots changing 1.6−12.7 
fold in relative abundance by adaptation of L. acidophilus NCFM to growth on lactitol. These 
proteins included β-galactosidase small subunit, galactokinase, galactose-1-phosphate 
uridylyltransferase and UDP-glucose 4-epimerase, which all are potentially involved in lactitol 
metabolism. This first comprehensive proteome analysis of L. acidophilus NCFM provides 
insights into protein abundance changes elicited by the prebiotic lactitol. 
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Introduction 
Lactobacillus acidophilus NCFM (NCFM) is a well-documented probiotic [1] with a 2.0 Mb 
genome of low G+C content (34.7%) and encoding 1862 predicted ORFs 
(http://www.ncbi.nlm.nih.gov; NCBI:CP000033) [2], including several transport systems and 
37 glycoside hydrolases (GH) (http://www.cazy.org/) involved in uptake and utilization of 
carbohydrates [1, 3, 4]. NCFM has the capacity to adapt its metabolic machinery in response 
to the gut nutrient composition by negative transcriptional regulation. This metabolic 
flexibility ensures survival of NCFM in a low nutrient and highly competitive environment [5]. 
In addition, NCFM contains a suite of mucus binding proteins as an adaptation to survive in 
the GIT [6].  
Lactitol (4-O-β-D-galactopyranosyl-D-glucitol) is a synthetic sugar alcohol obtained from 
lactose and used as a prebiotic. It is not metabolized by humans due to lack of a suitable β-
galactosidase and is also not absorbed in the small intestine. Lactitol therefore becomes readily 
accessible to the microbiota in the colon [7] and has been shown to stimulate growth and 
metabolism of intestinal Bifidobacterium and Lactobacillus species, thus creating 
unfavourable conditions for pathogens such as Clostridia and Enterobacteriaceae [8]. Daily 
consumption of the synbiotic combination of NCFM and lactitol by elderly volunteers 
increased stool frequency, fecal levels of NCFM and genus Bifidobacterium, and modulated 
fecal immune biomarkers, reflecting stimulation of intestinal mucosal functions [9]. 
Complementary beneficial effects with this synbiotic were also observed in a semi-continuous 
colon fermentation model [10]. 
In the present work, a comprehensive whole cell extract reference proteome of NCFM grown 
with glucose as carbon source was established using 2D-gel electrophoresis (pH 3−7). This 
signature proteome with most proteins distributed in the pI 4−7 range was used for 
understanding the protein abundance dynamics associated with stimulation by the prebiotic 
lactitol. Comparative proteomics using 2D-DIGE (pH 4−7) coupled with mass spectrometric 
protein identification, revealed proteins involved in the lactitol metabolism.  
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Materials and Methods 
Growth Conditions and Protein Extraction 
Lactobacillus acidophilus NCFM (Danisco USA Inc., Madison, US-WI) was grown under 
aerobic conditions without agitation at 37 °C in 40 ml batch cultures in semisynthetic medium 
for lactic acid bacteria (LABSEM) [3] supplemented with 1% of either glucose or lactitol 
(Danisco) for soluble whole cell proteome (pI 3−7) and DIGE analyses. Cultures were sub-
cultured in the LABSEM for three cycles prior to analysis to avoid chemical carry-over effects. 
Late-log phase cells with an A600nm of 2.0 for glucose and 0.4 for lactitol (Supplementary Fig. 
1) were harvested from four independent cultures by centrifugation (3,200 g, 10 min, 4 °C). 
Cell pellets were washed twice with 0.9% NaCl, vacuum-dried without heating for approx. 2 h 
until dry (SpeedVac, Savant, SC110A with Vacuum unit UVS400A; GMI Inc., Ramsey, US-
MN) and kept at 80 °C until use. Cells were disrupted by manual mechanical grinding with a 
small number of acid washed glass beads (<100 μm diameter) using a rounded glass Pasteur 
pipette.   
 
Sample Preparation for 2-DE and DIGE  
Disrupted cells from 40 ml cultures were added 60 μl sample buffer (28 mM Tris-HCl, 22 mM 
Tris-base pH 8.5, 0.3% SDS, 100 mM DTT), heated (100 ºC, 2 min), and incubated at room 
temperature (5 min) followed by addition of 240 μl pharmalyte buffer (8 M urea, 2 M thiourea, 
100 mM DTT, 2% pharmalyte pH 4−7 (GE Healthcare, Uppsala, Sweden), 0.52% Triton X-
100). The mixture was vortexed, centrifuged (10,000 g, 10 min), and the supernatant was 
collected. Protein concentration of the supernatant was quantified (2D Quant kit; GE 
Healthcare) and the samples were stored at 80 °C. Whole cell extract proteome (400 μg 
protein) was added with rehydration buffer (8 M urea, 2 M thiourea, 2% CHAPS, 0.5% 
pharmalyte 4−7, 0.3% DTT) up to 450 μl and applied on IPG strips (linear pH 3−7; 24 cm). 
For DIGE analysis, dye-swapping approach was used to avoid bias due to the interference 
from gel fluorescence properties at different wavelengths [11]. Protein aliquots (50 μg) of each 
of four biological replicates grown on glucose or lactitol were labeled interchangeably with 
400 pmol of either Cy3 or Cy5, vortexed, and left in the dark (30 min, 4 °C). In a similar 
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manner, aliquots (25 μg protein) of each sample were combined for internal standard and 
labeled with 400 pmol Cy2. Labeling reactions were quenched by 1 μl 10 mM lysine in the 
dark (10 min). The internal standard and the samples were mixed and the volume was made to 
450 μl with rehydration buffer for IPG strips (linear pH 4−7, 24 cm). 
 
2-DE for Whole Cell Extract Proteome and Differential Proteomics  
Separation in the first dimension was performed using IPG strips (pH 3−7; 24 cm; GE 
Healthcare) on Ettan
TM
 IPGphor (GE Healthcare). The reference map showed few proteins of 
pI < 4, hence for DIGE pH 4−7 IPG strips were used. After rehydration at 20 °C for 12 h at 50 
μA/strip, IEF was performed at a total of 78 kVh (1 h at 150 V, 1 h at 300 V, 1 h at 1,000 V, 
gradient to 8,000 V, hold at 8,000 V until a total of at least 78 kVh was reached). 
Subsequently, strips were equilibrated (2  15 min) in 5 ml equilibration buffer (6 M urea, 30% 
glycerol, 50 mM Tris-HCl, pH 8.8, 2% SDS, 0.01% bromophenol blue) supplemented with 1% 
DTT and 2.5% iodoacetamide in the first and second equilibration step, respectively. The 
strips and molecular weight (Mr) markers (Mark 12
TM
, Invitrogen) were placed on 12.5% 
SDS-PAGE gels and overlaid with 0.5% molten agarose in 1  SDS running buffer (0.25 M 
Tris-base, 1.92 M glycine, 1% SDS). The second dimension (SDS-PAGE) was performed on 
Ettan
TM 
DALT twelve Electrophoresis Unit (GE Healthcare) overnight at 1 W/gel until the dye 
front reached the gel bottom. The proteome reference map gels (pH 3−7) were stained by 
colloidal CBB as described previously [12].  
 
Image Analysis 
Images of colloidal CBB stained gels were generated (Microtek scanner; Scan maker 9800XL; 
Microtek, Carson, USA) using Photoshop CS4 software and image analysis was done using the 
algorithm for blob images [13]. Imaging of DIGE gels (four biological replicates and four 
internal standard gels) was done immediately after the second dimension run at 
excitation/emission wavelengths of Cy2 (488/520 nm), Cy3 (532/580 nm) and Cy5 (633/670 
nm), respectively (100 μm resolution; Typhoon 9410 Variable Mode Imager; GE Healthcare, 
Uppsala, Sweden). Gel images were aligned by automated calculation of ten manually 
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assigned alignment landmark vectors (Progenesis SameSpots version 3.3, nonlinear Dynamics 
Ltd, Newcastle upon Tyne, UK). Scanned gels were analyzed by intra-gel (difference in-gel) 
and inter-gel (biological variance) analysis. A 1.5-fold threshold (spot volume ratio change 
and ANOVA p < 0.05 and a false discovery rate of q < 0.05) was chosen as criterion in the 
identification of differentially expressed protein candidates. The 1.5 fold threshold value used 
was based on the Power analysis, which has a recommended value of80%. Power analysis can 
be used to calculate the minimum sample size required to accept the outcome of a statistical 
test with a particular level of confidence [14]. The experimental set up had enough statistical 
power with the four replicate gels. False discovery rate estimates the number of false positives 
within statistically significant changes in the experiment [15]. The q value was set to < 0.05 
giving a false discovery rate of 5%. Gels were post-stained with colloidal CBB prior to spot 
protein identification.  
 
In-gel Digestion and Protein Identification by MS 
Spots on 2-DE reference map and DIGE gels were excised manually and subjected to in-gel 
tryptic digestion with modifications as described below [16]. Gel pieces were washed with 100 
μl 40% ethanol (10 min) followed by 50 μl 100% ACN, and incubated 45 min on ice with 2 μl 
12.5 ng μl-1 trypsin (Promega) in 25 mM ammonium bicarbonate followed by addition of 10 
μl 25 mM ammonium bicarbonate for rehydration, and incubated at 37 °C overnight. A 
supernatant aliquot (1 μl) was applied to the Anchor Chip target (Bruker-Daltonics, Bremen, 
Germany), covered by 1 μl matrix solution (0.5 μg μl-1 α-cyano-4-hydroxycinnamic acid in 90% 
ACN, 0.1% TFA) and washed in 0.02% TFA. MS and MS/MS spectra were obtained by 
Ultraflex II MALDI-TOF MS mass spectrometer (Bruker-Daltonics) in auto-mode using Flex 
Control v3.0 (Bruker-Daltonics) and processed by Flex Analysis v3.0 (Bruker-Daltonics). 
Peptide mass maps were acquired in reflectron mode with 500 laser shots per spectrum. 
Spectra were externally calibrated using a tryptic digest of β-lactoglobulin (5 pmol µl-1); 
MS/MS data were acquired with stop conditions so that 10001600 laser shots were 
accumulated for each spectrum. The MS together with MS/MS spectra were searched against 
the NCBInr database for bacteria (NCBInr 20090826; 9523564 sequences; 3256669569 
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residues) using the MASCOT 2.0 software (http://www.matrixscience.com) integrated 
together with BioTools v3.1 (Bruker-Daltonics). Search parameters were: monoisotopic 
peptide mass accuracy of 80 ppm, fragment mass accuracy to + 0.7 Da; maximum of one 
missed cleavage; carbamidomethylation of cysteine and partial oxidation of methionine. 
Filtering of peaks was done for known keratin and autocatalytic trypsin peaks; the signal to 
noise threshold ratio was set to 1:6. Protein identifications by PMF were confirmed with a 
Mascot score of 80, p < 0.05 and should have a minimum of 6 matched peptides. Single 
peptide based protein identifications by MS/MS analysis were confirmed with a Mascot score 
of 40, p < 0.05.  
 
Semiquantitative RT-PCR 
Total RNA from glucose and lactitol grown cultures was extracted using the Trizol (Invitrogen) 
method according to manufacturer’s instructions. RNA was purified by Pure link RNA mini 
kit with on-column DNase treatment to remove contaminating DNA. The primer pairs were 
designed using Primer3 software (http://frodo.wi.mit.edu/primer3/), 1 μg of total RNA was 
used as the template for reverse transcription of 9 selected genes with Omniscript reverse 
transcriptase by OneStep RT-PCR (Qiagen) according to manufacturer’s instructions.  PCR 
was carried out with the primer pairs (Supplementary Table 1) in a Thermal cycler (PTC-200 
Peltier Thermal Cycler, GMI Inc., Ramsey, US-MN) (50 °C for 30 min, 95 °C for 15 min,
 
followed by 22 three-step cycles of 94 °C for 1 min,
 
55 °C for 1 min and 72 °C for 1 min). 
NCFM 16S ribosomal DNA (rDNA) (LBA2001 and LBA2071) transcript whose expression is 
always constant, was used as internal control [17]. The absence of DNA contamination in the 
RNA preparation was confirmed according to the manufacturer’s instructions (Qiagen), by 
heat inactivation of Omniscript reverse transcriptase. The PCR products were detected by 2% 
agarose gel electrophoresis with ethidium bromide staining.   
In silico Analysis  
The codon-anticodon adaptation index (CAAI) of all ORFs of NCFM was obtained using 
DAMBE (http://dambe.bio.uottawa.ca/dambe.asp) [18] in two steps. Firstly CAAI values were 
created using the codon table based on tRNA anticodons frequency, without a reference set of 
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highly expressed genes. The CAAI values were then adjusted to a range of 01 [18]. GRAVY 
values were calculated using the ProtParam tool (http://www.expasy.ch/tools/protparam.html).  
 
Results 
Growth of NCFM on Glucose and Lactitol 
Detailed growth curves and pH profiles of NCFM grown with glucose or lactitol as 
carbohydrate source (Supplementary Fig. 1) showed higher cell density and larger decrease in 
pH of cultures with glucose as compared to lactitol. Proteome changes with the prebiotic was 
determined at late exponential phase cultures under controlled conditions, because this is the 
stage with maximum synthesis of macromolecules [19] and where accumulation of stress 
proteins is minimal. The growth phase significantly affects the proteome pattern and in the 
stationary phase, stress-sensing and stress-related proteins are produced due to depletion of 
nutrients [19-21].  
 
The Reference Map of the NCFM Proteome (pH 3−7)  
A reference map using whole cell extract of NCFM grown on LABSEM medium was 
established to identify constitutively expressed proteins and describe the dynamics of this 
proteome in response to carbohydrate prebiotics. Initially the wide range of pH 3−10 (linear; 
18 cm; data not shown) was used for separation in the first dimension to get an overview of 
the NCFM proteome distribution on the 2-DE. However, since the vast majority of spots 
clustered at pH 4−7, IEF in pH 3−7 was applied to optimize spot resolution in the densely 
populated area of the 2D-gel. Six hundred and fifty well-resolved spots were selected for 
identification from the CBB stained 2D-gel (Fig. 1), which led to 507 protein identifications 
using MALDI-TOF MS and/or MS/MS (Supplementary Tables 2 and 3). Several proteins 
appeared in more than one spot and in total 275 unique proteins were identified 
(Supplementary Tables 2 and 3). Only 16 of the 275 unique proteins have theoretical pI > 7.0; 
most of these were identified from spots shaped as horizontal streaks in the pH range 3−7 (Fig. 
1). Proteins present in more than one spot showing pI and Mr heterogeneity were probably 
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post-translationally modified (PTM) or found as highly similar isoforms. Isoelectric 
heterogeneity in 2-DE is very common in proteomics [19, 22-24] and has been attributed to 
PTM or to artifacts, e.g. carbamylation by urea or deamidation [22]. Carbamylation generally 
leads to spot charge trains, not observed on the NCFM 2-DE (Fig. 1 and 4A) and the multiple 
protein forms probably stem from PTM.  
 
In silico Analysis and the Experimental Proteome  
The NCFM in silico proteome generated using the bioinformatics tool JVirGel version 2 
(http://www.jvirgel.de/) contains 705 intracellular proteins of pI 3−7 and Mr 5−200 kDa. The 
259 identified proteins (pI 3−7 range) thus constitute 36% of the theoretical proteome. 
Grouping the identified proteins according to functionality using Gene Role Category 
annotation (http://cmr.jcvi.org/tigr-scripts/CMR/CmrHomePage.cgi) (Fig. 2; Supplementary 
Tables 2 and 3) showed the majority are important in protein synthesis and energy metabolism. 
The cellular localization was predicted using PSORT version 3.0 (http://www.psort.org/) 
(Supplementary Tables 2 and 3), which indicated that 218 of the 275 identified proteins were 
cytoplasmic, 10 belonged to the cytoplasmic membrane, 2 were extracellular, 2 were 
associated with cell wall formation, and 43 had unknown cellular localization.  
One of the limitations of 2D-gel based proteomics is poor detection of low abundance proteins. 
The theoretical abundance of proteins on 2D-gels can be calculated using the codon-anticodon 
adaptive index (CAAI), which is based on the codon usage bias and the relative frequencies of 
tRNA anticodons [18].  CAAI is an indicator of translation efficiency used to predict gene 
expression levels in bacteria. Several recent reference proteomes used CAAI analyses to 
assess the genome with respect to translation efficiency [21, 21, 25, 26]. The relative protein 
abundance in L. acidophilus NCFM on 2D-gels (pH 37) correlated with CAAI (Fig. 1 and 
3A), proteins with low copy numbers being hard to identify. CAAI for proteins from the most 
intensely stained spots, e.g. elongation factor Tu (EF-Tu) (spot 140, 147, 215), L-LDH (spot 
261, 299, 290), glyceraldehyde-3-p dehydrogenase (spot 230, 232, 210), pyruvate kinase (spot 
46, 50, 60) and phosphopyruvate hydratase (spot 169, 166, 140) have value in the 0.5810.69 
range. Noticeably, among 23 proteins in the theoretical proteome with CAAI < 0.2, indicating 
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low abundance, 10 were identified from the 2D-gel. The GRAVY index for hydrophobicity of 
all NCFM coding sequences were calculated (Fig. 3B) and proteins identified from the 2D-gel 
have values from 0.179 to -1.244 (Fig. 3B). Only 18 identified proteins have a GRAVY value > 
0, and hydrophobic proteins with values > 0.2 were not identified due to loss during sample 
preparation and / or electrophoresis. The present percentage of hydrophobic proteins identified 
on the 2D-gel is similar to the previous reference proteomes of bacteria [21, 26]. 
 
Identification of Differentially Abundant Proteins with NCFM Grown on Lactitol  
Proteome changes of NCFM elicited by growth on lactitol compared to glucose 
(Supplementary Fig. 1) were identified using 2D-DIGE. The predicted cytosolic proteome has 
a total of 17 proteins of pI <  4.0, but only one, DNA-directed RNA polymerase subunit delta 
(LBA0232) (spot 463), was identified on the reference 2D-gel (Supplementary Table 2). DIGE 
was therefore performed at pI 47 to obtain better spot resolution. A total of 68 spots changed > 
1.5-fold in relative abundance. Forty-one identified spots representing, 32 unique proteins 
were differentially abundant in response to lactitol (Table 1), with 25 up-regulated (1.612.7 
fold) and 16 down-regulated (1.64.8 fold) proteins/protein forms (Fig. 4A; Table 1). Certain 
proteins such as galactokinase (spot 628, 629), mannose-6-phosphate isomerase (spot 630), 
fructokinase (spot 637) and deoxyadenosine kinase (spot 634), were identified from the DIGE 
experiment (Fig. 4A), but absent in the reference 2D-map. As further discussed below, 
proteins of the Leloir pathway; β-galactosidase small subunit; galactokinase; galactose-1-
phosphate uridylyltransferase; and UDP-glucose 4-epimerase were abundant by a significant 
fold (4.512.7 fold) (Fig. 4A). 
 
Validation of Differentially Abundant Proteins by Semiquantitative RT-PCR  
To confirm the differential abundance of proteins found by DIGE, semiquantitative RT-PCR 
was carried out for 7 gene transcripts of the Leloir pathway; β-galactosidase large subunit; β-
galactosidase small subunit; galactokinase; galactose-1-phosphate uridylyltransferase; lactose 
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permease, phosphoglucomutase and fructokinase. The results showed different expression 
patterns with glucose and lactitol consistent with the 2D-DIGE analysis (Fig. 4B).  
 
Discussion  
The Reference Map of the Soluble NCFM Proteome  
During the past years a number of proteome 2-DE profiles were described for lactic acid 
bacteria (LAB) [27] mostly related to changes associated with growth [19, 20, 24], growth 
medium [28], and adaptations to the gut [29, 30]. However, very few proteome reference maps 
were reported [19, 25, 31]. For example using narrow range pH windows of 4–7 and 4.5–5.5 a 
reference map of Lactococcus lactis IL14103 contained 230 proteins, corresponding to 25% 
coverage of the predicted acidic proteome [25]. Proteome analysis of cytosolic proteins of L. 
plantarum WCFS1 at pH range 3−10 covered 3.3% of all genes [19]. The present 275 unique 
proteins identified in the NCFM proteome, comprising 259 proteins of pI 37 and 16 proteins 
with pI > 7, constitute approximately 15% coverage of the theoretical proteome and 36% of 
the predicted intracellular acidic proteome. Proteome coverage was 3.321.4% in proteome 
studies of other Gram-positive bacteria [19, 21, 25, 26].  
The present proteome analysis used late exponential phase NCFM cultures to focus on 
enzymes associated with carbon metabolism and to avoid accumulation of stress proteins. 
Proteins associated with protein synthesis were dominated by components of the translational 
machinery, while proteins related to energy metabolism were dominated by enzymes of the 
glycolysis/gluconeogenesis. The current proteomics data complements an earlier 
transcriptome analysis of global gene expression patterns of NCFM grown on 8 different 
carbohydrate sources with glycolysis genes being consistently highly expressed [5].  
 
Differential Proteomics of NCFM in the Presence of Glucose and Lactitol 
Genome annotation showed that NCFM possesses transporter and fermentative capability to 
survive in the GIT and has the capacity of versatile utilization of an array of carbohydrate 
sources. The carbon flux in the metabolism of low G+C Gram-positive bacteria is tightly 
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regulated by carbon catabolite repression (CCR) [32], thus in the presence of glucose, genes 
not needed for growth with glucose are repressed. The regulation of the repression is brought 
upon by transcriptional control or regulation at the protein level by phosphorylation [32]. The 
present DIGE data show that abundant enzymes apparently responsible for utilization of 
lactitol are essentially identical to the metabolic machinery for utilization of lactose, i.e. the 
Leloir pathway. As will be further discussed below, it offers a view of how the physiology of 
NCFM adapts to lactitol and its hydrolysis products galactose and glucitol/sorbitol. 
 
Galactose Metabolism in NCFM 
Lactose has to be hydrolyzed either by a phospho-β-galactosidase (LacG), generating glucose 
and galactose-6-P, or by a β-galactosidase (LacZ or LacLM) to glucose and galactose [33]. In 
this context, β-galactosidase small subunit (LacM, LBA1468) was highly abundant (12.7 fold) 
on lactitol. The heterodimeric β-galactosidase (LacLM) belongs to GH2 (CAZy; 
http://www.cazy.org/); only the small, not the large subunit, was identified on the gel. 
Similarly, most enzymes for galactose metabolism were identified on 2D-gels of L. lactis 
grown on lactose, but not the β-galactosidase [25]. The other highly abundant proteins 
(4.55.0 fold) include galactokinase, galactose-1-phosphate uridylyltransferase and UDP-
glucose 4-epimerase from the Leloir pathway (Fig. 4B, 5). Galactose-1-P generated by ATP 
dependent galactokinase is transferred to UDP-glucose by galactose-1-phosphate 
uridylyltransferase in exchange with glucose-1-P. UDP-glucose 4-epimerase converts the 
generated UDP-galactose to UDP-glucose, which enters the glycolysis after phosphorylation 
to glucose-6-P by phosphoglucomutase, which was also abundant by 1.6 fold (Fig. 5, Table 1).  
The genes for lactose and galactose metabolism are distributed in two adjacent loci 
LBA1457−1459 and LBA1462−1469 in NCFM. In LAB the organization of lac and gal 
clusters can vary significantly, possessing or lacking operon-like structures and genes 
interspersed with insertion sequences [34]. The presence of lactose permease belonging to the 
glycoside-pentoside-hexuronide:cation symporter family, and the enzymes of the Leloir 
pathway suggests lactitol is transported into NCFM by lactose permease, rather than by a PEP-
PTS system [35]. The RT-PCR analysis confirms the clear up-regulation of lacS in lactitol 
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compared to glucose (Fig. 4B). These results complement previous extensive transcriptomic 
studies of NCFM grown on different carbohydrates [3, 5]. In the transcriptomic study with 
lactose and galactose, 10 different genes within the lac and gal loci were shown to be 
significantly up-regulated, galKTME being increased 2.717.6 fold, and lacSZL 2.829.5 fold 
[5]. The lac-gal locus region has two β-galactosidase genes lacZ (LBA1462) and lacLM 
(LBA1467-68) of GH42 and GH2 families, respectively. The lacZ gene was significantly 
overexpressed in an earlier transcriptome study [5]. The two β-galactosidases, were not 
identified in the present 2-DE, except for the small subunit of β-galactosidase (LacM). It was 
not possible to conclude from the proteome analysis which of the two β-galactosidases acts on 
lactitol, but the large subunit of β-galactosidase (lacL) was found to be highly expressed by 
semiquantitative RT-PCR (Fig. 4B). 
 
Sorbitol Metabolism in NCFM 
The DIGE analysis showed various enzymes involved in glucitol/sorbitol metabolism to be 
differentially abundant (1.7 to 4.3 fold; Table 1, Fig. 5). Sorbitol in NCFM is metabolized to 
fructose-6-P, ultimately leading to either glycolysis or fructose and mannose metabolism, 
according to the KEGG pathway (Kyoto Encyclopedia of Genes and Genomes; 
www.genome.ad.jp/kegg) [36]. Sorbitol has been described as a carbon source for certain 
Gram-positive bacteria, including LAB and enzymes for sorbitol metabolism are encoded by 
an operon-like structure and subject to catabolite repression by glucose in Gram-positive 
bacteria [37, 38]. This kind of organization for sorbitol utilization was not identified in the 
NCFM genome. The phosphotransferase system enzyme II (PTS EII, LBA0655) based on its 
conserved domains belongs to the class of PEP-PTS specific for glucitol 
(http://pfam.sanger.ac.uk/) [39]. The PTS components are involved in the phosphorylation of 
carbohydrate by the histidine-containing phosphocarrier protein (HPr). HPr is in turn 
phosphorylated by the PEP system or by ATP-dependent auto-phosphorylation [32]. PTS EII 
(LBA0655), phosphorylating glucitol to glucitol-6-phosphate, was abundant by 1.7 fold (Fig. 
5), and the two oxidoreductases (LBA1023 and LBA1027) were abundant by 2.9 and 3.9 fold, 
respectively. Oxidoreductase (LBA1023 and LBA1027) may be involved in the 
interconversion of D-glucitol-6-P to L-sorbose-1-P, and maintain the concentrations of 
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glucitol-6-P (KEGG). Glucitol-6-P has to be converted to β-D-fructose-6-P by 6-
phosphogluconate dehydrogenase, which was not identified by DIGE (Fig. 5). β-D-Fructose-6-
P is the central metabolite that can either enter glycolysis, amino sugar metabolism, or be 
converted to other carbohydrate metabolites. The other significantly differentially abundant 
enzymes were mannose-6-phosphate isomerase and fructokinase, which increased by 4.3 and 
2.4 fold, respectively. The β-D-fructose-6-P generated by sorbitol catabolism may thus enter 
either fructose or mannose metabolism or it enters glycolysis after being converted to β-D-
fructose-1, 6-bis-P by phosphofructokinase. Fructose-bisphosphate aldolase decreased (2.2 
fold) and there was an increase of glyceraldehyde-3-p dehydrogenase (2.2 fold) and 
dihydroxyacetone kinase (2.8 fold) (Table 1), which might channel all β-D-fructose-1, 6-bis-P 
into glycolysis. 
 
Carbon Catabolite Repression (CCR) and the Enzymes of Glycolysis 
In low G+C Gram-positive bacteria, PTS protein and HPr are the master regulators of carbon 
flow and metabolism. The phosphorylation and dephosphorylation of these proteins control 
the carbon metabolism via CCR [32, 40]. The CCR regulatory network in NCFM was also 
observed by microarray data with the presence of a flexible transcriptome controlled by CCR 
[5]. The key gene products involved in the regulation, i.e. catabolite control protein A (CcpA), 
HPr, HPrK/P, and PTS, were consistently highly abundant in the NCFM transcriptome, which 
suggested the regulation to occur at the protein rather than the transcriptional level [5]. PTS 
phosphotransferase activity and the phosphoenolpyruvate-to-pyruvate ratio regulates the 
concentrations of metabolites like fructose-1, 6-bis-P, ATP, PPi and Pi, which in turn control 
the HPr kinase activity [32, 41, 42]. Various enzymes indicating the regulation in the presence 
of lactitol were identified by DIGE analysis. In Streptococcus sp. transport of lactose via 
lactose permease containing the IIA domain was found to be regulated at the protein level by 
different HPr forms [43]. A similar mechanism is possible in NCFM owing to the absence of 
other transporters for lactose and the presence of a highly homologous lactose permease with 
IIA domain. The cellular concentration of pyruvate kinase, which has control over the 
phosphoenolpyruvate-to-pyruvate ratio, was 1.9 fold abundant, which indicates CCR. Lactate 
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dehydrogenase converts the generated pyruvate to lactate and noticeably, of two different 
NCFM lactate dehydrogenase forms, one increased in 3.1 fold abundance and the other 
decreased by 4.8 fold (Table 1). 
In Gram-positive bacteria when readily metabolized carbohydrate is available as energy 
source, the intracellular concentration of fructose-1, 6-bis-P increases and the concentrations 
of ATP and Pi decrease, while the opposite is true for unfavorable carbohydrate sources [32]. 
The presence of abundant enzymes for the intermediary metabolite β-D-fructose-6-P to 
fructose and mannose metabolism, abundant enzymes glyceraldehyde-3-p dehydrogenase (2.3 
fold), dihydroxyacetone kinase (2.8 fold) and a lower fructose-bisphosphate aldolase (2.2 fold) 
indicates β-D-fructose-6-P being converted to fructose, mannose or glyceraldehyde-3-p. This 
might lead to lowered concentrations of fructose-1, 6-bis-P, and therefore a complete switch in 
the metabolic machinery (35).  
More recently, glycolytic enzymes from low G+C bacteria have been ascribed multiple roles 
like mucus adhesion [30], mRNA processing [44] and interactions with key regulatory 
proteins. These proteins are often overlooked as housekeeping genes in proteome studies, but 
changes in their abundance may have significant effects on the metabolic pathways. Glucose-
6-phosphate 1-dehydrogenase, which is very important in maintaining the redox potential of 
the cell by generating NADPH, was found to be 1.6 fold lower in abundance, and 
phosphoglucomutase, which maintains a balance between the glucose-6-P and glucose-1-P, 
was found to be more abundant by 1.6 fold. Glucose-6-P is the metabolite that enters the 
glycolysis, and lower abundance of glucose-6-phosphate 1-dehydrogenase and higher 
abundance of phosphoglucomutase may lead to accumulation of glucose-1-P.  
 
Variation of Abundance in other Proteins Elicited by Lactitol 
The other differentially abundant proteins include elongation factor Tu (EF-Tu), putative 
stress-related phosphate starvation inducible protein both involved in protein synthesis 
(http://cmr.jcvi.org/tigr-scripts/CMR/CmrHomePage.cgi) Along with its function in protein 
translation, EF-Tu has been reported to have a role in other cellular processes, including acting 
as chaperone and protein folding in E. coli [45]. In several LAB, EF-Tu was localized to the 
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cell wall and described as a ‘moonlighting protein’, i.e. a protein which has multiple, 
apparently unrelated functions in different cell locations [46]. EF-Tu was moreover suggested 
to participate in intestinal cell adhesion [30, 46-48] and its 2.6 fold increase may be connected 
to the higher number of NCFM in the GIT during lactitol administration [9]. The proposed 
involvement of EF-Tu in intestinal adhesion of bacteria agrees with its increased abundance 
by lactitol. This effect presents a novel putative mechanism for synbiotic interactions between 
probiotics and specific prebiotics.  
At harvest pH of glucose and lactitol cultures was 5.2 and 6.3, respectively and the difference 
is due to higher growth rates in glucose and increased production of lactic acid. F0F1 ATP 
synthase subunit gamma was 1.8 fold higher in glucose compared to the lactitol grown 
cultures (Table 1). The increased abundance of F0F1 ATP synthase subunit gamma is due to its 
role in maintaining the proton motive force at lower pH [49]. Also the 1.9 fold increase of 
chaperonin GroEL in NCFM grown on glucose may be attributed to the low pH (Table 1). 
Chaperonin GroEL was reported to be induced as acid stress response in L. acidophilus [49], 
Lactococcus lactis and Enterococcus faecalis, which are all Gram-positive LAB [27]. 
Several NCFM proteins lowered in abundance in the presence of lactitol, including 
ribonucleoside triphosphate reductase, deoxyadenosine kinase, inosine-5′-monophosphate 
dehydrogenase, adenylosuccinate synthase, trigger factor, and citrate lyase -chain, most of 
which are involved in nucleotide metabolism. L. lactis grown on lactose showed a similar 
down-regulation of pyrimidine-regulated enzymes [25]. The catabolism of galactose-1-P to 
glucose-1-P, a process involving UDP-glucose and UDP-galactose and the enzymes UDP-
glucose-4-epimerase and galactose-1-phosphate uridylyltransferase, has been suggested to 
participate in the lower abundance of pyrimidine enzymes [25], and a similar physiological 
response may occur with lactitol. 
 
Concluding Remarks 
The present reference soluble whole cell extract proteome (pH 3−7) for L. acidophilus NCFM 
is the most comprehensive analysis for a probiotic bacterium to date. A dynamic view of the 
proteome at the late exponential phase of NCFM grown on lactitol as sole carbon source 
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provides insights into probiotic-prebiotic interactions, which are essential for understanding 
how a prebiotic source can benefit a probiotic strain and lead to selective stimulation of its 
growth. L. acidophilus NCFM has the capacity to metabolize the carbohydrate moieties 
generated from lactitol. Galactose thus likely enters the Leloir pathway, while glucitol is 
metabolized by a PTS-II component. Other proteins showing differential abundance in lactitol 
were indirectly involved in the CCR. Finally, lactitol increases EF-Tu that can participate in 
adhesion processes, which presumably constitute an important consequence of intake of the 
synbiotic combination of NCFM and lactitol.  
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Figure Legends 
 
Fig. 1.  A detailed 2-DE of the 400 µg whole cell extract soluble proteins (pH 3−7) of 
Lactobacillus acidophilus NCFM grown on LABSEM with 1% glucose. Numbered 
spots are chosen for analysis by in-gel digestion and mass spectrometry.   
Fig. 2. Functional grouping of the 275 identified unique proteins on the 2-DE (pH 37) of 
Lactobacillus acidophilus NCFM. 
Fig. 3 A. CAAI distribution of 1862 ORFs of Lactobacillus acidophilus NCFM (black bars) 
and of the 275 genes encoding proteins identified on 2-DE (pH 37) (open bars). B. 
GRAVY distribution of 1862 ORFs of Lactobacillus acidophilus NCFM (black bars) 
and of the 275 genes encoding proteins identified on 2-DE (pH 37) (open bars). 
Fig. 4 A. Representative 2D-DIGE images of whole cell extract soluble proteins of 
Lactobacillus acidophilus NCFM grown on glucose (Cy3 green) and lactitol (Cy5 red) 
and the corresponding gray scale image of the CBB stained gel. The numbers on the 
gel indicate spots picked for identification by mass spectrometry. B. The 
semiquantitative RT-PCR amplified fragments of selected genes of Lactobacillus 
acidophilus NCFM grown on SEM medium with 1% glucose and 1% lactitol. The 
expression of 16S rDNA was used as an internal control. LacM, β-galactosidase small 
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subunit; GalK, galactose kinase; GalT, galactose-1-phosphate uridylyltransferase; 
PGM, phosphoglucomutase; FK, fructokinase; LacL, β-galactosidase large subunit; 
LacS, lactose permease.  
Fig. 5. Schematic representation of the proposed proteins involved in lactitol metabolism. The 
proteins shaded in grey were identified by 2D-DIGE and MS, while the proteins in 
white were hypothesized to be involved in the metabolism of lactitol. Blue arrows by 
their orientation show differentially abundant proteins. Dashed red arrow shows 
proteins and metabolites involved in CCR. LacS, lactose permease; LacL, β-
galactosidase large subunit; LacM, β-galactosidase small subunit; GalK, galactose 
kinase; GalT, galactose-1-phosphate uridylyltransferase; GalE, UDP-glucose-4-
epimerase; PGM, phosphoglucomutase; FK, fructokinase; MPI, mannose-6-p-
isomerase; PTSII, phosphotransferase component specific for glucitol; PGD, 6-
phosphogluconate dehydrogenase; PFK, phosphofructokinase; FBA; fructose-
bisphosphate aldolase; GAPDH; glyceraldehyde-3-p dehydrogenase; DHAK; 
dihydroxyacetone kinase; PK; pyruvate kinase; EI; enzyme I; HPr; histidine-containing 
phosphocarrier protein; HPrK/P; HPr kinase/phosphorylase. Black dashed arrow 
indicates the entry of glyceraldehyde-3-P into glycolysis 
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Table 1: Protein identifications of differentially abundant spots (> 1.5-fold spot volume ratio 
change and ANOVA P < 0.05) of Lactobacillus acidophilus NCFM grown on SEM 
medium with 1% glucose and 1% lactitol. Protein identifications were confirmed with a 
Mascot score of 80 for peptide mass fingerprint and ANOVA p < 0.05, and a minimum 
of 6 matched peptides 
Spot 
Accesion 
number 
          Protein description Score 
Sequence 
coverage     
    % 
Peptides 
matched / 
searched 
MW/pI 
Fold 
change 
254 gi|58337734 beta-galactosidase small subunit 124 38 10/45 35966/ 5.53 +12.7 
628 gi|58337726 galactokinase 100 37 12/56 43521/4.74 +5.0 
29 gi|58337725 galactose-1-phosphate uridylyltransferase 146 43 20/68 55735/5.48 +4.8 
311 gi|58336405 D-lactate dehydrogenase 135 38 13/34 39177/4.96 -4.8 
255 gi|58337735 UDP-glucose 4-epimerase 163 37 14/36 36458/5.95 +4.7 
457 gi|58336994 
phosphate starvation inducible protein 
stressrelated 
113 48 12/71 21503/5.46 +4.4 
630 gi|58337059 mannose-6-phosphate isomerase 98 37 11/48 36677/6.03 +4.3 
458 gi|58336994 
phosphate starvation inducible protein 
stressrelated 
130 63 15/77 21503/5.46 +4.2 
631 Mixture      +3.9 
 gi|58337735 UDP-glucose 4-epimerase 235 76 25/92 36458/5.95  
 gi|58336950 
UTP-glucose-1-phosphate 
uridylyltransferase 
118 57 15/92 33875/5.90  
632 gi|58337322 oxidoreductase 124 42 13/63 31816/5.19 +3.9 
211 gi|58336405 D-lactate dehydrogenase 141 50 18/67 39177/4.96 +3.3 
633 gi|58337735 UDP-glucose 4-epimerase 303 83 30/85 36458/5.95 +3.1 
623 gi|58337488 hypothetical protein LBA1206 170 42 12/42 31352/5.15 +3.1 
16 gi|58336392 ribonucleoside triphosphate reductase 289 46 33/73 83982/5.62 +2.9 
634 gi|58338190 deoxyadenosine kinase 79 30 7/44 24765/5.70 -2.9 
635 gi|58336733 putative oxalyl-CoA decarboxylase 228 42 25/71 60969/5.03 -2.9 
213 gi|58337704 dihydroxyacetone kinase 110 36 12/44 36307/5.16 -2.9 
636 gi|58336994 
phosphate starvation inducible protein 
stressrelated 
79 33 7/24 21503/5.46 +2.8 
436 gi|58337318 oxidoreductase 104 49 9/23 23070/5.78 +2.6 
140 gi|58337152 elongation factor Tu 176 50 19/68 43609/4.97 +2.6 
637 gi|58336369 fructokinase 161 50 17/45 32016/5.08 +2.4 
232 gi|58337019 glyceraldehyde-3-p dehydrogenase 138 37 12/35 36643/5.92 +2.3 
321 gi|58337860 fructose-bisphosphate aldolase 206 65 21/85 33560/4.94 -2.2 
114 gi|58336560 
UDP-N-acetylglucosamine 
pyrophosphorylase 
100 30 13/46 50162/5.57 -2.2 
195 gi|58336608 ala racemase 81 29 10/39 41801/6.02 +2.1 
295 gi|58337322 oxidoreductase 116 44 12/50 31816/5.19 +2.1 
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50 gi|58337255 pyruvate kinase 233 38 29/79 63136/5.23 +1.9 
15 gi|58336392 ribonucleoside triphosphate reductase 91 13 10/26 83982/5.62 -1.9 
638 gi|58336743 chaperonin GroEL 167 45 15/97 57785/4.98 -1.9 
280 gi|58337019 glyceraldehyde-3-p dehydrogenase 239 76 24/97 36643/5.92 +1.8 
256 gi|58337089 F0F1 ATP synthase subunit gamma 136 42 18/73 35512/5.93 -1.8 
130 gi|58336600 serine hydroxymethyl transferase 112 26 12/44 45276/5.56 -1.8 
91 gi|58337153 trigger factor 93 34 17/90 49275/4.72 -1.7 
546 gi|58336978 phosphotransferase system enzyme II 105 55 9/38 13904/4.84 +1.7 
84 gi|58337008 phosphoglucomutase 186 47 26/100 64122/5.18 +1.6 
204 gi|58336540 inosine-5' monophosphate dehydrogenase 247 63 24/96 39816/5.75 -1.6 
115 gi|58336750 glucose-6-P 1-dehydrogenase 157 39 17/43 55824/5.57 -1.6 
75 gi|58337220 citrate lyase alpha chain 116 29 13/36 55315/5.53 -1.6 
108 gi|58338136 adenylosuccinate synthetase 157 51 21/82 47851/5.38 -1.6 
131 gi|58338136 adenylosuccinate synthetase 185 55 23/95 47851/5.38 -1.6 
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Fig. 2.  
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Fig. 3A. 
 
 
Fig. 3B.  
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Fig. 4A.  
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Fig. 4B. 
  
 
 
 
 
 
 
 
 
 
 
LacM
GalK
GalT
PGM
FK
LacL
LacS
16S rDNA (LBA2071)
16S rDNA (LBA2001)
Glucose
Glucose
Lactitol
Glucose
Lactitol
Lactitol
  
75 
 
Fig. 5.  
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Abstract 
Lactobacillus acidophilus NCFM (NCFM) is a well documented probiotic bacterium isolated 
from human gut. Detailed 2D-gel based NCFM proteomics addressed the so-called alkaline 
range, i.e. pH 6−11. Proteins were identified in 150 of the 202 spots picked from the 
Coomassie brilliant blue stained 2D-gel using MALDI-TOF-MS. The 102 unique gene 
products among the 150 protein identifications were assigned to different functional categories, 
and evaluated by considering a calculated distribution of abundance as well as GRAVY values. 
None of the very few available lactic acid bacteria proteome reference maps available 
included the range of pI > 7.0. The present report of such data on the proteome of NCFM 
fundamentally complements current knowledge on protein profiles limited to the acid and 
neutral pH range.  
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Lactobacillus acidophilus NCFM (NCFM) is a well documented probiotic Gram-positive, 
homo-fermentative bacterium isolated from a human source [1]. While, the carbohydrate 
utilization and bile stress tolerance of NCFM have been studied previously by transcriptomics 
[2, 3], gel-based proteomics was applied to gain insights into physiological processes (see [4] 
for a review). Thus various proteome analyses of lactic acid bacteria (LAB) address 
physiological changes associated with e.g. growth [5], culture medium composition [6] and 
adaptation to the intestinal environment [7]. A shortcoming of gel-based proteomics per se 
that also applies to LAB, stems from that only a sub-set of the soluble proteome is described at 
pI 3−7. Technical challenges associated with IEF at pH > 7 include migration of DTT causing 
streaky 2-DE patterns and the electro endosmosis that perturbs the steady-state position of the 
proteins [8]. Sample application strategies like cup loading and paper bridge loading have 
been reported to improve analysis of alkaline proteomes [9]. Thus, bacterial alkaline 
proteomes have been established for e.g.  Bacillus subtilis by using cup-loading [10], by 
enrichment using acid incubation of the Escherichia coli alkaline proteome [11], by cup-
loading in case of Lactococcus lactis [12], and by paper-bridge sample loading for 
Trypanosoma cruzi [13]. 
The NCFM genome encompasses a total of 1862 open reading frames (ORFs) 
(http://www.ncbi.nlm.nih.gov; NCBI: CP000033) and gives a characteristic bimodal 
distribution of the pI values which for 1104 proteins are predicted to pI > 7.0. The goal of the 
present study is to establish an NCFM proteome reference map for the alkaline region. The 
whole cell protein extract from the late-log phase of NCFM grown in semi-defined media 
(SEM) was cup-loaded onto IPG strips of pH 6−11. In-gel protein digestion and MALDI-TOF 
MS for 202 CBB stained spots resulted in 150 identifications that provide the first overview of 
an alkaline proteome from Lactobacillus sp.  
NCFM (Danisco USA Inc., Madison, WI, USA) was grown (in triplicate) under aerobic 
conditions without agitation at 37 °C in 40 mL batch culture in SEM for LAB [14] 
supplemented with 1% glucose as carbon source. The cells were harvested at late-log phase 
(A600 of 2.0) by centrifugation (3,200 g, 10 min, 4 °C), and washed twice with 0.9% NaCl. The 
cell pellet was added an approximately equal volume of acid washed glass beads (<100 μm 
diameter; Sigma, Brøndby, Denmark) followed by 300 μL phenol (Tris saturated pH 8.0) and 
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300 μL 10 mM Tris, 10 mM DTT (pH 8.0). Disruption was carried out (Bio 101 Savant 
FastPrep FP 120 bead beater, Savant, Farmingdale, USA) at a speed of 6.5 m/s for four cycles 
of 45 s each with intermittent cooling on ice. The cell lysate was centrifuged (10,000 g, 10 min, 
4 ºC) resulting in three distinct phases. The phenol phase was transferred to a microtube, 
added ice-cold ethanol (four volumes), kept at −20 ºC overnight and centrifuged (15,000 g, 10 
min, 4 ºC). The resulting precipitate was dissolved in 300 μl rehydration buffer (7 M urea, 2 M 
thiourea, 48 mM CHAPS, 200 mM bis(2-hydroxyethyl) disulfide (HED), 5% glycerol, 10% 2-
propanol, and 2% pharmalyte pH 6−11 (GE Life Sciences, Uppsala, Sweden)). The protein 
concentration was determined (2D Quant kit; GE Healthcare) and the samples kept at −80 °C 
until use. 
IPG strips (pH 6−11, 18 cm; GE Life Sciences), were passively rehydrated (340 μL 
rehydration buffer) overnight (Immobiline DryStrip Reswelling Tray) at room temperature. 
Proteins (350 μg) from whole cell extract in 100 μL rehydration buffer were applied using 
cup-loading (Cup Loading Manifold; GE Life Sciences) according to the manufacturer’s 
instructions and IEF was performed at 30 V for 10 min, 150 V for 2 h, 1000 V for 30 min, 
gradient to 8000 V for 4 h, and kept at 8000 V to a total of 31 kVh. 
Subsequently, strips were equilibrated in two steps of 15 min with 5 mL equilibration buffer (6 
M urea, 30% glycerol, 50 mM Tris-HCl, pH 8.8, 2% SDS, 0.01% bromophenol blue) 
supplemented with 1% DTT and 2.5% iodoacetamide, respectively. The second dimension 
(SDS-PAGE; Ettan
TM
 DALT six Electrophoresis Unit; GE Life Sciences) was run at 1 W/gel 
for 1 h followed by 12 W/gel until the dye front reached the gel bottom and stained by 
colloidal CBB [15]. Images of the gels were generated (Microtek scanner; Scan maker 
9800XL; Microtek, Carson, USA) using Photoshop CS4 software and image analysis was 
done using the algorithm for blob images [16]. The 202 gel spots consistently present (three 
biological and two technical replicates) were manually excised from a master gel (Fig. 1) and 
subjected to in-gel digestion by trypsin as described [17]. Aliquots (1 μL) of the trypsin spot-
digests were applied to the Anchor Chip target plate (Bruker-Daltonics, Bremen, Germany), 
covered by 1 μL matrix solution (0.5 μg μL-1 CHCA in 90% ACN, 0.1% TFA) and washed in 
0.02% TFA. MS and MS/MS spectra were obtained in auto-mode (Ultraflex II MALDI-TOF 
MS mass spectrometer; Bruker-Daltonics) operating in a result-dependent acquisition mode. 
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Peptide mass maps were acquired in reflectron mode with 500 laser shots per spectrum. 
Spectra were calibrated externally and internally using a tryptic digest of β-lactoglobulin (5 
pmol µl
-1
) and
 
 porcine trypsin autolysis products, respectively, to mass accuracy within 80 
ppm and + 0.7 Da. MS/MS data were acquired with stop conditions so that 10001600 laser 
shots were accumulated for each spectrum. MS together with MS/MS spectra were searched 
against NCBInr database for bacteria (NCBInr 20090826 (9523564 sequences; 3256669569 
residues) by using the MASCOT software (http://www.matrixscience.com), applying the 
search parameters; monoisotopic peptide mass accuracy of 80 ppm; maximum of one missed 
cleavage; carbamidomethylation of cysteine; and partial oxidation of methionine. There were 
no restrictions with respect to protein Mr and pI. Spectra were filtered for known autocatalytic 
trypsin peaks. Signal to noise threshold ratio was set to 1:6. Protein identifications were 
confirmed by a Mascot score of 80 for PMF, p < 0.05 and a minimum of 6 matched peptides 
and for MS/MS by a Mascot score of 50 and p < 0.05.  
A total of 150 proteins representing 102 unique gene products were identified from 202 2-DE 
spots. The majority of these proteins (61%) showed pI 8.010.0 agreeing with the theoretical 
proteome of pI > 7.0. The proteins were grouped into different functional categories (Fig. 2; 
Table 1) using Gene Role Category annotation (http://cmr.jcvi.org/tigr-
scripts/CMR/CmrHomePage.cgi). The CAAI (codon-anticodon adaptability index) values of 
the proteins obtained using DAMBE (http://dambe.bio.uottawa.ca/dambe.asp) were applied to 
calculate the theoretical relative abundance [18]. The present theoretical CAAI values are in 
the range 0.210.76. Noticeably CAAI values of 0.500.76 for the 15 ribosomal proteins 
indicated constant high abundance in the cell and a similar abundance pattern was observed 
for these proteins on the 2D-gel. The most intensely stained spots contain 30S ribosomal 
proteins S8 (spot 196) and S7 (spots 179 and 180) and 50S ribosomal proteins L1 (spot 108, 
118, 119 and 122), L5 (spots 157 and 158), L21 (spot 177) and L13 (spots 183 and 184) 
having CAAI 0.480.66. The cell wall associated S-layer protein (CAAI = 0.43) appeared to 
be the most abundant protein (spots 39ad) on the 2D-gel. Five proteins, hypothetical protein 
LBA1408, 16s pseudouridylate synthase, PhoH family phosphate starvation-induced protein, 
GTP-binding protein and pantothenate metabolism flavoprotein-like protein (Table 1) with 
low theoretical abundance (CAAI < 0.3) were identified on the 2D-gel (Table 1, 
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Supplementary Fig. 1A). The GRAVY index of hydrophobicity was calculated using 
ProtParam tool (http://www.expasy.ch/tools/protparam.html) for all NCFM coding sequences 
(Supplementary Fig. 1B). Proteins identified from the 2D-gel have GRAVY index of 0.907 - 
0.063 (Supplementary Fig. 1B), whereas no hydrophobic proteins (GRAVY index > 0.0) 
were identified probably due to loss during sample preparation and / or electrophoresis. The 
cellular localization predicted by PSORT version 3.0 (http://www.psort.org/) (Table 1) for the 
102 unique gene products indicated 68 proteins to belong to the cytoplasm, 8 to be associated 
with cytoplasmic membranes and three and two being cell wall and extracellular, respectively. 
The extracellular and cell wall associated proteins including the S-layer protein may have 
particularly important roles in the host-microbial interactions of a probiotic bacterium. Twenty 
one proteins were not assigned a cellular localization.  
The many identified proteins involved in protein synthesis (23%) were dominated by proteins 
of the ribosomal subunits, thus 15 of the 55 proteins forming the ribosome were identified on 
the 2D-gel. Proteins of unknown function constitute another large fraction (10%). Furthermore, 
the identifications confirmed the existence for 13 hypothetical proteins (Supplementary Table 
1). A BLAST search of these against the Conserved Domain Database 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) and similarity to homologs allowed 
prediction of a possible function for 10 hypothetical proteins based on the conserved domains 
(Supplementary Table 1).  A motif search using SMART (http://smart.embl-heidelberg.de/) 
for three hypothetical proteins, whose nearest homologs were identified as conserved 
hypothetical proteins, showed hypothetical protein LBA0695 to comprise a signal peptide 
sequence and Big_3 domain (PFAM accession number: PF07523). This entry represents 
bacterial domains with an Ig-like fold and is found in a variety of bacterial surface proteins. 
No domains, however were identified for the hypothetical proteins LBA0157, LBA0229 and 
LBA0864, but LBA0864, has a signal peptide and might be secreted to the extracellular milieu. 
Eighty-three of the 102 unique proteins were identified from a single spot, while 19 were 
found in spots with different pI indicating the presence of PTMs. Thus spots migrating with 
similar apparent molecular mass and varying pI from bacterial proteomes have been suggested 
to arise by phosphorylation [19] or deamidation [20]. Of the proteins showing such charge 
heterogeneity nine are ribosomal proteins. Furthermore, the 50S ribosomal protein L6 (spot 
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168) was present in 18 different spots showing both mass and charge heterogeneity. Some of 
the L6 forms were found at the site of cup-loading probably due to protein precipitation (Table 
1, Fig. 1), other forms of lower Mr indicated possible cleavage of the protein during sample 
preparation.  
The S-layer protein (LBA0169) was seen to be the most abundant on the 2D-gel (spots 39a-d) 
having an Mr of 46.5 kDa and pI of 9.59. S-layer proteins have been identified in major 
bacterial phyla and were documented to function in maintaining and determining the cell 
shape, protection against mechanical forces, and in interactions with the environment [21]. 
Noticeably interaction with the host is important for the probiotic function [22]. S-layer 
proteins from different bacterial genera have pI of 4−6, but S-layer proteins in Lactobacillus 
sp. are alkaline pI (9−10) and lack the SLH (S-layer homology) motif common (PF00395) to 
S-layer proteins (http://pfam.janelia.org/) [23]. The S-layer proteins from Lactobacillus 
contain SLAP (surface layer protein) domain (PFO3217) and recognize neutral polysaccharide 
as a binding site. In NCFM the S-layer protein has an important role in adhesion to intestinal 
cells and was shown to interact with dendritic cells via the dendritic cell specific ICAM-3-
grabbing nonintegrin receptor [22]. 
Very few bacterial proteome maps include information on proteins of pI > 7 [10, 12, 13, 24] 
and the present study adds knowledge on proteins of pI 611. The reference map with 102 
identified unique proteins is the first report of Lactobacillus sp. in the alkaline region. It 
represents a useful dataset for Gram-positive bacteria, and would aid studies into various 
physiological processes at the proteome level. 
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Figure Legends 
Fig. 1.  A detailed 2-DE of 350 µg whole cell extract soluble proteins (pH 6−11) of 
Lactobacillus acidophilus NCFM grown on LABSEM with 1% glucose. Numbered 
spots are chosen for analysis by in-gel digestion and mass spectrometry.   
Fig. 2. Functional grouping of the 102 identified unique proteins on the 2-DE (pH 6−11) of 
Lactobacillus acidophilus NCFM. 
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Table 1. Protein identifications from 2D-gel (pH 6−11) of whole cell extract of L. acidophilus NCFM grown on SEM medium 
with 1% glucose. Protein identifications were confirmed with a Mascot score of 80 for peptide mass fingerprint, 
ANOVA < 0.05 and a minimum of 6 matched peptides. Single peptide based protein identifications were confirmed 
with a Mascot score of 50, ANOVA < 0.05
a
 
Proteins identified by peptide mass fingerprint 
Spot 
Accession 
number 
Protein description Score ANOVA 
Sequence 
coverage% 
Peptides 
matched/ 
searched 
Mr/pI Localizationb 
Functional 
rolec 
3 gi|58336758 mismatch repair protein 162 3.3e-010 19% 18/33 88092/7.75 C DM 
4 gi|58337413 DNA topoisomerase IV subunit A 201 4.1e-014 26% 23/36 92270/8.1 C DM 
6 gi|58336622 ATPase 314 2.1e-025 44% 34/61 91966/7.71 C PF 
9 gi|58338020 Oligopeptidase 104 0.00021 15% 9/16 68213/4.84 C PF 
11 gi|58338214 
tRNA uridine 5-carboxymethylaminomethyl 
modification enzyme GidA 
106 0.00013 17% 12/16 70719/6.99 C UF 
14 gi|58337150 hypothetical protein LBA0843 87 0.01 14% 8/14 65599/8.78 C UF 
19 gi|58337016 hypothetical protein LBA0695 293 2.6e-023 38% 31/61 61777/9.24 U HP 
24 gi|58336504 hypothetical protein LBA0157 133 2.6e-007 35% 14/32 53966/8.76 C UF 
25 gi|58336866 RNA methyltransferase 241 4.1e-018 52% 31/78 50867/8.99 C PS 
26 gi|58337604 exodeoxyribonuclease VII (large subunit) EX7L 207 1.00E-14 50% 33/80 52626/9.1 C DM 
28 gi|58336533 fibronectin domain-containing protein 190 5.2e-013 44% 22/45 52088/9.59 U T 
30 gi|58337996 GTP-binding protein 229 6.5e-017 54% 24/38 47084/8.35 C UF 
31 gi|58337169 hypothetical protein LBA0864 93 0.0038 30% 14/79 54757/9.66 U HP 
34 gi|58337078 UDP-N-acetylmuramyl tripeptide synthetase 86 0.017 25% 11/51 50447/8.77 C CE 
35 gi|58337245 GTPase ObgE 143 2.6e-008 36% 19/38 47592/6.31 C UF 
36 gi|58337078 UDP-N-acetylmuramyl tripeptide synthetase 152 3.3e-009 34% 19/46 50447/8.77 C CE 
37 gi|58337101 thiazole biosynthesis protein 120 5.2e-006 18% 14/21 45812/6.24 C BCPC; PS 
39a gi|58336516 S-layer 119 6.5e-006 32% 15/56 46542/9.59 CW CE 
39b gi|58336516 S-layer 202 3.3e-014 46% 22/69 46542/9.59 CW CE 
39c gi|58336516 S-layer 268 8.2e-021 48% 23/63 46542/9.59 CW CE 
39d gi|58336516 S-layer 245 1.6e-018 40% 23/46 46542/9.59 CW CE 
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40 gi|58337078 UDP-N-acetylmuramyl tripeptide synthetase 86 0.017 25% 11/51 50447/8.77 C CE 
42 gi|58336608 ala racemase 116 1.3e-005 36% 12/29 41801/6.02 C CE 
45 gi|58337118 N-acetylglucosaminyl transferase 110 5.2e-005 29% 13/49 40718/8.56 U CE 
46 gi|58337238 
pantothenate metabolism flavoprotein-like 
protein 
99 0.0007 31% 12/43 43914/8.67 C BCPC 
47 gi|58336952 hydroxymethylglutaryl-CoA reductase 222 3.3e-016 43% 21/48 44143/8.91 U FP 
48 gi|58337440 hypothetical protein LBA1155 204 2.1e-014 43% 22/52 42521/9.18 C CIM 
51 gi|58337436 pseudouridine synthase 129 6.5e-007 44% 14/63 34227/9.11 C PS 
52 gi|58336409 penicillin-binding protein 125 1.6e-006 20% 9/22 42206/9.37 E CP 
53 gi|58337247 metallo-beta-lactamase superfamily 116 1.3e-005 52% 15/94 34806/8.84 C UF 
54 gi|58337019 glyceraldehyde-3-p dehydrogenase 182 3.3e-012 67% 22/90 36643/5.92 C EM 
55 gi|58337019 glyceraldehyde-3-p dehydrogenase 242 3.3e-018 67% 25/81 36643/5.92 C EM 
56 gi|58337019 glyceraldehyde-3-p dehydrogenase 284 2.1e-022 76% 30/74 36643/5.92 C EM 
57 gi|58336550 tryptophanyl-tRNA synthetase II 283 2.6e-022 52% 25/57 38302/6.49 C PS 
58 gi|58337019 glyceraldehyde-3-p dehydrogenase 290 5.2e-023 70% 26/50 36643/5.92 C EM 
59 gi|58336998 HPr kinase/phosphorylase 146 1.3e-008 44% 14/44 36305/6.73 C RF; T 
60 gi|58337430 site-specific tyrosine recombinase XerS 137 1.0e-07 35% 13/28 39747/9.54 U DM 
63 gi|58337483 GTP-binding protein Era 163 2.6e-010 52% 16/43 34097/7.03 CM CP; RF 
65 gi|58337012 hypothetical protein LBA0691 109 6.5e-005 36% 15/43 33454/7.72 C UF 
66 gi|58337089 F0F1 ATP synthase subunit gamma 141 4.1e-008 38% 15/28 35512/5.93 C EM 
67 gi|58337580 
oligopeptide ABC transporter ATP-binding 
protein 
141 4.1e-008 40% 14/38 37703/6.29 CM T 
68 gi|58336442 putative regulatory protein 263 2.6e-020 49% 21/33 35831/8.81 U RF 
69 gi|58337485 
PhoH family phosphate starvation-induced 
protein 
83 0.027 30% 7/25 35008/8.69 C UF 
70 gi|58337977 UTP-glucose-1-phosphate uridylyltransferase 152 3.3e-009 38% 11/20 33055/7.04 C CE 
71 gi|58336950 UTP-glucose-1-phosphate uridylyltransferase 184 2.1e-012 47% 19/52 33875/5.9 C CE 
72 gi|58337485 
PhoH family phosphate starvation-induced 
protein 
224 2.1e-016 67% 21/43 35008/8.69 C PS 
74 gi|58338074 chromosome partitioning protein 157 1.0e-09 60% 19/52 33130/9.15 C CP 
75 gi|58338074 chromosome partitioning protein 196 1.3e-013 60% 20/37 33130/9.15 C CP 
77 gi|58337302 penicillin-binding protein 112 3.3e-005 31% 15/65 40946/9.63 E CP 
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78 gi|58336456 hypothetical protein LBA0109 94 0.0026 29% 10/39 36207/8.62 C DM 
79 gi|58337735 UDP-glucose 4-epimerase 196 1.3e-013 39% 13/22 36458/5.95 U EM 
81 gi|58337028 
UDP-N-acetylenolpyruvoylglucosamine 
reductase 
81 0.05 23% 7/39 32470/6.19 C CE 
82 gi|58336565 ribose-p-pyrophosphokinase 195 1.6e-013 43% 18/40 35684/6.01 C PPNN 
83 gi|58337241 glyoxylate reductase 191 4.1e-013 49% 15/28 35749/6.01 C CIM 
84 gi|58337595 methionyl-tRNA formyltransferase FMT 150 5.2e-009 53% 18/47 34223/6.37 C PS 
85 gi|58338076 chromosome partitioning protein 205 1.6e-014 67% 25/73 31473/7.71 C CP 
86 gi|58338137 guanosine 5'-monophosphate oxidoreductase 162 3.3e-010 45% 16/39 36748/8.24 C PPNN 
89 gi|58337517 cysteine synthase 129 6.5e-007 44% 16/32 32655/6.99 C AA 
90 gi|58337517 cysteine synthase 100 0.00058 40% 11/34 32655/6.99 C AA 
92 gi|58337517 cysteine synthase 189 6.5e-013 61% 21/21 32655/6.99 C AA 
93 gi|58337532 tRNA pseudouridine synthase B 119 6.5e-006 31% 11/21 33657/8.78 C PS 
94 gi|58336431 putative heat shock related serine protease 102 0.00033 26% 7/27 43695/9.42 U PF 
96 gi|58336485 hypothetical protein LBA0138 163 2.6e-010 62% 17/44 28157/8.48 C HP 
97 gi|58337102 16s pseudouridylate synthase 108 8.2e-005 36% 10/26 26359/9.24 C PS 
99 gi|58337781 L-LDH 161 4.1e-010 30% 12/24 33804/7.03 C EM 
100 gi|58337781 L-LDH 219 6.5e-016 52% 18/55 33804/7.03 C EM 
101 gi|58336499 alkylphosphonate ABC transporter 144 2.1e-008 43% 12/26 28462/9.38 CM T 
102 gi|58336609 hypothetical protein LBA0270 83 0.026 34% 7/26 26569/6.31 C UF 
105 gi|58337187 transcriptional regulator 174 2.1e-011 39% 13/31 28083/7.82 C RF 
106 gi|58336702 phosphate ABC transporter ATP-binding protein 83 0.041 27% 7/26 29680/8.94 CM T 
108 gi|58336698 50S ribosomal protein L1   36% 7/51 24717/8.89 C PS 
109 gi|58336650 adenylate kinase 135 1.6e-007 49% 11/43 24743/6.36 C PPNN 
110 gi|58337948 hypothetical protein LBA1690 89 0.0067 34% 8/26 30975/9.66 U CE 
111 gi|58336650 adenylate kinase 142 3.3e-008 51% 12/35 24743/6.36 C PPNN 
112 gi|58336650 adenylate kinase 200 5.2e-014 61% 19/76 24743/6.36 C PPNN 
114 gi|58336630 50S ribosomal protein L3 228 8.2e-017 66% 20/49 23129/9.94 U PS 
115 gi|58336630 50S ribosomal protein L3 185 1.6e-012 54% 15/38 23129/9.94 U PS 
117 gi|58337938 ABC transporter ATP-binding protein 116 1.3e-005 45% 12/25 27358/6.93 CM T 
118 gi|58336698 50S ribosomal protein L1 83 0.028 28% 6/19 24717/8.89 C PS 
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119  mixture        
119 gi|58336698 50S ribosomal protein L1 123 2.6e-006 58% 15/55 24717/8.89 C PS 
119 gi|58337445 endonuclease III 105 0.00016 57% 12/55 23783/8.47 C DM 
121 gi|58337938 ABC transporter ATP-binding protein 98 0.00076 39% 10/23 27358/6.93 CM T 
122 gi|58336698 50S ribosomal protein L1 142 3.3e-008 61% 15/55 24717/8.89 C PS 
123 gi|58338086 ABC transporter ATP-binding protein 146 1.3e-008 60% 17/42 24611/9.24 CM T 
125 gi|58337845 methlytransferase 94 0.0021 27% 6/10 25401/6.84 U PS 
126 gi|58336844 transcriptional regulator 182 3.3e-012 57% 14/35 26627/8.8 C RF 
127 gi|58336636 30S ribosomal protein S3 147 1.0e-08 44% 12/27 25055/10.13 C PS 
128 gi|58336636 30S ribosomal protein S3 175 1.6e-011 50% 15/40 25055/10.13 C PS 
130 gi|58336636 30S ribosomal protein S3 156 1.3e-009 47% 14/45 25055/10.13 C PS 
131 gi|58336936 nitroreductase 97 0.0011 29% 10/28 24616/8.67 U EM 
132 gi|58337558 DNA polymerase 152 3.3e-009 57% 13/39 24927/9.11 C DM 
133 gi|58336905 glutamine ABC transporter ATP-binding protein 137 1.0e-07 40% 14/43 27895/6.4 CM CP; T 
134 gi|58337795 putative nicotinate-nucleotide adenyltransferase 119 6.5e-006 28% 13/31 24802/9.32 C BCPC 
136 gi|58337545 uridine mono phosphate kinase 93 0.0028 21% 7/22 25872/7.81 C PPNN 
137 gi|58337545 uridine mono phosphate kinase 108 8.2e-005 37% 13/56 25872/7.81 C PPNN 
138 gi|58337545 uridine mono phosphate kinase 91 0.0043 29% 12/51 25872/7.81 C PPNN 
139 gi|58337679 hypothetical protein LBA1408 152 3.3e-009 49% 15/36 24360/8.65 C HP 
142 gi|58338161 lysin 99 0.00065 35% 9/37 34603/10.28 CW AA 
143 gi|58337098 30S ribosomal protein S4 201 4.1e-014 60% 18/47 23453/9.89 C PS 
144 gi|58337811 dephospho-CoA kinase 134 2.1e-007 48% 11/24 22693/8.79 U BCPC 
145 gi|58337426 lysin 92 0.0049 15% 7/24 41475/9.64 CW AA 
148 gi|58337654 
bifunctional pyrimidine regulatory protein PyrR 
uracil phosphoribosyltransferase 
84 0.033 37% 7/27 20099/6.21 C PPNN 
150 gi|58338089 putative phosphoglycerate mutase 153 2.6e-009 52% 15/37 22750/6.31 C EM 
152 gi|58336528 pyrrolidone carboxyl peptidase 159 6.5e-010 55% 12/22 21848/8.85 C PF 
153 gi|58336611 peptidyl-tRNA hydrolase 95 0.0015 52% 9/25 21042/6.97 U PS 
154 gi|58337416 peptidyl-prolyl cis-trans isomerase 97 0.0011 29% 7/20 22351/6.84 C PF 
155 gi|58336389 putative cobalamin adenosyltransferase 114 2.1e-005 40% 9/28 21499/9.1 C BCPC 
156 gi|58337521 adenine phosphoribosyltransferase 189 6.5e-013 60% 11/23 19335/6.1 C PPNN 
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157 gi|58336642 50S ribosomal protein L5 222 3.3e-016 88% 19/32 20252/8.72 C PS 
158 gi|58336642 50S ribosomal protein L5 209 6.5e-015 88% 21/41 20252/8.72 C PS 
166 gi|58336644 50S ribosomal protein L6 145 1.6e-008 48% 10/25 19161/9.15 U PS 
167 gi|58336644 50S ribosomal protein L6 157 1e-009 56% 11/29 19161/9.15 U PS 
168 gi|58336644 50S ribosomal protein L6 146 1.3e-008 56% 11/41 19161/9.15 U PS 
169 gi|58336365 50S ribosomal protein L9 155 1.6e-009 79% 19/78 16941/9.54 C PS 
172 gi|58336644 50S ribosomal protein L6 107 0.0001 41% 8/22 19161/9.15 U PS 
173 gi|58336644 50S ribosomal protein L6 82 0.036 32% 6/21 19161/9.15 U PS 
175 gi|58336644 50S ribosomal protein L6 99 0.00065 32% 6/11 19161/9.15 U PS 
176 gi|58337095 hypothetical protein LBA0783 183 2.6e-012 78% 12/25 17028/5.93 C CP 
178 gi|58336644 50S ribosomal protein L6 83 0.024 32% 6/18 19161/9.15 U PS 
179 gi|58336627 30S ribosomal protein S7 198 8.2e-014 83% 17/43 17920/9.81 C PS 
180 gi|58336627 30S ribosomal protein S7 211 4.1e-015 80% 23/69 17920/9.81 C PS 
181 gi|58337810 transcriptional regulator NrdR 84 0.022 53% 9/67 18189/8.68 C HP 
182 gi|58336644 50S ribosomal protein L6 85 0.023 32% 6/32 19161/9.15 U PS 
183 gi|58336661 50S ribosomal protein L13 161 4.1e-010 82% 15/56 16479/9.54 U PS 
184 gi|58336661 50S ribosomal protein L13 128 8.2e-007 77% 12/42 16479/9.54 U PS 
185 gi|58336644 50S ribosomal protein L6 99 0.00065 32% 6/11 19161/9.15 U PS 
186 gi|58336644 50S ribosomal protein L6 82 0.05 32% 6/25 19161/9.15 U PS 
187 gi|58336644 50S ribosomal protein L6 93 0.0028 32% 6/22 19161/9.15 U PS 
188 gi|58336644 50S ribosomal protein L6 122 3.3e-006 39% 7/16 19161/9.15 U PS 
191 gi|58336635 50S ribosomal protein L22 135 1.6e-007 71% 9/36 12806/9.91 C PS 
193 gi|58336635 50S ribosomal protein L22 124 2.1e-006 35% 6/42 12806/9.91 C PS 
195 gi|58336643 30S ribosomal protein S8 104 0.00021 53% 9/59 14523/9.33 C PS 
197 gi|58336643 30S ribosomal protein S8 83 0.029 53% 9/53 14523/9.33 C PS 
199 gi|58336644 50S ribosomal protein L6 82 0.036 36% 7/39 19161/9.15 U PS 
200 gi|58336644 50S ribosomal protein L6 99 0.00065 32% 6/14 19161/9.15 U PS 
202 gi|58336644 50S ribosomal protein L6 90 0.0052 32% 6/15 19161/9.15 U PS 
203 gi|58336644 50S ribosomal protein L6 99 0.00065 32% 6/13 19161/9.15 U PS 
204 gi|58336644 50S ribosomal protein L6 99 0.00067 32% 6/13 19161/9.15 U PS 
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206 gi|58336644 50S ribosomal protein L6 93 0.0028 32% 6/13 19161/9.15 U PS 
212 gi|58336629 30S ribosomal protein S10 140 5.2e-008 71% 13/57 11455/9.63 U PS 
225 gi|58337267 DNA-binding protein II HB 92 0.003 60% 6/32 9726/9.52 U DM; T 
228 gi|58336604 50S ribosomal protein L31 type B 140 5.2e-008 88% 11/57 9174/8.86 C PS 
 
Proteins identified by MS/MS 
Spot 
Accession 
number 
Protein description 
Sequence 
coverage% 
Mr/pI Peptides Peptide sequence Score ANOVA Localization b 
Functional 
role c 
95 gi|58337812 
formamidopyrimidine-DNA 
glycosylase 
4% 31651/8.95 1 DKHDHVEFVFTDK 53 0.03 C DM 
98 gi|58337993 
exopolysaccharide 
biosynthesis protein 
6% 28517/9.0 1 SPIAEQFR 52 0.048 C CE 
141 gi|58337498 acetyltransferase 13% 22876/7.6 2 DYNLLADTDKEER 67 0.001 C UF 
      
DVPDNSLVVGVPG 89 7e-006 
  
151 gi|58336556 putative primase like 15% 21682/9.17 2 NFDAVIVVEGKDDTIR 70 0.00052 C UF 
      
QIIVFTDPDFNGER 
    
177 gi|58337611 50S ribosomal protein L21 20% 11334/9.18 2 VAEGDSVFVEK 90 6.3e-006 U PS 
      
VGTPLVDGAK 61 0.0043 
  
189 gi|58337486 
hypothetical protein 
LBA1204 
19% 16556/8.63 1 LGHDLTPDEELTVLNR 113 2.3e-008 C PS 
194 gi|58336643 30S ribosomal protein S8 21% 14523/9.33 2 DIILRPVITEK 51 0.021 C PS 
      
NAVEEIFDVK 63 0.0034 
  
196 gi|58336643 30S ribosomal protein S8 9% 14523/9.33 1 VMTDPIADYLTR 72 0.00032 C PS 
        a) Individual ion scores >50 indicate identity or extensive homology. 
b) Localization: C – cytoplasmic; CM – cytoplasmic membrane; CW – cell wall; E – extracellular; U – unknown functions.  
  c) Functional role: AA - Amino acid biosynthesis; BCPC - Biosynthesis of cofactors; prosthetic groups, and carriers; CE - Cell envelope; CIM - Central intermediary 
metabolism; CP - Cellular processes; DM - DNA metabolism; EM - Energy metabolism;  FP - Fatty acid and phospholipid metabolism; HP - 
Hypothetical proteins; PF - Protein fate; PPNN - Purines, pyrimidines, nucleosides and nucleotides; PS - Protein synthesis; RF - Regulatory 
functions; T - Transport; UF - Unknown functions. 
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Fig. 1. 
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Fig. 2. 
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Abbreviations:  
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Abstract 
A comparative differential proteome study of Lactobacillus acidophilus NCFM grown in 
semi-defined media (LABSEM) supplemented by glucose (control) or raffinose was 
performed to explore the carbohydrate metabolism pathways. The proteome analysis by 
2D-DIGE showed that the intracellular family GH36 -galactosidase (MelA) is highly 
abundant in growth on raffinose together with sucrose-6-phosphate hydrolase (LBA0400), 
maltose phosphorylase (LBA1870) and -galactosidase (LBA1467 and LBA1468). Sugar 
kinases specific for galactose, glucose and fructose also were found in the proteome of 
NCFM grown on raffinose. Furthermore the Lelior pathway for galactose utilization was 
found to be differentially expressed together with various enzymes from the glycolysis. D-
lactate dehydrogenase (LBA0055) and L-lactate dehydrogenase (LBA0910) were found to 
be differentially abundant with upregulation of L-lactate dehydrogenase and 
downregulation of D-lactate dehydrogenase, indicating a shift from the end product 
enatiomer ratio of lactic acid.  
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Introduction 
Functional foods i.e. food products with significant health benefits are being widely 
accepted by the consumers [1]. To be a probiotic microorganism there are certain basic 
characteristics to be fulfilled such as, being safe, identification to the strain level by using 
biochemical and genetic techniques, and have proven beneficial effect on human health [2]. 
Lactobacillus acidophilus NCFM (NCFM) according to the requirements is a probiotic 
bacterium and has been extensively studied [3]. The 2 Mb genome of NCFM has been 
sequenced [4] and transcriptomics analyses of the carbohydrate utilization of NCFM have 
been carried out [5, 6]. 
Prebiotics are food ingredients that promote the growth of selected bacterial species in the 
gut microbiota for the benefit of host health [7]. Raffinose (O-α-D-galactopyranosyl-
(1→6)-α-D-glucopyranosyl-(1→2)-β-D-fructofuranoside) is a trisaccharide with galactose 
α-(1→6) linked to the glucose moiety of sucrose and a major constituent of different 
legume seeds [8]. The absence of α-galactosidase in the intestinal mucosa leads to 
accumulation of raffinose and the raffinose family oligosaccharides (RFO) from the diet in 
the gut [9]. Raffinose has been shown to modulate the human intestinal microbiota and 
promote intestinal health [10]. The presence of α-galactosidase activity of various L. 
acidophilus strains has been documented [11]. The supplementation of milk with raffinose 
increased the viability of L. acidophilus in fermented milk during refrigerated storage [12]. 
The utilization of raffinose by NCFM and the high abundance of raffinose in various 
legumes in the diet [8] makes it imminent to study how the probiotic NCFM takes up and 
metabolizes raffinose.     
Gel-based proteomics has been used to describe the probiotic potential of Lactobacillus sp. 
related to bile tolerance [13, 14], acid tolerance [15] and interactions with the gut 
epithelium [16]. Studies are lacking, with regard to interaction and adaptation of probiotic 
Lactobacillus sp to different carbohydrates abundant in the gut. The present work focuses 
on proteome changes by the utilization of raffinose by NCFM using two-dimensional 
ﬂuorescence-based difference gel electrophoresis (2D-DIGE) coupled with mass 
spectrometry.  
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Materials and Methods 
Growth Conditions  
Freeze dried commercial Lactobacillus acidophilus NCFM (NCFM 150B, FloraFIT® 
Probiotics; Danisco USA Inc., Madison, US) with 150 X 10
9 
CFU/g was used in the 
present study. The culture was revived in semisynthetic medium for lactic acid bacteria 
(LABSEM) [17] supplemented with 1% glucose and grown under aerobic conditions 
without agitation at 37 °C. For DIGE analyses the cultures were sub-cultured in LABSEM 
supplemented with either 1% glucose or 1% raffinose for three cycles prior to analysis. 
Cells from late-log phase cultures of A600 of 1.1 for glucose and 0.9 for raffinose (pH 5.3 
for both) were harvested from four independent 40 ml cultures (centrifugation at 3,200 g, 
10 min, 4 °C). Cell pellets were washed twice with 0.9% NaCl, vacuum-dried without 
heating to dryness (SpeedVac, Savant, SC110A with Vacuum unit UVS400A; GMI Inc., 
Ramsey, US) and kept at −80 °C until use. 
 
Protein Extraction 
To prepare the whole cell extract proteins, cells were disrupted by mechanical grinding 
with a small number of acid washed glass beads (<100 μm diameter; Sigma, Brøndby, 
Denmark). The cell pellet was added an equal volume of glass beads, 300 μl phenol (Tris 
saturated pH 8.0) and 300 μl 10 mM Tris, 10 mM DTT (pH 8.0). Disruption was carried 
out using a Bio 101 Savant FastPrep FP 120 bead beater (Savant, Farmingdale, USA) at a 
speed of 6.5 m/s for four cycles of 45 s each with intermittent cooling on ice. The cell 
lysate was centrifuged (10,000 g, 10 min, 4 ºC) resulting in three distinct phases. The 
phenol phase were transferred to a fresh microtube, added ice-cold ethanol (four volumes) 
and kept at −20 ºC overnight. After centrifugation (15,000 g, 10 min, 4 ºC), the precipitate 
was dissolved in 300 μl rehydration buffer (8 M urea, 2 M thiourea, 2% CHAPS, and 1% 
pharmalyte pH range 4−7 (GE Life Sciences, Uppsala, Sweden)). The protein 
concentration was determined (2D Quant kit; GE Life Sciences) prior to storage at −80 °C 
until use. 
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CyDye labeling 
CyDye minimal-labeling for DIGE analysis was performed using a dye-swapping approach 
to avoid bias due to the interference from fluorescence properties of gels at different 
wavelengths. Protein aliquots (50 μg) of each of four biological replicates grown on 
glucose or raffinose were labeled interchangeably with 250 pmol of either Cy3 or Cy5 dye, 
vortexed, and left in the dark (30 min, 4 ºC). In a similar manner, aliquots (25 μg protein) 
of each sample were combined for internal standard and labeled with 250 pmol Cy2. 
Labeling reactions were quenched by 1 μl 10 mM lysine in the dark (10 min). The internal 
standard and the samples were mixed and the volume made to 450 μl with rehydration 
buffer (8 M urea, 2 M thiourea, 2% CHAPS, 0.3% DTT and 1% pharmalyte pH range 4−7 
(GE Life Sciences)). 
 
2-D Differential gel electrophoresis 
Separation in the first dimension (isoelectric focusing, IEF) was performed using IPG 
strips (pH 4−7; 24 cm; GE Life Sciences) on EttanTM IPGphor (GE Life Sciences). 
Rehydration was carried out at 20 ºC for 12 h at 30 V. IEF was performed at a total of 78 
kVh (1 h at 150 V, 1 h at 300 V, 1 h at 1,000 V, gradient to 8,000 V, hold at 8,000 V until 
a total of at least 78 kVh was reached). Subsequently, the strips were equilibrated for 2 x 
15 min in 5 ml equilibration buffer (6 M urea, 30%  glycerol, 50 mM Tris-HCl, pH 8.8, 2% 
SDS and 0.01% bromophenol blue) supplemented with 1% DTT and 2.5% iodoacetamide 
in the first and second equilibration step, respectively. The second dimension (SDS-PAGE) 
was performed on ETTAN
TM
 DALT twelve Electrophoresis unit (GE Lifesciences) 
overnight at 1 W/gel until the dye front reached the gel bottom. 
 
Image Analysis 
Imaging of the DIGE gels was done immediately after the second dimension run at 
excitation/emission wavelengths of Cy2 (488/520 nm), Cy3 (532/580 nm) and Cy5 
(633/670 nm), respectively (100 μm resolution; Typhoon 9410 Variable Mode Imager; GE 
Lifesciences). Gel images were analyzed by Progenesis SameSpots version 3.2 (nonlinear 
Dynamics Ltd, Newcastle upon Tyne, UK). The gel images were aligned by automated 
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calculation of manually assigned landmark vectors. Aligned gels were subjected to intra-
gel (difference in-gel) and inter-gel (biological variance) analyses. Spot volume ratio 
change of > 1.5 fold, ANOVA p < 0.05 and false discovery rate q < 0.05 were chosen as 
criterion in the identification of differentially abundant protein spots. Gels were post-
stained with CBB [18] for spot picking. 
 
In-gel Digestion and Protein Identification by MS/MS-MS 
Spots of interest were excised manually and subjected to in-gel digestion with some 
modifications as described below [19]. Gel pieces were washed with 100 μl 40% ethanol 
(10 min) followed by 50 μl 100% acetonitrile (ACN), and incubated 45 min on ice with 2 
μl 12.5 ng μl-1 trypsin (Promega, Nacka, Sweden) in 25 mM ammonium bicarbonate 
followed by addition of 10 μl 25 mM ammonium bicarbonate for rehydration, and 
incubated at 37 ºC overnight. A supernatant aliquot (1 μl) was applied to the Anchor Chip 
target plate (Bruker-Daltonics, Bremen, Germany), covered by 1 μl matrix solution (0.5 μg 
μl-1 α-cyano-4-hydroxycinnamic acid in 90% ACN, 0.1% TFA) and washed in 0.02% TFA. 
MS and MS/MS spectra were obtained by Ultraflex II MALDI-TOF MS mass 
spectrometer (Bruker-Daltonics) in auto-mode using Flex Control v3.0 (Bruker-Daltonics) 
and processed by Flex Analysis v3.0 (Bruker-Daltonics). Peptide mass maps were acquired 
in reflectron mode with 500 laser shots per spectrum. Spectra were externally calibrated 
using a tryptic digest of β-lactoglobulin (5 pmol μl-1); MS/MS data were acquired with stop 
conditions so that 10001600 laser shots were accumulated for each spectrum. The MS 
together with MS/MS spectra were searched against NCBInr database for bacteria 
(NCBInr 20100323 (10606545 sequences; 3615943919 residues) using MASCOT 2.0 
software (http://www.matrixscience.com) integrated together with Biotools v3.1 (Bruker-
Daltonics). Search parameters were as follows: monoisotopic peptide mass accuracy of 80 
ppm, fragment mass accuracy to + 0.7 Da; maximum of one missed cleavage; 
carbamidomethylation of cysteine and partial oxidation of methionine. There were no 
restrictions with respect to protein Mr and pI. Filtering of peaks was done for known 
autocatalytic trypsin peaks and keratin peaks; the signal to noise threshold ratio was set to 
1:6. A Mascot score of > 80 (p < 0.05) was used to confirm proteins identified by peptide 
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mass fingerprint and should have a minimum of six matched peptides. For single peptide 
based MS/MS identification of proteins, a Mascot score of > 40 (p < 0.05) was used. 
 
Results and Discussion 
Raffinose family of oligosaccharides (RFO) represented by raffinose, stachyose, 
verbascose and related oligosaccharides have been shown to be well documented 
prebiotics [10]. They confer positive bifidogenic effects during the manufacture of 
probiotic milk products [8] and have also been shown to have beneficial effects on the 
survival of probiotic cultures e.g. L. acidophilus and B. lactis [12]. The administration of 
raffinose and B. breve increased the number of bifidobacteria and lactobacilli in rat cecal 
microbiota [20]. Transcriptomic analysis of raffinose metabolism by NCFM showed 
induction of raffinose operon [5]. However, knowledge of raffinose metabolism in 
probiotic bacteria at the protein level is lacking and the present study addresses changes in 
protein profiles of NCFM grown on raffinose to gain insight into uptake and metabolism of 
raffinose by the probiotic NCFM. 
 
Differential abundance of proteins of NCFM grown on raffinose 
In total 108 spots were found by 2D-DIGE and image analysis to differ in relative 
abundancy for NCFM grown on raffinose compared to glucose (Fig. 1). Ninety spots were 
excised as detected by CBB staining for further identification by mass spectrometry after 
trypsin digestion. Among these 90 spots, proteins in 63 spots were identified by MS/MS-
MS (Table 1), and 48 showed higher (1.5–13.9 fold), while 15 showed lower (1.5–2.3 fold) 
relative abundance. The 63 identifications corresponding to 43 unique proteins are 
distributed among 12 functional categories based on the Comprehensive Microbial 
Research (CMR) database (http://cmr.jcvi.org) (Fig. 2) as follows; 3 with biosynthesis of 
cofactors, prosthetic groups and carriers; 23 from energy metabolism; 3 from the 
functional role cell envelope, protein synthesis and purines, pyrimidines, nucleosides and 
nucleotides; 1 protein each from the functional role cellular processes, hypothetical 
proteins, regulatory functions, transcription and transport; and 2 of unknown function.  
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Proteins involved in raffinose metabolism 
Several glycoside hydrolases with +2.5–13.9 fold change in the range were identified using 
2D-DIGE to be differentially abundant with growth of NCFM on raffinose compared to 
glucose (Table 1). These include α-galactosidase (MelA) in the raffinose operon, β-
galactosidase large and small subunit (LacLM) from the lactose gene locus, and sucrose-6-
p hydrolase (ScrB) of the sucrose gene locus (Fig 3). The glycoside hydrolases α-
galactosidase (spot 1, fold change +13.9;  spot 10, fold change +7.3), β-galactosidase large 
(spot 19, fold change +6.9; spot 36, fold change +3.3; spot 53, fold change +2.5) and small 
subunit (spot 6, fold change +5.7; spot 7, fold change +5.7) were identified on the 2D-gel 
in multiple forms of different pI (Fig 4). Raffinose in NCFM induces the raffinose operon, 
consisting of genes encoding the ABC transporter msmEFGK (msmEFGK), α-
galactosidase (melA) and sucrose phosphorylase (gftA), and the MsmEFGK transporter 
from the raffinose operon, has been shown to be involved in the uptake of raffinose in 
NCFM (Fig. 3) [5]. The NCFM α-galactosidase (E.C. 3.2.1.22) belongs to glycoside 
hydrolase family 36 and catalyzes hydrolysis of the galactose residue from raffinose [21]. 
In the present study α-galactosidase is the primary enzyme for raffinose metabolism to 
galactose and sucrose and was found to be significantly abundant (spot 1, fold change 
+13.9; spot 10, fold change +7.3) (Fig. 3). A similar induction of the raffinose operon in 
the presence of raffinose was observed in low G+C bacterium Streptococcus mutans [22]. 
Sucrose phosphorylase (GftA) of the raffinose operon may be involved in the conversion 
of sucrose to glucose-1-phosphate and fructose. This enzyme was significantly upregulated 
at the transcriptome level [17], but it has not been identified among the differentially 
abundant proteins by 2D-DIGE. Sucrose and galactose, catalyzed products of raffinose by 
α-galactosidase, could potentially induce the expression of sucrose, galactose and lactose 
gene loci. Indeed sucrose-6-p hydrolase (E.C. 3.2.1.26) (spot 20) was found to be 
upregulated by +5.4 fold in the presence of raffinose. The transcriptomic analysis of 
NCFM and low G+C S. mutans growth with sucrose shows induction of the sucrose locus 
[5]. Utilization of sucrose in most low G+C Gram-positive bacteria is under the regulation 
of the LacI/GalR transcriptional regulator [23] that controls the induction of the sucrose 
locus, encoding sucrose-6-p hydrolase, and the sucrose PTS transporter EIIBCA
Suc 
 [5, 23, 
24]. The sucrose 6-p hydrolase of glycoside hydrolase family 32, has been shown to 
hydrolyze sucrose-6-phosphate and sucrose to glucose-6-phosphate and fructose 
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(http://www.uniprot.org/uniprot/P27217) [25]. Sucrose-6-p hydrolase has been shown to 
be active on sucrose and sucrose-6-phosphate with a similar catalytic efficiency [25, 26]. 
Noticeably, while the enzymes of the Lelior pathway for galactose utilization and 
fructokinase were found to be differentially expressed in NCFM during growth on 
raffinose and also the for entry of fructose into the glycolysis was identified, no glucose or 
sucrose active kinases were found. Multiple forms of phosphoglucomutase (spot 21, 34 and 
54) and maltosephosphorylase (spot 15 and 28) were found to be differentially abundant 
during growth on raffinose, with a fold change of +5.3–2.4 and +6.2–4.5 respectively 
(Table 1). Both of these enzymes have been shown to be involved in glycolysis and 
glyconeogenesis [27]. Transcriptomics of galactose utilization has shown that galactose 
induce 10 different genes from two different loci in NCFM [5]. A similar induction of the 
galactose and lactose loci was found in the present study, with a differential abundance of 
+1.7–9.9 fold (Table 1). The proteins of the Leloir pathway, galactokinase (GalK) (spot 38, 
fold change +3.1; spot 43, fold change +2.9), galactose-1-epimerase (GalM) (spot 79, fold 
change +1.7), galactose-1-phosphate uridylyltransferase (GalT) (spot 4, fold change +8) 
and UDP-glucose 4-epimerase (GalE) (spot 11, fold change +9.6 and spot 24, fold change 
+5.4) are involved in the conversion of galactose to glucose-1-P. Glucose-1-P is converted 
to glucose-6-P by phosphoglucomutase (pgm) (spot 21, fold change +5.3; spot 34, fold 
change +3.3 and spot 54, fold change +2.4). The β-galactosidase large and small subunits 
from a different locus were also found to be differentially abundant (Table 1). The lactose 
transcriptional regulator (LacR) regulates the expression of LacLM and is induced by 
galactose [5]. Similar observation of lactose locus induction by galactose was observed in 
the low G+C bacteria S. gordonii [28]. Low G+C gram positive bacteria adapt to changing 
carbohydrate conditions by catabolite repression [29]. Catabolite control protein A (CcpA) 
involved in regulation of sugar utilization by maintaining sugar uptake and 
catabolic/metabolic balance [30] was found be +1.9 fold abundant (spot 71).  
 
Other abundant proteins  
Proteins with a functional role in energy predominate proteins upregulated by raffinose. 
These include enzymes of glycolysis, glyceraldehyde-3-p dehydrogenase; 
phosphofructokinase, L-lactate dehydrogenase; D-lactate dehydrogenase; pyruvate kinase; 
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pyruvate oxidase; maltose phosphorylase; and NAD-dependent aldehyde dehydrogenase 
(Table 1). The end product of anaerobic fermentation for lactic acid bacteria is lactate, 
which is formed as the end-product of glycolysis when pyruvate is reduced to lactate with 
NADH as a cofactor [31]. L-lactate dehydrogenase was found to be abundant (spot 18, fold 
change +5.4; spot 90, fold change +1.6); while pyruvate kinase was lower in abundance 
(spot 60, fold change -2.3; spot 80, fold change -1.7) with raffinose. Noticeably D-lactate 
dehydrogenase was found be lower in abundance (spot 83, fold change -1.7). NCFM 
ferments glucose to produce 33.8 % D-lactic acid and 66.2% L-lactic acid [3], The change 
in abundance of L-lactate dehydrogenase and D-lactate dehydrogenase indicates a change in 
the ratio of enantiomers of lactic acid during raffinose fermentation. Carbohydrate sources 
have been shown to influence the ratio of produced lactic acid enantiomers in L. 
acidophilus [32]. F0F1 ATP synthase maintains the proton motive force by ATP 
synthesis/hydrolysis and was found to be differentially abundant in conditions of acid and 
bile stress [13, 15]. Subunits of the multimeric F0F1 ATP synthase, subunit beta (spot 87), 
and subunit delta (spot 108) was reduced in abundance by -1.6 and -1.5 fold respectively.  
 
Conclusions  
The present investigation of the interaction of prebiotic raffinose with the probiotic NCFM 
at a proteome level revealed the abundance of various proteins involved in the raffinose 
utilization. α-Galactosidase cleaves raffinose to galactose and sucrose, which possibly 
induce the sucrose, galactose and lactose loci. NCFM was found to utilize galactose by the 
Leloir pathway and sucrose by sucrose 6-p hydrolase. Furthermore, various proteins of the 
glycolysis are shown to be differentially abundant, indicating regulation of the glycolytic 
flux. Interestingly, various proteins involved in raffinose metabolism were found in 
multiple isoforms and further characterization of these proteins may contribute to 
understanding the role of posttranslational modifications in prebiotic carbohydrate 
utilization.  
This study has so far only relied on data obtained by 2DE electrophoresis. Before 
submission to BMC microbiology the 2DE-DIGE data are to be verified by semi-
quantitative RT-PCR, DNA-microarrays or equivalent methods. Furthermore it is planned 
to make small organic acid profiles for the media in fermentations, to verify that the 
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changes observed in lactate dehydrogenase L and D forms in the 2D-DIGE experiments 
have a biological effect and changes the ratio between the produced lactic acid 
enantiomers. 
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Figure Legends 
 
Fig. 1 A. Pseudocolor map of whole cell extract proteome of NCFM by 2D-DIGE. 
Proteins from glucose and raffinose grown cells were labeled with Cy5 (green) and 
Cy3 (red) respectively. A pooled internal standard of glucose and raffinose cells 
extract was labeled with Cy2 (blue) (not shown). The image overlays of Cy5- and 
Cy3-labeled proteins appear yellow. B. Progenesis SameSpots image of analyzed 
2D-DIGE gel with spot numbers. The spots identified by mass spectrometry have 
been listed in Table 1, with their fold changes. 
Fig. 2 A. Functional role category chart reporting the percentage of unique proteins 
identified by differential proteome analysis of NCFM grown on raffinose 
compared to glucose. 
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Fig. 3. Schematic representation of the differentially abundant proteins involved in 
utilization of raffinose. The genetic organization of the raffinose induced, raffinose 
operon, sucrose, lactose and galactose gene loci are shown. The proteins identified 
by 2D-DIGE and MS analysis of cytosolic proteome (pH 4−7) are shown as arrows 
in black, while the arrows in white were found to be differentially expressed in the 
transcriptome analysis of NCFM grown on raffinose (Barrangou et al. 2006). The 
following abbreviations are used, msmEFGK, multiple sugar metabolism 
transporter; melA, α-galactosidase; gftA, sucrose phosphorylase; scrR, 
transcriptional regulator; scrB, sucrose-6 phosphate hydrolase; scrA, sucrose PTS 
transporter EIIBCA
suc
;  lacR, lacR transcription repressor; lacL, β-galactosidase 
large subunit; lacM, β-galactosidase small subunit; galK, galactose kinase; galT, 
galactose-1-phosphate uridylyltransferase; galM, galactose epimerase. 
Fig. 4 A. Inset image with fold changes of some spots from the 2D-DIGE analysis of 
NCFM growth on raffinose compared to glucose. B. Image with the position of 
glycoside hydrolases on the 2D-DIGE, marked with red circles. The proteins were 
found in isoforms differing in their pI. 
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Fig. 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3%
2.3%
2.3%
2.3%
2.3%
2.3%
4.6%
6.9%
6.9%
6.9%
6.9%
53.4%
Cellular processes
Hypothetical proteins 
Proteinfate 
Regulatory functions
Transcription 
Transport 
Unknown functions 
Biosynthesis of cofactors, prosthetic groups, and carriers 
Cell envelope
Protein synthesis
Purines, pyrimidines, nucleosides and nucleotides 
Energy metabolism 
  
115 
 
Fig. 3. 
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Fig. 4. 
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Table 1: Protein identifications of differentially abundant spots (> 1.5-fold spot volume ratio change and ANOVA p < 0.05) of Lactobacillus 
acidophilus NCFM grown on SEM medium with 1% glucose and 1% raffinose. Protein identifications were confirmed with a Mascot 
score of 80 for peptide mass fingerprint and ANOVA p < 0.05, and a minimum of 6 matched peptides. A Mascot ion score of 40 and 
ANOVA p < 0.05 were used for single peptide based identifications.  
Spot 
Fold 
Change 
Accession 
number 
Protein Name 
PMF 
Score 
Mr/pI 
Sequence 
Coverage 
Peptides 
Identified
/Searched 
Identified Peptides 
Ion 
Score 
1 +13.9 gi|58337709 alpha-galactosidase 83 84653/5.63 30% 20/95 -  
2 +10.9 gi|58337861  arginyl-tRNA synthetase 83 63274/5.60 13% 7/13 -  
4 +8.0 gi|58337725 galactose-1-phosphate uridylyltransferase 147 55735/5.48 42% 20/51 FADQVVNSGAYEPLDR 144 
        FWNQYSDPAR  54 
5 +7.6 gi|58336882 myosin-crossreactive antigen 89 67700/5.91 16% 8/24 GVPEVFASAFDVR 84 
6 +5.7 gi|58337734 beta-galactosidase small subunit 122 35966/5.53 53% 13/46 NFHYLFSYER 56 
        EGKFHVDGLPVTK  71 
7 +5.7 gi|58337734 beta-galactosidase small subunit 87 35966/5.53 20% 6/16 -  
10 +7.3 gi|58337709 alpha-galactosidase 233 84653/5.63 45% 33/84 EVTQFGTLYR  66 
11 +9.6 gi|58337735 udp-glucose 4-epimerase 263 36458/5.95 67% 20/39 -  
13 +7.3 gi|58336950 UTP-glucose-1-phosphate uridylyltransferase 153 33875/5.90 60% 13/37 QPHPAGLGDAIYR 111 
        HPEIKDQLR  58 
15 +6.2 gi|58338116  maltose phosphorylase 94 87353/5.05 12% 8/17 -  
18 +5.4 gi|58337213 L-lactate dehydrogenase 150 33442/4.95 49% 14/31 ISGFPKDR  54 
19 +6.9 gi|58337733 beta-galactosidase large subunit (lactase) 220 73492/4.98 43% 29/78 DHDIHIVFEGAER  103 
20 +5.4 gi|58336737 sucrose-6-p hydrolase 83 55364/5.30 13% 6/9 -  
21 +5.3 gi|58337008 phosphoglucomutase 136 64122/5.18 19% 11/14 -  
23 +5.2 gi|58336799 hypothetical protein LBA0466 138 63103/5.39 21% 11/17 -  
24 +5.4 gi|58337735 udp-glucose 4-epimerase 128 36458/5.95 30% 8/10 -  
28 +4.5 gi|58338116 maltose phosphorylase 93 87353/5.05 17% 8/20 -  
29 +4.4 gi|58336799 hypothetical protein LBA0466 281 63103/5.39 55% 25/45 -  
30 +4.1 gi|58337322 oxidoreductase 151 31816/5.19 40% 11/28 HIDTASAYGNEDSVGR 154 
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        SGINRHELFITTK  67 
        AIGVSNFR  53 
34 +3.3 gi|58337008 phosphoglucomutase 212 64122/5.18 40% 22/45 INLFTVGR  59 
        GVVIAFDSR  64 
        YGVAYEITR  71 
36 +3.3 gi|58337733 beta-galactosidase large subunit (lactase) 202 73492/4.98 38% 25/75 -  
38 +3.1 gi|58337726 galactokinase 173 43521/4.74 41% 15/38 -  
40 +3.9 gi|58337322 oxidoreductase 99 31816/5.19 37% 8/21 -  
41 +2.8 gi|58336369 fructokinase 121 32016/5.08 41% 9/25 FIVAVQDVETGKEVAR 134 
43 +2.9 gi|58337726 galactokinase 187 43521/4.74 44% 17/37 HAVSENQR 71 
46 +2.8 gi|58336994 putative phosphate starvation inducible protein 
stressrelated 
117 21503/5.46 52% 10/26 YNVRGENIEVTDALR 
86 
        GENIEVTDALR  104 
        SIDFVSEKLER  91 
        GLQDFFVEQPEEEKKPSEFDIVR  190 
47 +2.7 gi|58336994 putative phosphate starvation inducible protein 
stressrelated 
92 21503/5.46 45% 9/43 YNVRGENIEVTDALR 
97 
        SIDFVSEKLER  90 
        NDGRYGLIETNE  63 
        GLQDFFVEQPEEEKKPSEFDIVR  152 
49 +2.6 gi|58336994 putative phosphate starvation inducible protein 
stressrelated 
118 21503/5.46 43% 8/15 GENIEVTDALR 
90 
        SIDFVSEKLER  82 
52 +2.5 gi|58337043 phospho-beta-galactosidase II 123 56703/5.04 24% 13/35 -  
53 +2.5 gi|58337733 beta-galactosidase large subunit (lactase) 154 73492/4.98 32% 16/38 -  
54 +2.4 gi|58337008 phosphoglucomutase 114 64122/5.18 14% 9/11 -  
56 +2.4 gi|58337890 putative deoxyribosyltransferase  18978/4.88 32% 4/12 IYLGTPFYNDDQR 98 
60 -2.3 gi|58337255 pyruvate kinase 267 63136/5.23 48% 25/42 IVSTLGPASNDIETITALANAGA
NVFR 
188 
        TTEQEGGKFTINTGDTIR  95 
        FNFSHGDHEEHR 87 
        EGINFIFASFAR  76 
63 -2.1 gi|58338190 deoxyadenosine kinase 142 24765/5.70 42% 10/25 LAQINQAIQEK 70 
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        SFEQISTDPSLKDYYAR  135 
        SIYEDALFFK  61 
64 -2.1 gi|58337152 elongation factor Tu 225 43609/4.97 60% 22/43 DLLTEYDYPGDDIPVVR 151 
        LMDIVDEYIPTPER +  
Oxidation (M)  
83 
        QTDKPFLMPVEDVFTITGR + 
Oxidation (M) 70 
65 -2.1 gi|58337537 transcription elongation factor NusA 85 43534/4.55 20% 7/21   
67 -1.9 gi|58338213 pyruvate oxidase 187 66629/4.85 45% 21/50 TPELIPVLTDEAIR 115 
        GVVEDKFPAYIGTIGR  102 
        ALIEEGEERSESPLYK  80 
        ADDNAIFAIDVGNVNVDSCR  180 
70 +1.9 gi|58338125 phosphomethylpyrimidine kinase 82 29557/5.06 25% 5/8 -  
71 +1.9 gi|58336768 catabolite control protein A 163 37154/5.43 41% 13/23 YNIIITSIENR 56 
73 +1.9 gi|58337214 aminopeptidase 99 50308/5.31 37% 13/38 -  
74 +1.8 gi|58337254 phosphofructokinase 100 34511/5.15 29% 7/15 -  
75 +1.8 gi|58336848 nicotinate phosphoribosyltransferase 211 56238/5.35 40% 22/47 NAVFETFYR 68 
        AAYIGGFDSTSNVR 98 
78 +1.7 gi|58337891 NAD-dependent aldehyde dehydrogenase 99 50588/5.14 21% 9/25 IQGVALTGSER 67 
79 +1.7 gi|58337724 galactose-1-epimerase 152 36971/5.29 39% 12/26 -  
80 -1.7 gi|58337255 pyruvate kinase 261 63136/5.23 39% 25/42 TTEQEGGKFTINTGDTIR 118 
        FEAYKGSNVTEAIGESVVR  154 
        TIIAATNSGYTAR  101 
83 -1.7 gi|58336405 D-lactate dehydrogenase 203 39177/4.96 63% 20/56 -  
84 -1.6 gi|58337019 glyceraldehyde-3-p dehydrogenase 240 36643/5.92 78% 23/58 KYESPSFEYEPNNVVSSDILGR 196 
        YESPSFEYEPNNVVSSDILGR  171 
        TVAWYDNEYSFTCQMVR  74 
85 +1.6 gi|58336496 putative nucleotide-binding protein  18166/5.28 19%  VKESILVPVDGSESAER 148 
        DGAHVDVLNVIDTR  119 
86 +1.6 gi|58336965 p-enolpyruvate-protein p-transferase PTSI 155 63886/4.79 44% 23/63 GFITDVGGR 78 
        GNDNVSYLYQPYNPSVLR  106 
87 -1.6 gi|58337090 F0F1 ATP synthase subunit beta 319 52183/4.69 63% 31/51 VIDLLEPYVR 74 
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        FTQAGSEVSALLGR  118 
        LILDGHLDDLPEDAFR  116 
88 -1.6 gi|58337255 pyruvate kinase 282 63136/5.23 54% 32/68 IVSTLGPASNDIETITALANAGA
NVFR 
192 
        TTEQEGGKFTINTGDTIR  152 
        FNFSHGDHEEHR  89 
        EGINFIFASFAR  101 
89 -1.6 gi|58337220 citrate lyase alpha chain 113 55315/5.53 26% 10/21 -  
90 +1.6 gi|58337213 L-lactate dehydrogenase 97 33442/4.95 20% 6/8 -  
93 +1.5 gi|58336965 p-enolpyruvate-protein p-transferase PTSI 138 63886/4.79 44% 19/49 GFITDVGGR 54 
        LSLMNEEIFR + Oxidation (M) 70 
        GNDNVSYLYQPYNPSVLR  109 
95 -1.5 gi|58336484 d-alanine-d-alanine ligase 160 40278/4.86 52% 17/52 LQIPADLPQDIVDTVR 96 
        LFEEAGIPYTELITR  136 
        KVYEITECSGMAR +  
Oxidation (M)  
53 
96 -1.5 gi|58337019 glyceraldehyde-3-p dehydrogenase 166 36643/5.92 54% 14/47 KYESPSFEYEPNNVVSSDILGR 190 
        YESPSFEYEPNNVVSSDILGR  149 
 98 
(Mixture) 
+1.7        
 
  gi|58337488 hypothetical protein LBA1206 139 31352/5.15 47% 13/36 GFLEADVVLLGVSR 114 
  gi|58336527  phosphoglyceromutase 100 26509/5.00 43% 9/36 -  
101 +1.5 gi|58338213 pyruvate oxidase 105 66629/4.85 35% 15/66 TPELIPVLTDEAIR 100 
        GVVEDKFPAYIGTIGR  100 
        ALIEEGEERSESPLYK  75 
        ADDNAIFAIDVGNVNVDSCR  145 
106 +1.5 gi|58338023 hypothetical protein LBA1769 162 13558/5.65 68% 9/17 VLDDGHLIYLEK 100 
        AAVVVADVPTHTNVR  139 
107 -1.5 gi|58336492 2-deoxyribosyltransferase 90 18297/4.62 27% 5/12 ISELKDFDFNKPR 93 
        DFDFNKPR  56 
108 -1.5 gi|58337087 F0F1 ATP synthase subunit delta 140 20326/4.93 43% 9/17 KYDLNAVR  55 
110 +1.9 gi|58337891 NAD-dependent aldehyde dehydrogenase 200 50588/5.14 48% 19/57 IQGVALTGSER  91 
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Abstract 
Bifidobacterium animalis subsp. lactis Bl-04 is a well known probiotic bacteria used in 
many fermented milk products. In the present study a reference proteome map of 
Bifidobacterium animalis subsp. lactis Bl-04 was established using two-dimensional gel 
electrophoresis (2-DE) and the differential abundance of proteins with different prebiotic 
carbohydrates was studied using differential 2-DE (2D-DIGE). Whole-cell protein extracts 
were separated by 2DE in the pH ranges 3−10 and 3−7. A total of 328 unique proteins were 
identified by MS/MS-MS analysis from the 960 spots picked from the 2D gel. The 
identified spots were distributed among the 22 functional classes and the major fraction of 
the identifications possesses to the functional role translation and ribosomal structure. The 
2D-DIGE analysis with galactooligosaccharides, raffinose family oligosaccharides and 
isomaltooligosaccharides revealed various proteins involved in the metabolism of these 
prebiotic carbohydrates. The glycoside hydrolase β-galactosidace (Balac_0484) was found 
to be 2.0 fold more abundant with galactooligosaccharides than on glucose. The glycoside 
hydrolases α-galactosidase (Balac_1601), oligo-1,6-glucosidase (Balac_1593) and sucrose 
phosphorylase (Balac_0138) were found to be upregulated with 1.5−11.2 fold for 
melibiose, raffinose family oligosaccharides raffinose, and stachyose and 
isomaltooligosaccharides panose and isomaltose. Various proteins of the bifid shunt 
including L-ribulose-5-phosphate 4-epimerase, phosphoketolase, phosphoglucomutase, 
transketolase, 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase, 
glyceraldehyde-3-phosphate dehydrogenase, pyruvate kinase and L-lactate dehydrogenase 
were found to be differentially abundant with these prebiotic oligosaccharides candidates 
as carbon source. 
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Introduction 
Bifidobacteria are high G+C Gram-positive non-motile anaerobic rod-shaped bacteria from 
the actinobacterial branch of bacteria [1]. They are found in the large intestines of most 
mammals, including humans and different species from the genus bifidobacteria have been 
linked to health promoting probiotic traits. Bifidobacteria represents a significant genus of 
the gastro intestinal tract (GIT) microbiota (up to 3% of the total fecal microflora of adults) 
[2]. Bifidobacteria have been shown to survive in the GIT, to adhere to human epithelial 
cells in vitro, modify fecal flora, modulate the host immune response and to prevent 
microbial gastroenteritis as well as colitis [3,4,5,6,7,8]. Currently bifidobacteria are used 
with increasing frequency in the food industry as health-promoting microorganisms. 
Efforts have been made to increase the diversity and number of bifidobacterial species in 
the intestinal tract by supplying certain bifidobacteria strains or prebiotic food ingredients 
that can stimulate the growth of bifidobacteria or a combination of both. The therapeutic 
effects of these practices have been described by treatment and prevention of 
gastrointestinal disorders [9]. Bifidobacteria are thought to act as scavengers of 
carbohydrate oligosaccharides in the large intestine [1,10,11]. They possess a range of 
carbohydrate transporters and glycoside hydrolases that confer a growth advantage where 
readily fermentable carbohydrates are in low supply [1,12].  
Bifidobacterium animalis subsp. lactis Bl-04 (Bl-04) has been isolated from different 
sources e.g. human and animal feces, sewage and fermented milk [13]. The 1.94 Mb 
genome of Bl-04 encodes for 1567 proteins 
(http://www.ncbi.nlm.nih.gov/genome/844?project_id=59359), comprising of 38 glycoside 
hydrolases (http://www.cazy.org/b982.html) capable of hydrolyzing carbohydrates of 
varying linkage type and monosaccharide composition. Three different groups of prebiotic 
carbohydrates including, β-galactosyl linked galactooligosaccharides (GOS), α-galactosyl 
linked melibiose, and raffinose family oligosaccharides (RFO) as well as 
isomaltooligosaccharides (IMO) i.e α-(1→6) linked glucose oligomers were used in the 
present study using 2D-DIGE, to monitor the specific effects of potential prebiotic 
carbohydrates. GOS are well described prebiotics able to promote growth and beneficial 
activities of bifidobacteria [14]. Furthermore GOS have been proposed to act as a 
molecular decoy that mimic the epithelial carbohydrate binding sites recognized by 
pathogens and thereby suppress infection of pathogenic species [15]. RFO constitute an 
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emerging class of prebiotic carbohydrates derived from soybean and lupins. Raffinose was 
been shown to modulate the human intestinal microbiota with beneficial effects [16]. 
Finally IMO are known to be selectively fermented by bifidobacteria and increase their 
number in the presence of the human gut microflora [14].  
Proteome studies of bifidobacteria primarily focused on establishing reference proteome of 
B. longum [17,18], utilization of different carbohydrate sources [19,20], and adaptation to 
stress conditions [21,22]. There are no previous reports on the reference proteome of B. 
animalis and this is the first report of B. animalis reference proteome and the adaptations to 
various prebiotics. The whole cell extract reference proteome of Bl-04 grown MRS-
glucose was established by using 2D-gel electrophoresis (pH 3−7 and pH 3−10) to provide 
a basis for subsequent differential proteome studies of the prebiotic metabolism. CyDye 
minimal labeling using a dye swapping approach was used for the differential proteome 
analysis using 2-DE DIGE.  
 
Material and Methods 
Growth Conditions and Protein Extraction 
Bifidobacterium animalis subsp. lactis Bl-04 (Bl-04); (DuPont Nutrition & Health, Kantvik, 
Finland) was grown under anaerobic conditions without agitation at 37 °C in 50 mL batch 
cultures in MRS media [23] for analyzing the soluble whole cell reference proteome (pH 
3−7 and pH 3−10). Bl-04 was grown under anaerobic conditions without agitation at 37 °C 
in 50 mL batch cultures in semi-synthetic medium (LABSEM) [24], supplemented with 1% 
of carbohydrate carbon source for the DIGE analysis (pH 3−7). Cultures were sub-cultured 
in the LABSEM media for three cycles prior to analysis, to avoid chemical carry-over 
effects. The cells were harvested at late-log phase by centrifugation (3200 g, 10 min, 4 °C), 
and washed twice with 0.9% NaCl. The cell pellet was added an approximately equal 
volume of acid washed glass beads (<100 μm diameter; Sigma, Brøndby, Denmark) 
followed by 300 μL phenol (Tris saturated, pH 8.0) and 300 μL 10 mM DTT, 10 mM Tris 
(pH 8.0). Disruption was carried out (Bio 101 Savant FastPrep FP 120 bead beater, Savant, 
Farmingdale, USA) at a speed of 6.5 m/s for four cycles of 45 s each with intermittent 
cooling on ice. The cell lysate was centrifuged (10,000 g, 10 min, 4 ºC) resulting in three 
distinct phases. The phenol phase was transferred to a microtube, added ice-cold ethanol 
(four volumes), kept at −20 ºC overnight and centrifuged (15000 g, 10 min, 4 ºC). The 
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resulting precipitate was dissolved in 300 μL rehydration buffer (7 M urea, 2 M thiourea, 2 % 
CHAPS, 200 mM bis(2-hydroxyethyl) disulfide (HED), and 2% pharmalyte pH 3−10  (GE 
Life Sciences, Uppsala, Sweden). The protein concentration was determined (2D Quant kit; 
GE Life Sciences) and the samples kept at −80 °C until use. 
 
Sample Preparation for 2-DE and DIGE 
For the MRS grown whole cell soluble proteome an extract containing 300 μg protein was 
diluted with rehydration buffer (8 M urea, 2 M thiourea, 2 % CHAPS, 0.5% pharmalyte pH 
4−7 , 0.3% DTT) up to 450 μL and applied on immobilized pH gradient (IPG) strips (linear 
pH 3−7 and pH 3−10; 24 cm). For the DIGE analysis, a dye-swapping approach was used 
to avoid bias due to the interference from fluorescence properties of gels at different 
wavelengths [25]. A protein aliquot (50 μg) of each of four biological replicates grown 
with the same carbon source was labeled interchangeably with 400 pmol of either Cy3 or 
Cy5 dye. For the internal standard, aliquots (25 μg protein) of each sample in the 
experiment were pooled and labeled with 400 pmol Cy2. The Cy dye labeled samples were 
vortexed, and left in the dark (30 min, 4 °C). Labeling reactions were quenched by 2 μL 
200 mM lysine in the dark (20 min). The internal standard and the samples were mixed and 
the volume was made to 450 μL with rehydration buffer for IPG strips (linear pH 3−7, 24 
cm). 
 
2-D gel electrophoresis 
Separation in the first dimension (isoelectric focusing, IEF) was performed using IPG 
strips (pH 3−7 and 3−10; 24 cm; GE Lifesciences) on EttanTM IPGphor (GE Lifesciences). 
Rehydration was carried out at 20 °C for 12 h. IEF was performed at a total of 70 kVh (1 h 
at 150 V, 1 h at 300 V, 1 h at 1,000 V, gradient to 8,000 V, hold at 8,000 V until a total of at 
least 70 kVh was reached). Subsequently, strips were equilibrated for 2  15 min in 5 mL 
equilibration buffer (6 M urea, 30% glycerol, 50 mM Tris-HCl, pH 8.8, 2% SDS, and 0.01% 
bromophenol blue) supplemented with 1% DTT and 2.5% iodoacetamide in the first and 
second equilibration step, respectively. The strips were placed on 12.5% SDS-PAGE gels 
and overlaid with 0.5% molten agarose in 1  SDS running buffer (0.25 M Tris-base, 1.92 
M glycine, and 1% SDS). The second dimension (SDS-PAGE) was performed on Ettan
TM 
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DALT twelve Electrophoresis Unit (GE Lifesciences) overnight at 1 W/gel until the dye 
front reached the gel bottom. The reference map gels for whole cell extract proteome (pH 
3−7 and pH 3−10) were stained by colloidal Coomassie Brilliant Blue (CBB) as described 
previously [26]. 
 
Image Analysis 
Images of CBB stained gels were generated (Microtek scanner; Scan maker 9800XL; 
Microtek, Carson, USA) using Photoshop CS4 software. Imaging of DIGE gels (four 
biological replicates and four internal standard gels) was done immediately after the 
second dimension run at excitation/emission wavelengths of Cy2 (488/520 nm), Cy3 
(532/580 nm) and Cy5 (633/670 nm), respectively (100 μm resolution; Typhoon 9410 
Variable Mode Imager; GE Lifesciences). Gel images were analyzed by Progenesis 
SameSpots version 3.3 (nonlinear Dynamics Ltd, Newcastle upon Tyne, UK). Scanned gels 
were analyzed by intra-gel (difference in-gel analysis) and inter-gel (biological variance 
analysis) analysis. A 1.5-fold threshold (spot volume ratio change and ANOVA p < 0.05) 
and false discovery rate q < 0.05 was chosen as criterion in the identification of 
differentially abundant protein spots. Gels were post-stained with CBB prior to spot 
protein identification. 
 
In-gel Digestion and Protein Identification by MS 
Spots on the 2-DE reference map and DIGE gels were excised manually and subjected to 
in-gel tryptic digestion with some modifications as described below [27]. Gel pieces were 
washed with 100 μL 40% ethanol (10 min) followed by 50 μl 100% acetonitrile (ACN), 
and incubated 45 min on ice with 2 μL 12.5 ng μL-1 trypsin (Promega, Nacka, Sweden) in 
25 mM ammonium bicarbonate followed by addition of 10 μL 25 mM ammonium 
bicarbonate for rehydration, and incubated at 37 °C overnight. A supernatant aliquot (1 μL) 
was applied to the Anchor Chip target plate (Bruker Daltonics, Bremen, Germany), 
covered by 1 μL matrix solution (0.5 μg μL-1 α-cyano-4-hydroxycinnamic acid in 90% 
ACN, 0.1% TFA) and washed in 0.02% TFA. MS and MS/MS spectra measurements were 
performed on a Bruker Ultraflex II TOF/TOF-MS (Bruker Daltronics) equipped with a 
nitrogen laser, working in reflecton mode. Spectra were externally calibrated using a 
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tryptic digest of β-lactoglobulin (5 pmol µL-1). The MS together with MS/MS spectra were 
searched against the NCBInr database for bacteria (NCBInr 20091112; 10032801 
sequences; 3422028181 residues) using the MASCOT 2.4 software 
(http://www.matrixscience.com) integrated together with BioTools v3.1 (Bruker-Daltonics). 
Database search parameters used were, peptide charge of +1, peptide mass accuracy of 80 
ppm, maximum one partial cleavage, fragment mass accuracy was set to + 0.5 Da,  
carbamidomethylation was set as fixed modification of cysteine and partial oxidation of 
methionine. Filtering of peaks was done for known autocatalytic trypsin peaks and keratin 
peaks; the signal to noise threshold ratio was set to 1:6. Protein identifications were 
confirmed with a Mascot score cutoff of 84 for peptide mass fingerprint (PMF) and 42 for 
single peptide based MS/MS analysis which refer to significant P-values (p < 0.05). 
Mascot uses probability based scoring and is described by −10×Log10(P), where P is the 
probability that the observed match is a random event. Protein scores greater than 84 are 
significant (p < 0.05). PMF identifications with low scores were confirmed by additional 
MS/MS identification. 
 
Results and Discussion 
Reference Proteome of Bifidobacterium animalis subsp. lactis Bl-04 
The Bl-04 genome with 1631 annotated genes encodes a proteome comprosing 1567 
proteins. The cytosolic proteome excluding predicted secreted and membrane proteins is 
predicted to encompass ~800 proteins. The cytosolic proteins are predicted to be 
distributed in the pI 3.5−12 and Mr 5−200 kDa and are the primary focus in the present 
proteome study. Bacterial proteomes show a bimodal distribution based on pI, with 
proteins moving away from the cytoplasmic pH [28]. The bimodal pattern of proteome 
distribution of Bl-04 is similar to reported proteomes of gut microbiota [19,29,30] with a 
high concentration of proteins in the pI 3−7. The in silico virtual gel of the cytosolic 
proteins show a high density of proteins in the pI 3−7 and constitute to ~75 % of the total 
cytosolic proteins (http://web.expasy.org/protparam/). A similar distribution corresponding 
to the virtual gel was observed for the reference gel in the pH 3−10 (Fig. 1). 585 spots were 
picked for identification by MALDI MS/MS-MS and resulted in 517 protein identifications 
(Supplementary Table 1A). To better resolve proteins in the dense pH 3−7 range, the whole 
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cell extract proteome was resolved on a 2D-gel within the pH 3−7 (Fig. 2). A total of 375 
spots were picked from the 2D-gel in the pH 3−7 and resulted in 353 protein identifications 
(Supplementary Table 1B). From the 2D-gels of pH 3−7 and pH 3−10 a total of 960 spots 
were picked and 870 spots were identified (Supplementary Table 1A and B). The 
observation that only 328 unique protein identifications were made from the 870 protein 
identifications, possibly reflects PTMs. A similar pattern was observed for the B. longum 2-
DE based reference map, where 369 unique identifications were made from 708 spots 
identified [18]. In the present study the proteome coverage was ~21% and previous 
proteome studies of Bifidobacteria have reported coverage of 6−22% [17,31]. Other 
proteome studies of Gram-positive bacteria have reported identification rates of 3.3−22% 
[18,32,33,34].  
A relatively large part of the proteins identified in the composite reference proteome 
(~18%) are involved in protein synthesis including ribosomal proteins, translational factors 
and tRNA-synthases (Fig. 3; Supplementary Table 1A and B). This suggests that cells were 
propagating at a relatively high growth rate at the time of harvest since ribosomal proteins 
are growth rate regulated in most bacteria [35,36]. Another dominant class found in the Bl-
04 reference map was proteins involved in carbohydrate metabolism and energy 
conversion, 11% and 6% respectively. The proteins of the metabolic pathway “bifid shunt”, 
including the taxonomic marker enzyme phosphoketolase (Fig. 2, spot 50−54 and 357) 
were found in the 2-DE maps, within the pH 3−7. The key enzymes of the bifid shunt 
where found in multiple spots indicating PTMs. Putative xylulose-5-phosphate/fructose-6-
phosphate (X5P/F6P) phosphoketolase (Balac_0971) (Fig. 2, spot 50−54), transketolase 
(Balac_0842) (Fig. 2, spot 23−26), and transaldolase (Balac_0843) (Fig. 2, spot 175 and 
176), were identified in multiple spots of differing pI values and Mr. Post translational 
modifications are in  regulating the activity of glycolytic enzymes [37] and this multiple 
spot pattern has often been observed in 2-DE proteomic studies [18,19]. Noticeably 
proteins involved in the metabolism of carbohydrates other than glucose were also 
identified in the reference proteome. For example proteins involved in galactose 
metabolism, galactokinase (Fig. 1, spot 207; Supplementary Table 1A) and UDP-glucose 
4-epimerase (Fig. 1, spot 231 and 232; Fig. 2, spot 169,192 and 193; Supplementary Table 
1A and 1B); in sucrose metabolism, sucrose phosphorylase (Fig. 2, spot 100; 
Supplementary Table 1B); and in degradation of β-linked glucans, β-D-
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glucosideglucohydrolase (Fig. 2, spot 8 and 9) and β-glucosidase (Fig. 2 spot 104; 
Supplementary Table 1B) ; in degradation of maltodextrins, 4-α-glucanotransferase (Fig. 1, 
spot 334−337; Supplementary Table 1A). A third prominent group of proteins identified in 
the Bl-04 2-DE reference map were involved in amino acid and nucleotide transport and 
metabolism corresponding to ~10 % and ~8 % respectively (Fig. 3). Especially enzymes 
catalyzing steps in the metabolism of threonine, glutamine, arginine, histidine and serine 
were observed.   
 
2DE-DIGE 
Molecular mechanisms of adaptation of probiotic bacteria to prebiotic carbohydrates have 
been previously studied in lactobacillus and bifidobacteria using transcriptomic and 
proteomic approaches [38,39,40,41]. Bifidobacteria are able to ferment several 
oligosaccharides, including GOS, RFO and IMO. Here we apply differential proteomics 
using (2DE-DIGE) to gain insights into Bl-04 utilization of various oligosaccharides at 
proteome level. Carbohydrate utilization in bifidobacteria is characterized by the 
channeling of the carbohydrate via the bifid shunt (pentose phosphate pathway). The ratio 
of the end products of carbohydrate metabolism i.e. lactate to acetate changes with the type 
of sugar fermented in bifidobacteria [19,42]. The differential abundance of proteins in the 
whole cell proteome of Bl-04 grown on glucose was compared to growth on GOS, RFO 
and IMO.  
 
Differential abundance of proteins in Bl-04 with GOS 
2D-DIGE analysis of the differential proteome revealed a total of 35 spots to have > 1.5-
fold difference in relative abundance (Fig. 4). Thirty protein identifications were possible 
from the 35 spots and represent, 27 unique proteins (Table 1). Identified proteins of the 
carbohydrate metabolism include, -galactosidase (Balac_0484) (spot 286); UDP-glucose-
4-epimerase (spot 620); L-ribulose-5-phosphate 4-epimerase (spot 849); X5P/F6P-
phosphoketolase (spot 238); phosphoglucomutase (spot 353); transketolase (spot 274); 2,3-
bisphosphoglycerate-dependent phosphoglycerate mutase (spot 478); glyceraldehyde-3-
phosphate dehydrogenase (spot 633); and pyruvate kinase (spot 361). Bifidobacteria are 
known to poses multiple copies of -galactosidase (http://www.cazy.org/), while the Bl-04 
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genome encodes three -galactosidases. -Galactosidase (spot 286) was found to be +2.0 
fold upregulated in the presence of GOS and is the primary glycoside hydrolase 
hydrolysing -linked galactose oligomers. UDP-glucose-4-epimerase and 
phosphoglucomutase involved in the conversion of galactose moieties to α-D-glucose-6-P 
were found to be 2.4 and 1.6 fold upregulated. α-D-Glucose-6-P enters the bifid shunt [43] 
and L-ribulose-5-phosphate 4-epimerase, transketolase, and putative phosphoketolase of 
the bifid shunt were found to be differentially abundant (+1.6−(+3.7) fold) (Table 1). The 
glycerate-3-P generated by glyceraldehyde-3-phosphate dehydrogenase is converted to 
glycerate-2-P and finally to pyruvate by 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase and pyruvate kinase, which were found to be lower in abundance 
by 1.5 and 1.7 fold respectively. The end products of bifidobacteria carbohydrate 
fermentation include acetate, L-lactate, ethyl alcohol, and formate [42]. The bifunctional 
acetaldehyde-CoA/alcohol dehydrogenase (spot 110) involved in the inter conversion of 
acetaldehyde to ethyl alcohol was found to be 2.6 fold upregulated when grown on GOS. 
The differential abundance of proteins of the end product carbohydrate metabolism in the 
GOS proteome suggests a change in the lactate to acetate ratio. Proteome investigation of 
B. longum grown on galactose resulted in similar differential abundance UDP-glucose-4-
epimerase and phosphoglucomutase and lowered acetate to lactate ratio [19]. Additional 
noticeable observations from the proteome of GOS grown Bl-04 cells is the down 
regulation (−1.6−2.2 fold) of proteins belonging to the COG group involved in 
transcription and translation. 
 
Differential abundance of proteins in Bl-04 grown on RFO 
Raffinose family oligosaccharides (RFO) are α-galactosyl derivatives of sucrose. In the 
present study, the trisaccharide raffinose (α-D-Galp-(1→6)-D-Glcp-(α1,β2)-D-Fruf) and 
tetrasaccharide stachyose (α-D-Galp-(1→6)-D-Galp-(1→6)-D-Glcp-(α1,β2)-D-Fruf) were 
used along with the disaccharide melibiose (α-D-Galp-(1→6)-D-Glcp). The administration 
of raffinose has shown to increase the levels of bifidobacteria sp. in the gut [44]. In the 
present study a total of 61, 39 and 63 spots were found to be differentially abundant with > 
1.5-fold relative abundance and 52, 33 and 63 protein identifications were possible, with 
growth on α-galactose linked carbohydrates, stachyose, raffinose and melibiose 
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respectively (Fig. 5; Table 2A, B and C). The glycoside hydrolases -galactosidase (GH36; 
Balac_1601) and the oligo-1-6-glucosidase (GH31; Balac_1593) were found to be 
abundant in the proteome of Bl-04 with growth on the three oligosaccharides. -
Galactosidase was found in the three corresponding proteomes as two multiple forms 
differing in pI, with a fold change abundance of 2.7−5.0 fold (Fig. 4; Table 3). The -
galactosidase, releases the galactose moiety liberating glucose, sucrose and raffinose from 
melibiose, raffinose and staychose respectively [45]. The liberated galactose enters the 
central metabolism via the Leloir pathway, and UDP-glucose-4-epimerase of this pathway 
was 2.2−3.7 fold upregulated. Sucrose is generated from the hydrolysis of raffinose and 
stachyose and sucrose phosphorylase (GH 13_18; Balac_0138) acts on sucrose to liberate 
fructose and glucose-1-P  [46]. Sucrose phosphorylase could be identified on 2D-DIGE 
gels of cultures grown on melibiose (spot 416, fold +1.6) and stachyose (spot 416, fold 
+1.6) but not raffinose. Induction of sucrose phosphorylase was found to be under the 
transcriptional regulation of GalR-LacI-type regulator and was induced in the presence of 
sucrose and raffinose in B. lactis and B. longum [47,48]. Melibiose also seems to induce 
the synthesis of Bl-04 sucrose phosphorylase. Sucrose phosphorylase mutants of the Gram-
positive bacteria Streptococcus mutans failed to utilize melibiose, and require a functional 
sucrose phosphorylase for metabolizing melibiose [49]. A similar interaction with sucrose 
phosphorylase for utilization of melibiose in Bl-04 is a plausible explanation for the 
induction of sucrose phosphorylase with melibiose.  
In addition to changes in abundance of various proteins of the bifid shunt (Table 2A, B and 
C), notably, is the change in abundance of glycoside hydrolase oligo-1,6-glucosidase 
(+1.5−(+2.2) fold) with growth in all the three carbohydrates (Table 2A, B and C). The 
gene cluster involved in the metabolism of -galactose linked sugars includes two -
galactosidases (Balac_1596 and Balac_1601), components of the ABC transporter for 
sugars, oligo-1,6-glucosidase and two transcriptional regulators (Fig. 7). The gene cluster 
is similar to the multiple sugar metabolism gene cluster in Gram-positive bacteria capable 
of utilizing melibiose, raffinose and isomalooligosaccharides [50,51,52]. Only one of the 
-galactosidases (Balac_1601) was found to be differentially abundant in cultures grown 
on -galactose linked sugars (Table 2A, B and C). The presence and induction of oligo-1-
6-glucosidase indicates transcriptional regulation and induction by -galactose linked 
sugars and the capability of the gene cluster in Bl-04 to utilize multiple sugars.  
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Differential abundance of proteins in Bl-04 grown on IMO 
IMO are glucose oligomers with α-D-(1→6)-linkages, and in the present study the 
disaccharide isomaltose (α-D-Glcp(1→6)-α-D-Glcp) and trisaccharide panose (α-D-
Glcp(1→6)-α-D-Glcp-(1→4)-D-Glcp) were used. A total of 105 and 96 spots were found to 
be differentially expressed with > 1.5- relative fold change and 92 and 84 protein 
identifications were possible after growth on IMO isomaltose and panose respectively (Fig. 
6; Table 4A and B). Oligo-1-6-glucosidase (GH 13) shows preferential activity towards 
panose and isomaltose in bifidobacteria [43] and was found to be 1.6−3.1 fold upregulated, 
by growth on isomaltose and panose (Fig. 6; Table 4A and B). Oligo-1,6-glucosidase 
(Balac_1593) liberates two molecules of glucose from isomaltose and glucose together 
with the α-1→4 linked glucose disaccharide maltose from panose. The gene encoding 
oligo-1,6-glucosidase is located in the gene cluster involved in the metabolism of -
galactose linked sugars, and -galactosidase was upregulated 3.1−11.2 fold (Fig. 6; Table 
4A and B). The coexpression of the proteins for melibiose, isomaltose and raffinose 
utilization in similar gene clusters has been reported for Gram-positive bacteria [53]. 
Remarkably sucrose phosphoryalase was also found to be differentially abundant with 
+1.5−(+1.7) fold change during growth on isomaltose and panose. Similarly, in B. lactis, 
sucrose phosphorylase was found to be induced by oligofructose in addition to sucrose and 
raffinose and was repressed by glucose [48]. The increase in abundancy of sucrose 
phosphorylase (Balac_0138), during growth on the carbohydrates melibiose, isomaltose 
and panose for Bl-04, suggests differences in regulation of GalR-LacI-type transcriptional 
regulator from other Gram-positive bacteria. The exact mechanism of regulation in 
bifidobacteria is not known, but the divergent evolution of GalR-LacI type repressor from 
other Gram-positive bacteria has been suggested to the differences in regulation from other 
known regulatory mechanisms [48].  
Similar to the differential abundance of proteins of the bifid shunt during growth on GOS 
and RFO’s, growth on IMO, alters the abundance of proteins from this pathway (Fig. 6; 
Table 4A and B). Carbohydrate sources have been shown to influence the end products of 
their metabolism, primarily influencing the lactate to acetate ratio [19,54]. The isoforms of 
L-lactate dehydrogenase 2 (spots 640 and 643; Fig. 6; Table 4A and B) involved in the 
inter conversion of pyruvate to L-lactate was found to be lower in abundance by 2.0−2.9 
fold (Table 4A and B). The lowered abundance of L-lactate dehydrogenase indicates a 
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change in the ratio of lactate to acetate. Degradation of inulin-type fructans has been 
shown to increase acetic acid production in B. animalis [55]. It has been suggested in 
bifidobacteria that the presence of high intracellular sugar concentrations leads to lactic 
acid production, while low intracellular sugar concentrations with less fermentable sugars 
leads to short chain fatty acids like formic and acetic acid production to maintain the redox 
balance in the cell [55,56].  
 
Concluding Remarks 
The bifidobacteria in the gut are shown to promote human health. Proteome analyses of 
bifidobacteria have been previously carried out for B. longum sp. involving reference 
proteomes, adaptation to bile stress and carbohydrate sources have been studied. In the 
present work 2D-gel based proteomics to establish the cytosolic proteome of 
Bifidobacterium animalis subsp lactis Bl-04 and the molecular mechanisms of prebiotic 
carbohydrate metabolism of Bl-04 with different carbohydrate sources was analyzed using 
2D-DIGE. On the reference cytosolic proteome of Bl-04, 870 protein spots were identified 
representing 328 unique proteins. The differential proteome analysis of Bl-04 with 
prebiotic carbohydrates GOS, ROS and IMO identified proteins involved in the 
metabolism of carbohydrates with different glycosidic linkages and composition. The 
prebiotic carbohydrate sources have been shown to influence abundance of the proteins of 
the bifid shunt and play a role in the production of end product metabolites. A single gene 
cluster was found to be involved in the metabolism of multiple sugars like α-galactosides 
melibiose, raffinose, stachyose and the α-glucosides isomaltose and panose. 
This study has so far only relied on data obtained by 2DE electrophoresis. Before 
submission to PLOS ONE the 2DE-DIGE data are to be verified by semi-quantitative RT-
PCR, DNA-microarrays or equivalent methods. Furthermore it is planned to make small 
organic acid profiles for the media in the different fermentations in the study, to verify that 
the changes observed in pyruvate metabolism in the 2D-DIGE experiments have a 
biological effect. 
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Legend to Figures 
 
Fig. 1.  A detailed 2-DE of the 400 µg whole cell extract soluble proteins (pH 3−10) of 
Bifidobacterium animalis subsp. lactis Bl-04 grown on MRS medium with 1% 
glucose. Numbered spots are chosen for analysis by in-gel digestion and mass 
spectrometry.   
Fig. 2.  A detailed 2-DE of the 300 µg whole cell extract soluble proteins (pH 3−7) of 
Bifidobacterium animalis subsp. lactis Bl-04 grown on MRS medium with 1% 
glucose. Numbered spots are chosen for analysis by in-gel digestion and mass 
spectrometry.   
Fig. 3. Functional grouping of the 328 identified unique proteins on the 2-DE (pH 37 and 
310) of Bifidobacterium animalis subsp. lactis Bl-04. 
Fig. 4. Progenesis Samespots image of analyzed 2D-DIGE gel of Bifidobacterium animalis 
subsp. lactis Bl-04 grown with glucose and GOS as the carbon source. The 
numbers on the gel indicate differentially abundant spots (Fold change: > 1.5; 
ANOVA p < 0.05; False discovery rate q < 0.05). The spots were analysed by in-
gel digestion and mass spectrometry.   
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Fig. 5. Progenesis Samespots image of analyzed 2D-DIGE gel of Bifidobacterium animalis 
subsp. lactis Bl-04 grown with glucose and staychose (A), with glucose and 
raffinose (B) and with glucose and melibiose (C) as the carbon source. The 
numbers on the gel indicate differentially abundant spots (Fold change: > 1.5; 
ANOVA p < 0.05; False discovery rate q < 0.05). The spots were analysed by in-
gel digestion and mass spectrometry.   
Fig. 6. Progenesis Samespots image of analyzed 2D-DIGE gel of Bifidobacterium animalis 
subsp. lactis Bl-04 grown with glucose and panose (A) and with glucose and 
isomaltose (B) as the carbon source. The numbers on the gel indicate differentially 
abundant spots (Fold change: > 1.5; ANOVA p < 0.05; False discovery rate q < 
0.05). The spots were analysed by in-gel digestion and mass spectrometry.   
Fig. 7. Schematic representation of the differentially abundant proteins involved in the 
utilization of RFO and IMO. The genetic organization of the melibiose, raffinose 
fanily oligosaccharide and isomaltooligosaccharide induced, gene cluster, and 
sucrose uttilization gene loci are shown. The proteins identified by 2D-DIGE and 
MS analysis of cytosolic proteome (pH 3−7) are shown as arrows in black.  
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Table 1: Protein identifications of differentially abundant spots (≥ 1.5-fold spot volume ratio change and ANOVA p ≤ 0.05) of 
Bifidobacterium animalis subsp. lactis grown on SEM medium with 1% glucose and 1% GOS. 
 
Spot  Accession Protein name 
Mascot 
score 
Mr /pI 
Anova (p) 
(DIGE)  
Fold  
COG Functional 
role* 
849 gi|241190131 L-ribulose-5-phosphate 4-epimerase  417 24576/5.06 2.53E-05 +3.7 G 
110 gi|241190429 bifunctional acetaldehyde-CoA/alcohol dehydrogenase  397 105257/5.69 0.006 +2.6 C 
620 gi|241190508 UDP-glucose 4-epimerase  427 34894/4.81 0.007 +2.4 M 
56 gi|241190667 Carbamoylphosphate synthase large subunit  415 125134/4.9 0.0009531 +2.2 EF 
388 gi|241190132 L-arabinose isomerase  343 55406/4.90 0.007 +2.1 G 
286 gi|241190531 beta-galactosidase  393 69369/4.78 0.002 +2.0 G 
374 gi|241190571 inosine-5'-monophosphate dehydrogenase  537 58116/5.3 0.0005322 +2.0 F 
431 gi|241190489 aminopeptidase C  330 48233/4.97 0.000745 +1.9 E 
238 gi|241191000 X5P/F6P phosphoketolase  441 84552/4.95 0.003 +1.9 G 
678 gi|241191290 ATP binding protein of ABC transporter for glutamate_aspartate  377 29894/5.24 0.005 +1.8 E 
245 gi|241191166 dipeptide transport ATP-binding protein  267 83448/5.33 0.002 +1.8 R 
237 gi|241191166 dipeptide transport ATP-binding protein  374 84828/5.29 0.006 +1.6 R 
353 gi|241190474 phosphoglucomutase  400 60826/5.16 0.008 +1.6 G 
274 gi|241190872 transketolase  386 74062/4.67 0.003 +1.6 G 
        1032 gi|241191249 histidinol dehydrogenase  330 22768/4.66 0.004 -3.2 E 
990 gi|241190823 hypothetical protein Balac_0787  129 11541/5.01 0.009 -3.1 − 
1029 gi|241190089 oxidoreductase  191 23011/4.76 0.0007991 -2.3 R 
906 gi|241190812 ribosome recycling factor  97 21331/5.52 0.007 -2.2 J 
790 gi|241190653 phosphoribosylaminoimidazole-succinocarboxamidesynthase  359 27087/5.03 0.002 -2.1 F 
1003 gi|241190258 hypothetical protein Balac_0197  150 12297/5.28 0.008 -2 S 
470 gi|241190472 seryl-tRNA synthetase  266 42494/5.35 0.004 -1.9 J 
463 gi|241190661 elongation factor Tu  170 44726/4.76 0.002 -1.8 J 
537 gi|241190463 transcription elongation factor NusA  173 38588/5.64 0.003 -1.8 K 
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672 gi|241191625 thioredoxin reductase  219 30210/4.66 0.014 -1.8 O 
475 gi|241191613 ATP binding protein of ABC transporter for sugars  171 42016/5.29 0.015 -1.7 G 
633 gi|241191186 Glyceraldehyde-3-phosphate dehydrogenase  339 33607/5.35 0.003 -1.7 G 
361 gi|241191011 pyruvate kinase  235 58913/5.00 0.01 -1.7 G 
817 gi|241190768 elongation factor Tu  183 44281/4.91 0.015 -1.6 IQR 
478 gi|241191613 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase  171 27636/5.33 0.003 -1.5 G 
964 gi|241190504 Hypothetical redox protein  301 15191/5.36 0.01 -1.5 O 
 
*COG Functional role: J, Translation, ribosomal structure and biogenesis; G, Carbohydrate transport and metabolism; E, Amino acid transport and metabolism; F, Nucleotide 
transport and metabolism, R, General function prediction only; O, Signal transduction mechanisms; C, Energy production and conversion, −, ORFs with 
no COG annotation; K, Transcription; M, Cell envelope biogenesis, outer membrane; L, DNA replication, recombination and repair; T, Posttranslational 
modification, protein turnover, chaperones; H, Coenzyme metabolism; I, Lipid metabolism; P, Inorganic ion transport and metabolism; S, Function 
unknown; D, Cell division and chromosome partitioning; U, Intracellular trafficking and secretion; A, RNA processing and modification; V, Defence 
mechanisms; Q, Secondary metabolites biosynthesis, transport and catabolism; N, Cell motility and secretion  
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Table 2A: Protein identifications of differentially abundant spots (≥ 1.5-fold spot volume ratio change and ANOVA p ≤ 0.05) of 
Bifidobacterium animalis subsp. lactis grown on SEM medium with 1% glucose and 1% stachyose. 
 
Spot  Accession Protein name 
Mascot  
score 
Mr /pI  
Anova (p) 
(DIGE)  
Fold  
COG Functional 
role* 
252 gi|241191604 alpha-galactosidase  232 81516/5.03 0.0003917 +5.0 G 
250 gi|241191604 alpha-galactosidase  170 81792/5.00 0.003 +4.3 G 
620 gi|241190508 UDP-glucose 4-epimerase  427 34894/4.81 0.0008372 +3.7 M 
451 gi|241190304 UDP-N-acetylglucosamine1-carboxyvinyltransferase  352 45842/5.97 0.008 +2.9 M 
893 gi|241190445 50S ribosomal protein L5  328 22228/5.09 0.009 +2.6 J 
470 gi|241190472 seryl-tRNA synthetase  266 42494/5.35 0.001 +2.3 J 
678 gi|241191290 ATP binding protein of ABC transporter for 
glutamate_aspartate  
377 29894/5.24 0.00000929 +2.3 E 
852 gi|241191594 NAD-dependent protein deacetylase  141 24522/5.53 0.001 +2.2 K 
263 gi|241191596 oligo-1,6-glucosidase  123 7627/4.59 0.0002007 +2.2 G 
841 gi|241190572 oligoribonuclease  172 25224/4.57 0.001 +2.1 A 
316 gi|241191015 30S ribosomal protein S1  313 64174/4.59 0.002 +2.0 J 
538 gi|241190463 transcription elongation factor NusA  234 39474/5.58 0.0003608 +2.0 K 
388 gi|241190132 L-arabinose isomerase  343 55406/4.9 0.001 +1.9 G 
374 gi|241190571 inosine-5'-monophosphate dehydrogenase  537 58116/5.30 0.008 +1.9 F 
296 gi|241191566 molecular chaperone DnaK  433 66884/4.50 0.0004101 +1.9 O 
812 gi|241191244 1-(5-phosphoribosyl-5-[(5-
phosphoribosylaminomethylideneamino]imidazole-4-
carboxamide isomerase)  
176 26196/4.71 0.00005617 +1.9 E 
562 gi|241190280 myo-inositol-1-phosphate synthase  335 37518/4.74 0.006 +1.8 I 
785 gi|241190700 response regulator of two-component system  367 27141/4.63 0.013 +1.8 TK 
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565 gi|241190137 Tryptophanyl-tRNA synthetase  174 37415/5.85 0.015 +1.8 J 
624 gi|241190210 ketol-acid reductoisomerase  372 34533/4.73 0.00005012 +1.8 EH 
1036 gi|241190779 threonine synthase  144 47914/4.51 0.0002614 +1.8 E 
897 gi|241191102 ATP-dependent Clp protease proteolytic subunit 2  104 2191/4.45 0.004 +1.7 OU 
524 gi|241191186 Glyceraldehyde-3-phosphate dehydrogenase  342 39783/4.90 0.007 +1.7 G 
702 gi|241190946 ABC transporter ATP-binding protein  301 28895/5.04 0.008 +1.7 O 
1029 gi|241190089 oxidoreductase  191 23011/4.76 0.009 +1.7 R 
910 gi|241190664 elongation factor P  290 20863/4.91 0.005 +1.6 J 
416 gi|241190200 sucrose phosphorylase 262 51899/4.69 0.007 +1.6 G 
1038 gi|241190569 Sua5/YciO/YrdC family protein  220 26061/4.65 0.013 +1.6 J 
261 gi|241191596 oligo-1,6-glucosidase  82 76822/4.57 0.014 +1.6 G 
323 gi|241190709 hypothetical protein Balac_0668  302 63377/5.52 0.0002135 +1.6 − 
311 gi|241190948 ABC-type transport system for Fe-S cluster assembly 
permease component  
439 64971/4.69 0.0005644 +1.6 O 
655 gi|241190306 glycerol-3-phosphate dehydrogenase  264 31909/4.70 0.001 +1.5 C 
791 gi|241190494 2,3-bisphosphoglycerate-dependent phosphoglycerate 
mutase  
545 2706/5.21 0.002 +1.5 G 
301 gi|241190670 dihydroxy-acid dehydratase  273 66406/5.03 0.005 +1.5 EG 
425 gi|241191067 6-phosphogluconate dehydrogenase  274 50146/5.18 0.006 +1.5 G 
493 gi|241190804 isocitrate dehydrogenase  185 41069/4.93 0.01 +1.5 C 
        
170 gi|241191107 formate acetyltransferase  407 89654/5.08 0.002 -5.3 C 
832 gi|241190768 L-2,3-butanediol dehydrogenase/acetoinreductase  198 28506/5.10 0.00004879 -5.2 IQR 
70 gi|241190407 hypothetical protein Balac_0352  356 134591/5.66 0.004 -4.9 − 
203 gi|241190264 polyphosphate kinase  114 83817/5.86 0.002 -3.5 P 
1024 gi|241190768 L-2,3-butanediol dehydrogenase/acetoinreductase  466 28506/5.10 0.00006948 -3.2 IQR 
102 gi|241190429 bifunctional acetaldehyde-CoA/alcohol dehydrogenase  180 100490/5.69 0.0008908 -2.6 C 
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361 gi|241191011 pyruvate kinase  235 49697/5.28 0.0000405 -2.2 G 
617 gi|241190361 GTPase ObgE  144 61812/5.09 0.003 -2.1 R 
663 gi|241190893 bile salt hydrolase, choloylglycine hydrolase  148 35286/4.70 0.003 -2.0 M 
348 gi|241190372 propionyl-CoA carboxylase beta chain  297 58221/5.82 0.013 -2.0 I 
463 gi|241190661 elongation factor Tu  170 44281/4.91 0.00005892 -1.8 J 
191 gi|241191473 Trehalose-6-phosphate hydrolase  152 81871/5.57 0.007 -1.7 G 
223 gi|241190140 glycogen phosphorylase  150 92737/4.94 0.003 -1.6 G 
817 gi|241190768 L-2,3-butanediol dehydrogenase/acetoinreductase  183 28506/5.10 0.009 -1.6 IQR 
671 gi|241190342 reductase  241 37488/5.44 0.012 -1.6 C 
362 gi|241191011 pyruvate kinase  314 49697/5.28 0.008 -1.5 G 
         
*COG Functional role: J, Translation, ribosomal structure and biogenesis; G, Carbohydrate transport and metabolism; E, Amino acid transport and metabolism; F, Nucleotide 
transport and metabolism, R, General function prediction only; O, Signal transduction mechanisms; C, Energy production and conversion, −, ORFs with no 
COG annotation; K, Transcription; M, Cell envelope biogenesis, outer membrane; L, DNA replication, recombination and repair; T, Posttranslational 
modification, protein turnover, chaperones; H, Coenzyme metabolism; I, Lipid metabolism; P, Inorganic ion transport and metabolism; S, Function unknown; 
D, Cell division and chromosome partitioning; U, Intracellular trafficking and secretion; A, RNA processing and modification; V, Defence mechanisms; Q, 
Secondary metabolites biosynthesis, transport and catabolism; N, Cell motility and secretion 
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Table 2B: Protein identifications of differentially abundant spots (≥1.5-fold spot volume ratio change and ANOVA p ≤ 0.05) of Bifidobacterium 
animalis subsp. lactis grown on SEM medium with 1% glucose and 1% raffinose. 
 
Spot  Accession Protein name 
Mascot  
score 
Mr /pI  Anova (p)  Fold  COG Functional 
role* 
250 gi|241191604 alpha-galactosidase 170 81792/5.00 0.02 +3.2 G 
252 gi|241191604 alpha-galactosidase 232 81516/5.03 0.013 +2.7 G 
620 gi|241190508 UDP-glucose 4-epimerase 427 34894/4.81 0.004 +2.2 M 
296 gi|241191566 molecular chaperone DnaK 433 66884/4.50 0.001 +2.2 O 
350 gi|241190697 chaperonin GroEL 294 60986/4.54 0.003 +2.1 O 
365 gi|241190697 chaperonin GroEL 515 58754/4.57 0.007 +1.9 O 
841 gi|241190572 oligoribonuclease 172 25224/4.57 0.014 +1.9 A 
263 gi|241191596 oligo-1,6-glucosidase 123 7627/4.59 0.016 +1.8 G 
624 gi|241190210 ketol-acid reductoisomerase 372 34533/4.73 0.007 +1.8 EH 
879 gi|241190669 Guanylate kinase 155 23254/5.05 0.007 +1.7 F 
470 gi|241190472 seryl-tRNA synthetase 266 42494/5.35 0.002 +1.6 J 
55 gi|241190667 Carbamoylphosphate synthase large subunit 289 48144/4.88 0.007 +1.6 EF 
584 gi|241191452 homoserine O-succinyltransferase 140 36592/4.82 0.0009344 +1.6 E 
270 gi|241190872 transketolase 324 75442/4.64 0.004 +1.6 G 
240 gi|241191166 dipeptide transport ATP-binding protein 203 84552/5.24 0.009 +1.5 R 
795 gi|241190653 phosphoribosylaminoimidazole-
succinocarboxamidesynthase 
198 26898/4.51 0.006 +1.5 F 
261 gi|241191596 oligo-1,6-glucosidase 182 76822/4.57 0.031 +1.5 G 
633 gi|241191186 Glyceraldehyde-3-phosphate dehydrogenase 339 33607/5.35 0.012 +1.5 G 
        
1025 gi|241190768 L-2,3-butanediol dehydrogenase/acetoinreductase 383 25548/4.97 0.0002132 -5.5 IQR 
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832 gi|241190768 L-2,3-butanediol dehydrogenase/acetoinreductase 198 25629/4.88 0.00002664 -5.3 IQR 
1024 gi|241190768 L-2,3-butanediol dehydrogenase/acetoinreductase 466 25845/4.97 0.0007374 -4.8 IQR 
602 gi|241190317 Ribokinase family sugar kinase 292 35357/5.84 0.000557 -4.0 G 
170 gi|241191107 formate acetyltransferase 407 94491/4.98 0.008 -3.8 C 
671 gi|241190342 reductase 241 30313/5.19 0.0008577 -3.0 C 
605 gi|241190317 Ribokinase family sugar kinase 273 35254/5.84 0.3731 -2.9 G 
958 gi|241190788 hypothetical protein Balac_0750 203 15247/4.70 0.003 -1.8 R 
617 gi|241190361 GTPase ObgE 144 34997/4.97 0.012 -1.8 R 
824 gi|241190731 polyphosphate glucokinase 76 25791/5.17 0.008 -1.7 KG 
828 gi|241190731 polyphosphate glucokinase 207 2571/5.04 0.014 -1.6 KG 
248 gi|241191022 glycogen branching enzyme 346 8262/4.85 0.015 -1.6 G 
320 gi|241190709 hypothetical protein Balac_0668 217 63696/5.42 0.016 -1.6 − 
761 gi|241190869 hypothetical protein Balac_0839 118 27789/4.98 0.005 -1.5 G 
862 gi|241191021 transcriptional regulator 466 24171/4.99 0.004 -1.5 K 
 
*COG Functional role: J, Translation, ribosomal structure and biogenesis; G, Carbohydrate transport and metabolism; E, Amino acid transport and metabolism; F, Nucleotide 
transport and metabolism, R, General function prediction only; O, Signal transduction mechanisms; C, Energy production and conversion, −, ORFs with no 
COG annotation; K, Transcription; M, Cell envelope biogenesis, outer membrane; L, DNA replication, recombination and repair; T, Posttranslational 
modification, protein turnover, chaperones; H, Coenzyme metabolism; I, Lipid metabolism; P, Inorganic ion transport and metabolism; S, Function unknown; 
D, Cell division and chromosome partitioning; U, Intracellular trafficking and secretion; A, RNA processing and modification; V, Defence mechanisms; Q, 
Secondary metabolites biosynthesis, transport and catabolism; N, Cell motility and secretion 
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Table 2C: Protein identifications of differentially abundant spots (≥ 1.5-fold spot volume ratio change and ANOVA p ≤ 0.05) of Bifidobacterium 
animalis subsp. lactis grown on SEM medium with 1% glucose and 1% melibiose. 
 
Spot  Accession Protein name 
Mascot 
score 
Mr/pI  
Anova (p) 
(DIGE)  
Fold  
COG Functional 
Role* 
252 gi|241191604 alpha-galactosidase 232 81516/5.03 0.002 +3.4 G 
620 gi|241190508 UDP-glucose 4-epimerase 427 34894/4.81 0.002 +3.1 M 
250 gi|241191604 alpha-galactosidase 170 81792/5.00 0.0015 +2.8 G 
302 gi|241190670 dihydroxy-acid dehydratase 470 66246/5.06 0.0005674 +2.2 EG 
249 gi|241191005 glycogen operon protein GlgX 126 82068/5.06 0.0004014 +2.1 G 
852 gi|241191594 NAD-dependent protein deacetylase 141 24522/5.53 0.012 +2.1 K 
374 gi|241190571 inosine-5'-monophosphate dehydrogenase 537 58116/5.30 0.000146 +2.0 F 
365 gi|241190697 chaperonin GroEL 515 58754/4.57 0.002 +1.9 O 
482 gi|241191613 ATP binding protein of ABC transporter for sugars 322 41378/5.60 0.003 +1.9 G 
263 gi|241191596 oligo-1.6-glucosidase 123 7627/4.59 0.003 +1.9 G 
245 gi|241191166 dipeptide transport ATP-binding protein 267 83448/5.33 0.004 +1.9 R 
565 gi|241190137 Tryptophanyl-tRNA synthetase 174 37415/5.85 0.0003011 +1.8 J 
316 gi|241191015 30S ribosomal protein S1 313 64174/4.59 0.0008851 +1.8 J 
615 gi|241190508 UDP-glucose 4-epimerase 182 35048/4.88 0.012 +1.8 M 
337 gi|241191221 UDP-N-acetylmuramate--L-alanine ligase 85 61942/4.75 0.009 +1.7 M 
237 gi|241191166 dipeptide transport ATP-binding protein 374 84828/5.29 0.0003814 +1.6 R 
562 gi|241190280 myo-inositol-1-phosphate synthase 335 37518/4.74 0.00004229 +1.6 I 
1047 gi|241191445 F0F1 ATP synthase subunit beta 535 53972/4.72 0.002 +1.6 C 
375 gi|241190571 inosine-5'-monophosphate dehydrogenase 378 57797/5.21 0.003 +1.6 F 
286 gi|241190896 thioredoxin reductase-like protein 393 69369/4.78 0.007 +1.6 O 
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372 gi|241190386 protease or peptidase 213 58435/5.38 0.012 +1.6 O 
311 gi|241190948 ABC-type transport system for Fe-S cluster assembly 
permease component 
439 64971/4.69 0.013 +1.6 O 
879 gi|241190669 Guanylate kinase 155 23254/5.05 0.5515 +1.5 F 
480 gi|241191613 ATP binding protein of ABC transporter for sugars 165 41697/5.69 0.001 +1.5 G 
416 gi|241190200 sucrose phosphorylase 262 51899/4.69 0.002 +1.5 G 
97 gi|241191008 DNA polymerase I 238 107742/5.04 0.002 +1.5 L 
238 gi|241191000 putative phosphoketolase 441 84552/4.95 0.006 +1.5 G 
749 gi|241190851 succinyl-CoA synthetase subunit alpha 203 28112/4.79 0.006 +1.5 C 
296 gi|241191566 molecular chaperone DnaK 433 66884/4.50 0.01 +1.5 O 
56 gi|241190667 Carbamoylphosphate synthase large subunit 415 125134/4.90 0.011 +1.5 EF 
702 gi|241190946 ABC transporter ATP-binding protein 301 28895/5.04 0.011 +1.5 O 
596 gi|241190873 transaldolase 534 35871/4.52 0.012 +1.5 G 
        
1032 gi|241191249 histidinol dehydrogenase 330 22768/4.66 0.0004245 -3.9 E 
1029 gi|241190089 oxidoreductase 191 23011/4.76 0.0001958 -2.4 R 
895 gi|241190445 50S ribosomal protein L5 164 22066/5.20 0.0005478 -2.2 J 
896 gi|241190821 Uracil-DNA glycosylase. putative 245 21932/5.36 0.013 -2 L 
899 gi|241190311 AcrR-type transcriptional regulator 119 21799/5.42 0.013 -2  
640 gi|241191238 L-lactate dehydrogenase 2 167 33504/6.00 0.014 -2 C 
654 gi|241190306 glycerol-3-phosphate dehydrogenase 113 32012/4.64 0.003 -1.9 C 
643 gi|241191238 L-lactate dehydrogenase 2 326 33401/6.00 0.0006494 -1.8 C 
470 gi|241190472 seryl-tRNA synthetase 266 42494/5.35 0.001 -1.8 J 
1040 gi|241191011 pyruvate kinase 451 58435/5.14 0.00003524 -1.7 G 
631 gi|241190260 phosphodiesterase 520 33761/5.08 0.001 -1.7 C 
828 gi|241190731 polyphosphate glucokinase 207 2571/5.04 0.003 -1.7 KG 
602 gi|241190317 Ribokinase family sugar kinase 292 35357/5.32 0.012 -1.7 G 
685 gi|241190789 phosphoglycerate mutase 306 29489/5.00 0.015 -1.7 G 
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478 gi|241190661 elongation factor Tu 259 41697/4.82 0.0001849 -1.6 J 
672 gi|241191625 thioredoxin reductase 219 3021/4.66 0.001 -1.6 O 
1003 gi|241190258 hypothetical protein Balac_0197 150 12297/5.00 0.001 -1.6 S 
573 gi|241190288 hypothetical protein Balac_0227 197 37107/5.37 0.004 -1.6 R 
611 gi|241190809 30S ribosomal protein S2 187 35099/5.00 0.005 -1.6 J 
582 gi|241190503 Universal stress protein 146 36643/4.90 0.0003764 -1.5 T 
 
*COG Functional role: J, Translation, ribosomal structure and biogenesis; G, Carbohydrate transport and metabolism; E, Amino acid transport and metabolism; F, Nucleotide 
transport and metabolism, R, General function prediction only; O, Signal transduction mechanisms; C, Energy production and conversion, −, ORFs with no 
COG annotation; K, Transcription; M, Cell envelope biogenesis, outer membrane; L, DNA replication, recombination and repair; T, Posttranslational 
modification, protein turnover, chaperones; H, Coenzyme metabolism; I, Lipid metabolism; P, Inorganic ion transport and metabolism; S, Function unknown; 
D, Cell division and chromosome partitioning; U, Intracellular trafficking and secretion; A, RNA processing and modification; V, Defence mechanisms; Q, 
Secondary metabolites biosynthesis, transport and catabolism; N, Cell motility and secretion 
 
 
Table 3A: Protein identifications of differentially abundant spots (≥ 1.5-fold spot volume ratio change and ANOVA p ≤ 0.05) of Bifidobacterium 
animalis subsp. lactis grown on SEM medium with 1% glucose and 1% panose. 
 
Spot  Accession Protein name 
Mascot 
score 
Mr/pI Anova (p)  Fold  COG Functional 
role* 
852 gi|241191594 NAD-dependent protein deacetylase 141 24522/5.53 0.008025 +3.4 K 
506 gi|241190365 Transcription antiterminator 259 40555/4.27 0.001 +3.2 K 
263 gi|241191596 oligo-1,6-glucosidase 235 7627/4.59 0.0002323 +3.1 G 
252 gi|241191604 alpha-galactosidase 335 81516/5.03 0.013 +3.1 G 
470 gi|241190472 seryl-tRNA synthetase 155 42494/5.35 0.0001037 +2.6 J 
302 gi|241190670 dihydroxy-acid dehydratase 470 66246/5.06 0.0006334 +2.3 EG 
796 gi|241190494 2,3-bisphosphoglycerate-dependent phosphoglycerate 
mutase 
266 26898/4.55 0.003 +2.3 G 
365 gi|241190697 chaperonin GroEL 217 58754/4.57 0.0006899 +2.2 O 
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1038 gi|241191585 NADPH-flavin oxidoreductase 451 26061/4.65 0.008 +2.2 C 
562 gi|241190280 myo-inositol-1-phosphate synthase 123 37518/4.74 0.0002543 +2.1 I 
624 gi|241190210 ketol-acid reductoisomerase 198 34533/4.73 0.006 +2.1 EH 
482 gi|241191613 ATP binding protein of ABC transporter for sugars 509 41378/5.60 0.001 +2.0 G 
296 gi|241191566 molecular chaperone DnaK 383 66884/4.50 0.002 +2.0 O 
569 gi|241191273 4-hydroxy-3-methylbut-2-en-1-yl diphosphatesynthase 197 37312/6.12 0.014 +2.0 I 
357 gi|241190474 phosphoglucomutase 537 60508/4.67 0.0002975 +1.9 G 
1029 gi|241190089 oxidoreductase 187 23011/4.76 0.0006402 +1.9 R 
316 gi|241191015 30S ribosomal protein S1 185 64174/4.59 0.006 +1.9 J 
374 gi|241190571 inosine-5'-monophosphate dehydrogenase 114 58116/5.30 0.0004365 +1.8 F 
493 gi|241190804 isocitrate dehydrogenase 191 41069/4.93 0.0005736 +1.8 C 
655 gi|241190306 glycerol-3-phosphate dehydrogenase 515 31909/4.70 0.002 +1.8 C 
897 gi|241191102 ATP-dependent Clp protease proteolytic subunit 2 415 2191/4.45 0.003 +1.8 OU 
337 gi|241191221 UDP-N-acetylmuramate--L-alanine ligase 308 61942/4.75 0.011 +1.8 M 
405 gi|241190741 dihydrolipoamide dehydrogenase 144 53812/5.26 0.013 +1.8 C 
879 gi|241190669 Guanylate kinase 262 23254/5.05 0.00004702 +1.7 F 
696 gi|241190385 aldo/keto reductase family oxidoreductase 128 29057/4.72 0.001 +1.7 C 
226 gi|241190660 elongation factor G 322 85657/4.63 0.008 +1.7 J 
1047 gi|241191445 F0F1 ATP synthase subunit beta 398 53972/4.72 0.011 +1.7 C 
1040 gi|241191011 pyruvate kinase 66 58435/5.14 0.0001956 +1.6 G 
311 gi|241190948 ABC-type transport system for Fe-S cluster assembly 
permease component 
314 64971/4.69 0.002 +1.6 O 
983 gi|241190405 50S ribosomal protein L7/L12 170 13219/4.40 0.004 +1.6 J 
742 gi|241190728 morphine 6-dehydrogenase 278 28193/4.65 0.004 +1.6 R 
676 gi|241190810 elongation factor Ts 264 30056/4.70 0.007 +1.6 J 
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872 gi|241191244 1-(5-phosphoribosyl-5-[(5-
phosphoribosylaminomethylideneamino]imidazole-4-
carboxamide isomerase) 
113 2374/4.52 0.01 +1.6 E 
809 gi|241190470 ribose-5-phosphate isomerase A 433 26223/4.61 0.01 +1.6 G 
1031 gi|241190342 reductase 292 30056/5.31 0.014 +1.6 C 
56 gi|241190667 Carbamoylphosphate synthase large subunit 382 125134/4.90 0.0007002 +1.5 EF 
416 gi|241190200 sucrose phosphorylase 439 51899/4.69 0.0009437 +1.5 G 
279 gi|241190843 hypothetical protein Balac_0807 267 73786/5.15 0.002 +1.5 K 
425 gi|241191067 6-phosphogluconate dehydrogenase 104 50146/5.18 0.004 +1.5 G 
480 gi|241191613 ATP binding protein of ABC transporter for sugars 225 41697/5.69 0.004 +1.5 G 
1030 gi|241190342 reductase 203 29813/5.31 0.005 +1.5 C 
865 gi|241190928 Ribosomal protein L25 399 2409/4.48 0.009 +1.5 J 
388 gi|241190132 L-arabinose isomerase 167 55406/4.90 0.01 +1.5 G 
261 gi|241191596 oligo-1,6-glucosidase 471 76822/4.57 0.011 +1.5 G 
538 gi|241190463 transcription elongation factor NusA 274 39474/5.58 0.014 +1.5 K 
795 gi|241190653 phosphoribosylaminoimidazole-
succinocarboxamidesynthase 
165 26898/4.51 0.014 +1.5 F 
        
70 gi|241190407 hypothetical protein Balac_0352 180 120717/5.52 0.01 -4.3 − 
203 gi|241190264 polyphosphate kinase 458 87865/5.86 0.0006028 -4.1 P 
832 gi|241190768 L-2,3-butanediol dehydrogenase/acetoinreductase 249 25629/4.88 0.0002888 -3.6 IQR 
200 gi|241191232 hypothetical protein Balac_1208 326 88141/5.68 0.0007811 -3.5 R 
1025 gi|241190768 L-2,3-butanediol dehydrogenase/acetoinreductase 168 25548/4.97 0.0004042 -3.1 IQR 
610 gi|241190809 30S ribosomal protein S2 250 35151/4.95 0.001 -3.1 J 
906 gi|241190812 ribosome recycling factor 313 21331/5.52 0.0004173 -2.9 J 
602 gi|241190317 Ribokinase family sugar kinase 372 35357/5.84 0.002 -2.9 G 
214 gi|241190264 polyphosphate kinase 207 87037/5.86 0.003 -2.8 P 
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640 gi|241191238 L-lactate dehydrogenase 2 297 33504/6.00 0.004 -2.7 C 
348 gi|241190372 propionyl-CoA carboxylase beta chain 531 61145/5.54 0.006 -2.6 I 
361 gi|241191011 pyruvate kinase 466 58913/5.00 0.02201 -2.5 G 
320 gi|241190709 hypothetical protein Balac_0668 387 63696/5.42 0.1656 -2.5 − 
990 gi|241190823 hypothetical protein Balac_0787 451 11541/4.65 0.014 -2.4 − 
611 gi|241190809 30S ribosomal protein S2 591 35099/5.00 0.0005575 -2.3 J 
197 gi|241191000 putative phosphoketolase 407 88141/4.86 0.011 -2.3 G 
102 gi|241190429 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 249 106085/5.52 0.004 -2.2 C 
1024 gi|241190768 L-2,3-butanediol dehydrogenase/acetoinreductase 494 25845/4.97 0.007 -2.2 IQR 
213 gi|241191000 putative phosphoketolase 356 87037/4.89 0.001 -2.1 G 
890 gi|241190445 50S ribosomal protein L5 176 22525/4.99 0.005 -2.1 J 
219 gi|241190264 polyphosphate kinase 310 86485/5.86 0.008 -2.1 P 
617 gi|241190361 GTPase ObgE 343 34997/4.97 0.0008641 -2 R 
463 gi|241190661 elongation factor Tu 209 44726/4.76 0.001 -2 J 
654 gi|241190306 glycerol-3-phosphate dehydrogenase 508 32012/4.64 0.002 -2 C 
643 gi|241191238 L-lactate dehydrogenase 2 185 33401/6.00 0.005 -2 C 
587 gi|241191399 glycosyltransferase 182 36386/5.08 0.01 -2 M 
170 gi|241191107 formate acetyltransferase 535 94491/4.98 0.008 -1.9 C 
362 gi|241191011 pyruvate kinase 359 58913/5.04 0.001 -1.8 G 
191 gi|241191473 Trehalose-6-phosphate hydrolase 152 88969/5.56 0.012 -1.8 G 
895 gi|241190445 50S ribosomal protein L5 232 22066/5.20 0.015 -1.8 J 
240 gi|241191166 dipeptide transport ATP-binding protein 196 84552/5.24 0.003 -1.7 R 
253 gi|241190140 glycogen phosphorylase 151 80963/5.10 0.004 -1.7 G 
612 gi|241190809 30S ribosomal protein S2 129 35099/5.06 0.009 -1.7 J 
790 gi|241190653 phosphoribosylaminoimidazole-
succinocarboxamidesynthase 
250 27087/5.03 0.012 -1.7 F 
478 gi|241190661 elongation factor Tu 234 41697/4.82 0.01019 -1.6 J 
  
162 
 
96 gi|241191480 valyl-tRNA synthetase 198 108018/5.02 0.002 -1.6 J 
828 gi|241190731 polyphosphate glucokinase 164 2571/5.04 0.006 -1.5 KG 
 
*COG Functional role: J, Translation, ribosomal structure and biogenesis; G, Carbohydrate transport and metabolism; E, Amino acid transport and metabolism; F, Nucleotide 
transport and metabolism, R, General function prediction only; O, Signal transduction mechanisms; C, Energy production and conversion, −, ORFs with no 
COG annotation; K, Transcription; M, Cell envelope biogenesis, outer membrane; L, DNA replication, recombination and repair; T, Posttranslational 
modification, protein turnover, chaperones; H, Coenzyme metabolism; I, Lipid metabolism; P, Inorganic ion transport and metabolism; S, Function unknown; 
D, Cell division and chromosome partitioning; U, Intracellular trafficking and secretion; A, RNA processing and modification; V, Defence mechanisms; Q, 
Secondary metabolites biosynthesis, transport and catabolism; N, Cell motility and secretion 
 
Table 3B: Protein identifications of differentially abundant spots (> 1.5-fold spot volume ratio change and ANOVA p < 0.05) of 
Bifidobacterium  animalis subsp. lactis grown on SEM medium with 1% glucose and 1% isomaltose. 
 
Spot  Accession Protein name 
Mascot 
score 
Mr/pI 
Anova (p) 
(DIGE)  
Fold  
COG Functional 
role* 
252 gi|241191604 alpha-galactosidase 232 81516/5.03 0.0000389 +11.2 G 
250 gi|241191604 alpha-galactosidase 170 81792/5.00 0.0009143 +8 G 
451 gi|241190304 UDP-N-acetylglucosamine1-carboxyvinyltransferase 352 45842/5.97 0.0008448 +4.7 M 
633 gi|241191186 Glyceraldehyde-3-phosphate dehydrogenase 339 33607/5.35 0.00003908 +4.6 G 
249 gi|241191005 glycogen operon protein GlgX 126 82068/5.06 0.00009128 +3.2 G 
272 gi|241191552 methionyl-tRNA synthetase 203 74890/4.95 0.0008658 +3.2 J 
569 gi|241191273 4-hydroxy-3-methylbut-2-en-1-yl diphosphatesynthase 151 37312/6.12 0.003 +2.9 I 
263 gi|241191596 oligo-1,6-glucosidase 123 76270/4.59 0.0005277 +2.8 G 
870 gi|241191609 deoxycytidine triphosphate deaminase 92 23767/4.94 0.0001457 +2.6 F 
353 gi|241190474 phosphoglucomutase 400 60826/5.16 0.00001167 +2.5 G 
1029 gi|241190089 oxidoreductase 191 23011/4.76 0.000323 +2.4 R 
110 gi|241190429 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 397 105257/5.69 0.001 +2.3 C 
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852 gi|241191594 NAD-dependent protein deacetylase 141 24522/5.53 0.0003636 +2.3 K 
447 gi|241190304 UDP-N-acetylglucosamine1-carboxyvinyltransferase 387 46001/5.97 0.014 +2.3 M 
482 gi|241191613 ATP binding protein of ABC transporter for sugars 322 41378/5.60 0.0003708 +2.2 G 
1047 gi|241191445 F0F1 ATP synthase subunit beta 535 53972/4.72 0.0002322 +2.2 C 
1032 gi|241191249 histidinol dehydrogenase 330 22768/4.66 0.005 +2.2 E 
893 gi|241190445 50S ribosomal protein L5 328 22228/5.09 0.0006042 +2.1 J 
374 gi|241190571 inosine-5'-monophosphate dehydrogenase 537 58116/5.30 0.0001217 +2.1 F 
508 gi|241190770 tyrosyl-tRNA synthetase 171 40400/4.98 0.0008026 +2 J 
365 gi|241190697 chaperonin GroEL 515 58754/4.57 0.0006345 +2 O 
630 gi|241190190 fructose-bisphosphate aldolase 204 33761/4.92 0.0002316 +2 G 
438 gi|241191595 threonine dehydratase 255 47117/5.27 0.0004706 +2 E 
388 gi|241190132 L-arabinose isomerase 343 55406/4.90 0.00006148 +1.9 G 
227 gi|241190371 JadJ 101 85657/5.09 0.01 +1.9 I 
853 gi|241191204 hypothetical protein Balac_1180 137 24495/5.29 0.0007814 +1.8 − 
302 gi|241190670 dihydroxy-acid dehydratase 470 66246/5.06 0.0003967 +1.8 EG 
565 gi|241190137 Tryptophanyl-tRNA synthetase 174 37415/5.85 0.0007447 +1.8 J 
245 gi|241191166 dipeptide transport ATP-binding protein 267 83448/5.33 0.001 +1.7 R 
416 gi|241190200 sucrose phosphorylase 262 51899/4.69 0.0001131 +1.7 G 
301 gi|241190670 dihydroxy-acid dehydratase 273 66406/5.03 0.0004106 +1.7 EG 
271 gi|241191552 methionyl-tRNA synthetase 271 74890/4.92 0.003 +1.7 J 
562 gi|241190280 myo-inositol-1-phosphate synthase 335 37518/4.74 0.00005233 +1.7 I 
316 gi|241191015 30S ribosomal protein S1 313 64174/4.59 0.011 +1.6 J 
56 gi|241190667 Carbamoylphosphate synthase large subunit 415 125134/4.90 0.005 +1.6 EF 
303 gi|241191433 diaminopimelate decarboxylase 359 66087/5.22 0.005 +1.6 E 
493 gi|241190804 isocitrate dehydrogenase 185 41069/4.93 0.003 +1.6 C 
261 gi|241191596 oligo-1,6-glucosidase 82 76822/4.57 0.01 +1.6 G 
298 gi|241190361 GTPase ObgE 290 66565/4.99 0.01 +1.6 R 
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470 gi|241190472 seryl-tRNA synthetase 266 42494/5.35 0.01 +1.6 J 
457 gi|241190673 cyclopropane-fatty-acyl-phospholipid synthase 222 45523/5.43 0.003 +1.5 M 
279 gi|241190843 hypothetical protein Balac_0807 267 73786/5.15 0.00007065 +1.5 K 
626 gi|241191065 hypothetical protein Balac_1039 284 34070/4.93 0.003 +1.5 G 
902 gi|241190542 hypoxanthine-guanine phosphoribosyltransferase 472 21665/4.54 0.0006402 +1.5 F 
624 gi|241190210 ketol-acid reductoisomerase 372 34533/4.73 0.008 +1.5 EH 
305 gi|241191423 long-chain-fatty acid CoA ligase 475 65449/5.08 0.003 +1.5 I 
296 gi|241191566 molecular chaperone DnaK 433 66884/4.50 0.004 +1.5 O 
357 gi|241190474 phosphoglucomutase 509 60508/4.67 0.003 +1.5 G 
384 gi|241190350 glucose-6-phosphate isomerase 255 56522/4.65 0.012 +1.5 G 
1040 gi|241191011 pyruvate kinase 451 58435/5.14 0.002 +1.5 G 
        
896 gi|241190821 Uracil-DNA glycosylase, putative 245 21932/5.36 0.00001353 -6.9 L 
990 gi|241190823 hypothetical protein Balac_0787 129 11541/4.65 0.0004729 -4.2 − 
1003 gi|241190258 hypothetical protein Balac_0197 150 12297/5 0.00008026 -3.2 S 
909 gi|241190812 ribosome recycling factor 351 21219/7.85 0.006 -3.0 J 
956 gi|241190962 3-dehydroquinate dehydratase 82 15269/5.69 0.0003593 -2.9 E 
989 gi|241190823 hypothetical protein Balac_0787 205 4.74/5.01 0.0005827 -2.9 − 
640 gi|241191238 L-lactate dehydrogenase 2 167 33504/6.00 0.0002105 -2.9 C 
197 gi|241191000 putative phosphoketolase 508 88141/4.86 0.004 -2.8 G 
984 gi|241191037 peptidyl-prolyl cis-trans isomerase 163 13219/4.80 0.00003749 -2.6 − 
643 gi|241191238 L-lactate dehydrogenase 2 326 33401/6.00 0.00004103 -2.5 C 
832 gi|241190768 L-2,3-butanediol dehydrogenase/acetoinreductase 198 25629/4.88 0.00001199 -2.5 IQR 
200 gi|241191232 hypothetical protein Balac_1208 308 88141/5.68 0.005 -2.4 R 
663 gi|241190893 bile salt hydrolase, choloylglycine hydrolase 148 30468/4.51 0.0003166 -2.3 M 
828 gi|241190731 polyphosphate glucokinase 207 25710/5.04 0.00001994 -2.3 KG 
906 gi|241190812 ribosome recycling factor 97 21331/5.52 0.009 -2.3 J 
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654 gi|241190306 glycerol-3-phosphate dehydrogenase 113 32012/4.64 0.0003306 -2.2 C 
213 gi|241191000 putative phosphoketolase 398 87037/4.89 0.0004891 -2.1 G 
361 gi|241191011 pyruvate kinase 235 58913/5.00 0.002 -2.1 G 
664 gi|241190893 bile salt hydrolase, choloylglycine hydrolase 309 30468/4.55 0.001 -2.0 M 
790 gi|241190653 phosphoribosylaminoimidazole-
succinocarboxamidesynthase 
359 27087/5.03 0.002 -2.0 F 
685 gi|241190789 phosphoglycerate mutase 306 29489/5.00 0.007 -2.0 G 
817 gi|241190768 L-2,3-butanediol dehydrogenase/acetoinreductase 183 25980/4.83 0.0001795 -1.9 IQR 
661 gi|241191009 Putative response regulator 196 30571/4.56 0.012 -1.9 T 
594 gi|241190873 transaldolase 376 36026/4.47 0.0001764 -1.8 G 
829 gi|241191023 Putative response regulator 318 25710/5.26 0.002 -1.8 TK 
1005 gi|241191436 Putative translation initiation inhibitor 139 13926/4.70 0.004 -1.8 J 
582 gi|241190503 Universal stress protein 146 36643/4.90 0.0008694 -1.8 T 
784 gi|241190494 2,3-bisphosphoglycerate-dependent phosphoglycerate 
mutase 
520 27168/5.11 0.002 -1.7 G 
540 gi|241191043 enolase 503 39371/4.56 0.013 -1.7 G 
602 gi|241190317 Ribokinase family sugar kinase 292 37762/35357 0.007 -1.7 G 
634 gi|241190783 ribose-phosphate pyrophosphokinase 328 37067/33607 0.0006434 -1.7 FE 
703 gi|241190946 ABC transporter ATP-binding protein 149 28868/4.95 0.015 -1.6 O 
320 gi|241190709 hypothetical protein Balac_0668 217 63696/5.42 0.003 -1.6 − 
838 gi|241190710 hypothetical protein Balac_0669 149 25332/5.41 0.002 -1.6 − 
705 gi|241190728 morphine 6-dehydrogenase 147 28841/4.61 0.013 -1.6 R 
795 gi|241190653 phosphoribosylaminoimidazole-
succinocarboxamidesynthase 
198 26898/4.51 0.002 -1.6 F 
233 gi|241191000 putative phosphoketolase 354 85104/4.92 0.001 -1.6 G 
270 gi|241190872 transketolase 324 75442/4.64 0.003 -1.6 G 
478 gi|241190661 elongation factor Tu 259 41697/4.82 0.00001842 -1.5 J 
463 gi|241190661 elongation factor Tu 170 44726/4.76 0.0001908 -1.5 J 
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824 gi|241190731 polyphosphate glucokinase 76 25791/5.17 0.002 -1.5 KG 
362 gi|241191011 pyruvate kinase 314 58913/5.04 0.006 -1.5 G 
 
*COG Functional role: J, Translation, ribosomal structure and biogenesis; G, Carbohydrate transport and metabolism; E, Amino acid transport and metabolism; F, Nucleotide 
transport and metabolism, R, General function prediction only; O, Signal transduction mechanisms; C, Energy production and conversion, −, ORFs with no 
COG annotation; K, Transcription; M, Cell envelope biogenesis, outer membrane; L, DNA replication, recombination and repair; T, Posttranslational 
modification, protein turnover, chaperones; H, Coenzyme metabolism; I, Lipid metabolism; P, Inorganic ion transport and metabolism; S, Function unknown; 
D, Cell division and chromosome partitioning; U, Intracellular trafficking and secretion; A, RNA processing and modification; V, Defence mechanisms; Q, 
Secondary metabolites biosynthesis, transport and catabolism; N, Cell motility and secretio
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Capsule  
Background:  
Xylooligosaccharides (XOS) selectively stimulate the growth of probiotic bifidobacteria, 
thus acting as prebiotics. Several intracellular glycoside hydrolases (GHs) involved in the 
degradation of XOS have been characterized to date, but molecular insight on XOS uptake 
by bifidobacteria is lacking. An operon including a transcriptional regulator, three GH43 
enzymes, and an ATP-binding cassette (ABC) transporter is implicated in XOS uptake and 
degradation in the probiotic Bifidobacterium animalis subsp. lactis Bl-04, and the ABC 
transport system of this operon is conserved across different Bifidobacterium species. 
 
Results: 
SBP of the ABC transport system of the XOS operon from Bifidobacterium animalis 
subsp.lactis Bl-04 (BlXBP) was produced and its ligand preference and affinity 
determined. The crystal structures of BlXBP in complex with xylotriose, xylotetraose and 
xylohexaose were determined, thus providing a structural rationale for the binding data and 
highlighting structural elements responsible for XOS recognition and binding. 
 
Conclusion: 
BlXBP shows a narrow preference with optimal affinity for undecorated or arabinosyl 
decorated XOS ligands of degree of polymerization of 3 – 4. Binding kinetics play a role in 
the selectivity with the association rate (kon) as a major contributor to the affinity. 
 
Significance:  
This data, presenting the first structure of a xylooligosaccharide specific SBP from a 
probiotic bacterium, provide novel insight into the biochemical and structural basis of XOS 
utilization by bifidobacteria and contribute to a better understanding of Bifidobacterium 
animalis subsp. lactis Bl-04’s role in the gut microbiome. 
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Abstract 
The xylooligosaccharides (XOS) binding protein of the ABC import system (BlXBP) has 
been produced in Escherichia coli and biophysically and structurally characterised. Surface 
plasmon resonance binding assays showed that BlXBP was specific for XOS with a degree 
of polymerization (DP) 2– 6 with optimal affinity (Kd ~100 nM) for xylotetraose followed 
by xylotriose. Differences in binding affinity was governed largely by the association rate 
(kon), while koff had a more modest contribution to binding affinities, except for xylobiose, 
which displayed the highest koff. The binding affinity and kinetics of arabinose decorated 
XOS were similar to undecorated counterparts, thus providing evidence that arabinoxylan 
fragments are efficiently captured by the ABC import system. The binding affinity towards 
xylotriose and xylotetraose was corroborated using fluorescence emission spectroscopy 
and isothermal titration calorimetry that revealed that the binding free energy was 
dominated by a favourable enthalpy, which was off-set by a large unfavourable entropy 
change. 
The crystal structures of BlXBP in complex with xylotriose, xylotetraose and xylohexaose 
were determined and showed a binding cleft large enough to accommodate the preferred 
ligand xylotetraose. The helical structure of xylan fragments was recognized by aromatic 
stacking of xyloxyl rings 1, 3 and 4, in addition to several direct and solvent mediated 
hydrogen-bonds that contribute to the binding enthalpy. Binding of larger ligands requires 
conformational changes in a lid loop that contributes to the structural plasticity of BlXBP. 
This data bring novel insight into the molecular basis for XOS uptake by bifidobacteria, 
and xylan utilization by the gut microbiome. 
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Introduction 
The human gut hosts a highly diverse microbial community (1) giving rise to the most 
densely populated ecological niche in nature (2). Despite the diversity and dynamic nature 
of the gut microbiome, the majority of species it constitutes belong to a few dominant 
phyla, with Firmicutes being the most abundant followed by Bacteroidetes, Actinobacteria 
and Proteobacteria (3). The abundance of actinobacteria owes to the Bifidobacterium 
members constituting the third most abundant genus in the gut. Bifidobacteria are 
considered beneficial for human health and include several probiotic strains able to prevent 
or alleviate infectious diarrhea through their modulation of the immune system and to 
confer host resistance against colonization of pathogens (4-6). An important attribute of 
probiotic bacteria is their ability to utilize a variety of non-digestible oligosaccharides by 
the human host, which provides an advantage in the highly competitive gut niche (7). 
Specifically, the occurrence of certain ATP-binding cassette (ABC) carbohydrate 
transporters in bifidobacteria and high acetate production associated with carbohydrate 
metabolism have been correlated to probiotic traits such as protection from pathogenic 
infection in mice (8). Thus the activity and abundance of probiotics can be modulated by 
prebiotics, mainly comprising non-digestible oligosaccharides and certain polysaccharides 
(9).  
Xylan is the main constituent of hemicellulose in the plant cell wall of monocotyledons 
and the second most abundant non-starch polysaccharide after cellulose in many cereal 
grains, where it occurs as decorated arabinoxylan and amounts to 25 – 40% (w/w) of the 
dietary fiber content in grains (10,11). Hence, human diet is rich in arabinoxylan, that 
reaches the colon intact and is degraded mainly by species belonging to the Bacteroides 
and Roseburia genera that possess extracellular endo-xylanases necessary for the 
degradation of the xylan backbone (12). The endo-xylanases releases both undecorated 
xylooligosaccharides (XOS) and decorated arabinooligosaccharides (AXOS), some of 
which escape uptake by the arabinoxylan degraders and become accessible for other 
species (13). Growth on AXOS and XOS, however, is limited to a few taxa amongst 
oligosaccharide degraders (14). Several gut commensals and potential pathogens e.g. 
members of the Clostridium and Escherichia genera are unable to utilize this substrate 
(15). Bifidobacteria possess glycoside hydrolases (GHs) capable of degradating XOS and 
AXOS to arabinose and xylose (16,17). This is highlighted by the widespread ability of 
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different Bifidobacterum species to grow on XOS and AXOS in mono-cultures (18). Some 
species e.g. B. adolecencis, B. catenulatum, B. lactis and B. pseudolomgum, were shown to 
grow more efficiently on XOS as compared to xylose, suggesting the existence of an 
oligosaccharide specific transport system (14,19). Larger increase in B. animalis subsp. 
lactis count was measured on XOS compared to the well established prebiotic 
fructooligosaccharides (FOS) in a colon simulator study, thus highlighting the potential of 
the former substrate as a selective prebiotic for bifidobacteria (20). Recently, a genetic 
locus encoding a LacI transcriptional regulator,  a GH43 β-xylosidase and  2 GH43 
arabinofuranosidases, and an ATB-binding cassette (ABC) transport system was shown to 
confer XOS utilization in B. animalis subsp. lactis BB-12 using combined transcriptome 
and proteome analysis (21). The organization of this locus is identical to other B. lactis 
strains including the widely used probiotic B. animalis subsp. lactis Bl-04 (22), and the 
ABC system in the locus is conserved in different Bifidobaterium species. The ligand 
preference and the structural basis for XOS recognition by the transporter, however, are 
currently unknown. Canonical ABC import systems share a common structural 
organization comprising two transmembrane domains (TMDs) that form the translocation 
pore, two intracellular nucleotide binding domains that power the transport process by 
harnessing energy from ATP hydrolysis, and an extracellular solute binding protein (SBP). 
The affinity and the specificity of ABC import systems is governed by their SBPs 
responsible for high affinity capture of substrates for uptake across the membrane (23). 
Here, the ligand preference, binding energetics and kinetics of the SBP responsible for the 
capture of both XOS and AXOS in B. animalis spp. lactis Bl-04 are reported. The complex 
structures between this SBP and three different XOS ligands are also determined, 
presenting the first structural data on XOS capture by an ABC import system in probiotic 
bacteria and providing novel insight on the structural basis of XOS uptake by a 
physiologically important group of the gut microbiome.  
 
Experimental procedures 
Chemicals. 
All chemicals used in this study were of analytical grade. Carbohydrate ligands with 
purities in : XOS Longlive 95P (84% xylooligosaccharides composed of 43% xylobiose 
(X2), 30% xylotriose (X3), 10% xylotetraose (X4), 17% dp≥X5 ), 13.5 % other 
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monosaccharides) was from Shandong Biotechnology (Heze China) (20). 
Xylooligosachharides X2–X4 >95%, X5 and X6 ~95% were from Megazyme (Wicklow, 
Ireland). Arabinoxylooligosaccharides (AXOS), all ~95% pure with degrees of 
polymerization (DP) 3–5 were a kind gift from Dr. Barry McCleary (Megazyme), and their 
structure and composition was as follows: AX2: [α-L-Araf-(1,3)]-β-D-Xylp-(1,4)-D-Xylp; 
AX3(1): mixture of [α-L-Araf-(1,2)]-β-D-Xylp-(1,4)-β-D-Xylp-(1,4)-D-Xylp (90%) + β-D-
Xylp-(1,4)-[α-L-Araf-(1,3)]-β-D-Xylp-(1,4)-D-Xylp (10%); AX3(2): xylotriose substituted 
with a single arabinosyl residue, precise structure not determined; AX4: β-D-Xylp-(1,4)-[α-
L-Araf-(1,3)]-β-D-Xylp-(1,4)-β-D-Xylp-(1,4)-D-Xylp (80%) + β-D-Xylp-(1,4)-[α-L-Araf-
(1,2)]-β-D-Xylp-(1,4)-β-D-Xylp-(1,4)-D-Xylp (20%). Xylose, sucrose, cellobiose, 
melibiose, isomaltose, raffinose, fructo-oligosaccharides from chicory (DP 2–60 average of 
10) were >98%. Pure (Sigma-Aldrich, St.Louis, MO, USA). Commercial β-
galactooligosacchride mix with degree of polymerization (DP) 2–6, 95% pure was a gift 
from Sampo Lathinen at DuPont Nutrition and Health, Kantvik, Finland (24). 
 
Cloning, expression and purification of the XOS solute binding protein 
Chromosomal DNA of Bifidobacterium animalis subsp lactis Bl-04 (22) was isolated from 
bead beated MRS grown cells according to (25). The gene fragment encoding the 
xylooligosaccharide binding protein of the ATP-binding cassette (ABC) transporter in the 
XOS utilization operon (locus tag number, balac_0514, GenBank accession number 
NC_01281; 609361..610638; GI:241190066 ) without the signal peptide predicted by 
SignalP v.3.0 (26) (basepairs 1–54) was cloned using the sense primer: 5´-
CTAGCTAGCATGAGCGCATGTGGCGGG-3´ and antisense primer: 5´-
CCGGAGCTCTCAGCCCTTCTGGGCGG-3´ and the TaKaRa PrimeStar high GC PCR 
kit (Takara Bio Inc., Otsu, Shiga, Japan) using the NheI and XhoI restriction sites (bold) 
and pET28a(+) (Novagen, Darmpstadt Germany) to yield the expression vector 
pET28aBalac_0514, which was transformed into Escherichia coli 
LB plates supplemented with 50 µg/ml kanamycin. Following restriction analysis and full 
sequencing, pET28aBalac_0514 was transformed into E. coli BL21(DE3) and B834DE3 
(Novagen) for expression of unlabelled and selenomethionine labelled protein respectively. 
The recombinant xylooligosaccharide binding protein, designated as BlXBP, was produced 
as an N-terminal fusion of a thrombin cleavable hexa-histidine tag with the BlXBP mature 
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peptide lacking the native transit peptide (amino acid residues 1–18), but having a six 
amino acid insertion (GSHMAS) flanking the N-terminus of the protein following the tag 
cleavage. 
E. coli BL21(DE3) cells harboring pET28Balac_0514 were used to produce BlXBP in a 5 
L Biostat B (B. Braun Biotech International, Melsungen, Germany) bioreactor as 
previously described (27) except for induction OD600 and temperature which were 7.5 and 
20 °C, respectively. The fermentation was harvested after 16 h of induction by 
centrifugation (10000 x g, 20 min, 4°C) yielding ~200 g cell wet weight. The cell pellet 
was resuspended in HisA buffer (10 mM Hepes, 500 mM NaCl, 10 mM imidazole, 10% 
glycerol (pH 7.5)) and disrupted by high pressure homogenization at 1000 bar (Stansted 
Fluid Power, Stansted, UK). Disintegrated cells were benzonase nuclease treated 
(Invitrogen, Carlsbad, CA, US; 30 min at room temperature) and centrifuged (20000 x g , 
40 min, 4 °C). The supernatant was sterile filtered (0.45 μm) and loaded onto a 5 ml 
HisTrap HP column (GE Healthcare, Uppsala, Sweden). After washing by HisA (10 
column volumes), bound protein was eluted with a linear gradient of 10 column volumes to 
100% HisB (HisA but with 400 mM imidazole instead of 10 mM). Fractions enriched with 
BlXBP, identified by SDS-PAGE, were concentrated and loaded on a gel filtration on a 
Hiload Superdex 200 16/60 column (GE Healthcare) and eluted with 10 mM MES, 150 
mM NaCl, pH 6.5 at 1 ml/min. BlXBP-containing fractions were pooled, concentrated and 
dialysed against (10 mM MES, pH 6.5), loaded onto a 6 ml anion exchange Resource Q 
column (GE Heathcare) and eluted by a 3 stepNaCl gradient resulting in ~2.5 mg  
homogenous BlXBP  per g cell pellet. Chromatographic steps were performed using an 
ÄKTA-AVANT chromatograph (GE Healthcare) at 4 °C. The His tag was removed using 
human thrombin (Calbiochem, Merck, Darmstadt, Germany) as recommended by the 
manufacturer. 
 
Differential scanning calorimetry (DSC) 
DSC analysis was performed to assess the conformational integrity of the apo (unliganded) 
recombinant protein and possible stabilization due to ligand binding. A VP-DSC 
calorimeter (MicroCal, Northampton, MA, USA) with a cell volume of 0.52061 ml was 
used and samples were scanned in the temperature interval 20–90 C at 1 C·min-1. BlXBP 
(11.3 µM) was dialysed in 1000 volumes of either 20 mM MES, pH 6.5 with or without 
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2.5 mg/ml commercial XOS mixture (~5 mM assuming an average DP of 3 and 84% 
purity), and degassed for 10 min at 20 C. Baseline scans collected with buffer in the 
reference and sample cells were subtracted from sample scans. Origin v7.038 software 
with a DSC add-on module was used for assigning Tm and the unfolding enthalpy accessed 
by fitting a non-two state model to the thermogram.  
 
Surface plasmon resonance (SPR) 
Affinity of BlXBP for the different xylooligosaccharides was determined using a Biacore 
T100 (GE Healthcare). BlXBP, diluted into 10 mM Na-acetate pH 4.1 to 2.3 µM, was 
immobilized on a CM5 sensor chip using a random amine coupling kit (GE Healthcare) to 
a density of 2900 response units (RU). Sensograms were recorded at 25 ºC in 20 mM 
Na2HPO4/citrate; 150 mM NaCl; pH 6.5, 0.005% (v/v) P20 surfactant (GE Healthcare) at a 
flow of 30 l/min, with an association time of 90 s, and dissociation time of 240 s. 
Experiments were performed in triplicates in the range 3 nM–10 µM for X3–X5, and 
AXOS; X2 and X6 were from 0.5 µM–1 mM all dissolved in the same buffer as above. To 
investigate the specificity of BlXBP binding was tested towards 5 mM of xylose, 
cellobiose, raffinose, sucrose, melibiose, isomaltose; FOS and GOS in the same buffer. 
The pH dependence of the binding affinity of BlXBP to xylotetraose was investigated at 8 
different pH values in the range pH3–9 (Supplementary Fig. 4), while dependence of 
binding on temperature was examined in the range 15–30 ºC. Data analysis was carried out 
using the Biacore T100 evaluation software, and equilibrium dissociation constants (Kd) 
were calculated by fitting either the steady state response data or the full sensograms to a 
one site binding model allowing the determination of binding kinetics. The van 't Hoff non-
linear equation was used to extract the thermodynamic parameters of binding from the 
temperature dependence of BlXBP. 
 
Isothermal titration calorimetry (ITC) 
Binding of X3 and X4 to recombinant BlXBP was measured using an ITC200 
microcalorimeter (MicroCal) at 25 ºC in 10 mM sodium phosphate, pH 6.5. BlXBP (14 or 
25 µM) in the sample cell (200 µl), was titrated by a first injection of 0.5 µl followed by 18 
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× 2 µl injections of carbohydrate ligand (140 or 250 µM) with 120 s between injections. 
Data was analyzed using the MicroCal software provided (29). 
 
Fluorescence titration spectroscopy 
Intrinsic tryptophan emission was measured on a Spex Fluorlog 322 fluorescence 
spectrometer (HORIBA Jobin Yvon, Irvine, California, US) in a 1 ml stirred quartz cuvette 
at 25 °C. Purified BlXBP diluted in 10mM sodium phosphate, pH 6.5 to 4 µM and pre-
equilibrated for 5 min was titrated with 0.5 mM of X3 or X4 in 0.5 µl steps. Instrument 
settings and data analysis were as previously reported (30). The ligand specific 
contribution to fluorescence quenching was corrected for in all measurements. 
 
Crystallization and structure determination 
BlXBP and selenomethionine labeled BlXBP (15 mg/ml in 10 mM MES, pH 6.5 and 150 
mM NaCl) were used to screen for crystallisation conditions. Crystals grew only in the 
presence of xylooligosaccharide (1 mM) after 30 h incubation at 5°C by vapor diffusion in 
hanging drops from the following condition: 1:1 ratio of BlXBP and reservoir 0.1 M Tris 
pH 7.5, 47% PEG 300 and 5% PEG 1000. Due to the high concentrations of PEG in the 
reservoir solution no further cryoprotectant was needed and the crystals were flash frozen 
directly in liquid nitrogen. Diffaction data was collected to 3.1 Å for the selenomethionine 
BlXBP:X4, 2.2 Å for BlXBP:X4, 2.4 Å for BlXBP:X3 and 2.6 Å for BlXBP:X6 complexes 
at the SLS beamlines PXI and PXIII, Villigen, Switzerland. The structure of 
selenomethionine BlXBP was solved using the single anomalous diffraction (SAD) method 
with the experimental phase information obtained from data collected at the Selenium K-
edge. All datasets were processed with XDS (31). The program Phenix.AutoSol [29] 
identified 15 out of 17 selenomethionine residues present in the BlXBP. An initial partial 
model was obtained with AutoBuild and further corrections and model building using the 
program Coot resulted in a 75% complete model The latter model was used in molecular 
replacement to solve the structure of BlXBP:X4 . The model was further completed using 
automatic and manual model building and the structure was refined using Phenix.Refine 
randomly setting aside 5% of the reflections (and monitoring Rcryst/Rfree factors). The 
BlXBP:X3 and BlXBP:X6 structures were solved using the protein part of the BlXBP:X4 
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structure. The BlXBP:X4 Rfree-set was used for BlXBP:X3. Ligand molecules were 
included after the protein parts were build and water molecules were manually added. The 
overall quality of all models was checked using the MolProbity server [30]. 
 
Results  
Production and Purification of recombinant BlXBP 
The balac_0514 gene in the B. animalis spp. lactis Bl-04 genome (22), annotated as a 
putative sugar transporter solute-binding protein (Pfam family: SBP_bac_1 (PF05147) 
(32), was predicted to have XOS specificity based on gene landscape analysis and 
comparison to the XOS utilization cluster identified in the homolog from B. animalis spp. 
lactis strain BB-12 (21). Recombinant unlabelled and selenomethionine labelled BlXBP 
were produced and purified at yields of (~2.5 mg/ g of cell wet weight). BlXBP occurred as 
a mixture of monomer and dimer in solution based on analytical size exclusion 
chromatography and static light scattering (Supplementary Fig. 1).  
 
Thermal Stability 
The conformational stability of BlXBP was evaluated by differential scanning calorimetry 
(DSC) (33). The thermogram of the apo-protein displayed a well defined albeit broad 
asymmetric thermal transition with an assigned Tm of 65.0 °C for the main peak and a 
shoulder at ≈ 70 °C (Fig. 1A) attesting the conformational integrity and stability of the 
recombinant protein, but suggesting a complex unfolding behaviour. Indeed, the unfolding 
thermogram was best described by a non-two-state model with two thermal transitions 
deconvoluted (Tm1 =65.0 °C and Tm2 =70.8 °C) with an overall calorimetric enthalpy of 
404 kJ/mol. The presence of ~ 450 fold excess of a XOS mixture resulted in an increase of 
Tm and calorimetric enthalpy to 69.5°C and 543 kJ/mol, respectively. The narrow 
cooperative thermal transition was also best described by a non-two-state model, in this 
case however a single peak was adequate to describe the transition suggesting the overlap 
of the two processes which were deconvoluted in the apo form of the protein (Fig. 1). 
Thus, significant stabilisation of BlXBP mounting to 25% increase in calorimetric enthalpy 
occurred in presence of XOS, supportive of the functionality of the protein and the 
predicted specificity towards XOS.  
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Specificity and affinity of BlXBP 
Binding of BlXBP to xylooligosaccharides with DP 2–6, arabinosyl decorated 
xylooligosaccharides (DP 3–5) in additions to 8 other mono-, di- and oligosaccharides was 
analyzed by surface plasmon resonance. Only XOS and AXOS resulted in significant 
binding at the tested concentrations, and good quality data (Fig. 2) enabled discerning the 
kinetics of binding of the different ligands. BlXBP displayed highest affinity towards X4 
with a Kd = 45 nM followed closely by AX3(1), AX3(2) AX2 and X3 (Table 1). The 
affinity towards xylobiose was ~200 fold lower than X4 owing to a lower association rate 
constant (kon) and faster dissociation (koff) (Table 1). Similarly, the relative affinity 
compared to X4 dropped about 12 and 400 fold for X5 and X6, respectively (Table 1) 
owing largely to decreased kon, whereas koff changed only modestly. The presence of an 
arabinosyl sidechain contributed to affinity and binding kinetics in a similar way as adding 
a backbone xylosyl (Table 1, Fig. 2).  
The temperature dependence of binding in the range 15–30°C (Supplementary Table 1) 
was used to analyse the energetics of BlXBP binding to X4. The non-linear van´t Hoff plot 
was used for this analysis (Supplementary Fig. 2) and showed a favorable van´t Hoff 
standard enthalphy change ΔH° = -100 kJ/mol, which was complemented by an 
unfavorable entropy change of TΔS° kJ/mol = -62. The thermodynamic parameters for 
binding of X3 andX4 were determined using ITC and the obtained binding isotherms were 
sigmoidal (Fig. 3), which allowed the determination of binding stoichiometry (n) to 0.95 
and 0.83 for X3 and X4, respectively. The binding affinity was the highest for xylotetraose 
and the magnitude of the binding constants was in very good agreement with those 
obtained from SPR and fluorescent spectroscopy measurements (Table 2). For X3 and X4, 
the energetics of binding were similar but the magnitude of the enthalpy and entropy 
changes were larger than those determined by the indirect van´t Hoff extrapolation 
(Supplementary Table 1). 
 
Crystallization, data collection and structure determination 
Crystallization was performed using the hanging drop vapor-diffusion method at 278K. 
The initial condition was obtained with the Cryo crystallization screen (Emerals 
BioSystems, MA, USA). Crystals were only obtained in the presence of 1 mM 
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xylooligosaccharide ligands in drops containing solution E5 (Tris pH 7, 40% PEG-300 and 
5% PEG-1000). This condition was optimized to (0.1 M Tris pH 7.5, 47% PEG-300 and 
5% PEG-1000), which resulted in rod shaped crystals that grew in 30 h. The crystals of the 
SeMet-BlXBP in complex with X4 were assigned into the orthorhombic space group 
P21212 with one molecule in the asymmetric unit.  The crystals of BlXBP in complex with 
X3 and X4 belonged to the same space group, while BlXBP in complex with X6 crystals 
were assigned into the monoclinic P121 space group with two molecules in the asymmetric 
unit. A model of BlXBP was build based on single-anomalous dispersion (SAD) X-ray 
diffraction data from SeMet labeled BlXBP in complex with X4 and used as search model 
for molecular replacement in native datasets of BlXBP co-crystalized with X3, X4 and X6 
at 2.4 Å, 2.2 Å and 2.6 Å respectively. The data collection and refinement statistics are 
shown in Table 3. The final models of BlXBP in complex with X3, X4 and X6 were 
refined to Rcryst /Rfree values 0.21/0.26, 0.27/0.29 and 0.21/0.26 for complexes with X4, X3 
and X6 respectively. The three complexes are very similar in conformation and 
superposition of the individual monomers results in an overall RMSD of 0.27 Å between 
aligned C-alpha atoms. The final models and refined electrondesity maps are provided in 
the supplementary material of the thesis.  
 
Overall three-dimensional structure 
BlXBP displays a bilobate architecture that consists of two domains of different size joined 
by a tripartite hinge region with the ligand binding site buried at the interface between the 
two domains (Fig. 4), consistent with a type I and cluster B assignment according to 
secondary structure topology based and structural alignment classification systems, 
respectively. The N-terminal domain (domain I) (1–143; 318–362) consists of 7 α-helices 
and 5 β-strands, two of which form a part of the hinge region and continue into the C-
terminal domain (domain II) (147–314; 365–425). Domain II consists of 11 α-helices and 4 
β-strands. The domain is stabilized by a disulphide bridge between Cys 209 and Cys 227. 
The tripartite hinge region comprises two β-strands arranged in an anti-parallel β-sheet 
spanning the 2 domains (144–146; 315–317) and the loop region 363–365.  
 
 
  
180 
 
 
Ligand binding site. 
The crystal structures of BlXBP in complex with X3 and X4 show well defined densities 
for 3 and 4 xylose units, respectively in the binding site in contrast to the X6 complex 
where only 5 xylose units are visible in the electron density map. The XOS ligands are 
oriented with the non-reducing end docked against domain II. The xylose units are 
numbered starting with 1 at the non-reducing end. Residues from both domains contribute 
to the binding of the XOS ligand: residues from the C-terminal domain II are both involved 
in polar contacts and van der Waals interactions through aromatic ring stacking with first 
two xylose units from the non-reducing end of the XOS ligand, while the N-terminal 
domain I exclusively makes polar contacts including a number of water mediated hydrogen 
bonds. The xylooligosaccharides are recognized by aromatic stacking interactions with 
Trp195, Trp277,Trp 384 and Phe350 but also polar interactions with residues His199 and 
Asp386 are coordinating the two xylose units 1 and 2 (Fig. 5 and 6). The hydroxyl groups 
of the ligands form direct hydrogen bonds to the side chains of Asn72, His199, Gln254 and 
to the peptide backbone (Fig. 6), but especially hydrogen bonds mediated through ordered 
water in the binding pocket seem to have an important contribution to the binding. In all 
three complex structures ordered water molecules mediate hydrogen bonds between the 
ligands and the protein, and the binding pocket contain ordered waters. Thus water-
mediated hydrogen bonds between the ligands and the protein contribute greatly to the 
ligand protein interactions (Fig. 5). The main difference between the 3 complex structures 
is the conformational change in loop region Asn39–Glu44 that forms a lid that blocks the 
entrance to the binding site in the X3 structure but bends out towards the solvent side in the 
X4 and X6 structures, this region makes hydrogen bonds form the Cα-peptide backbone to 
the XOS ligand. (Shown in Fig. 6).  
   
Discussion 
Although the concept of stimulation of probiotic bacteria by prebiotic carbohydrates is 
currently well established (34), the molecular mechanisms governing prebiotic selectivity 
remain elusive. Several transcriptional studies implicated a diversity of carbohydrate 
transport systems in uptake of oligosaccharides, which are subsequently degraded by 
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intracellular enzymes in probiotic bacteria (21,35,36). By contrast, data on the molecular 
properties of carbohydrate transport systems is essentially lacking on the protein level with 
the exception of the lacto-N-biose solute binding protein from Bifidobacterium longum 
(37). In the present study, the binding properties and the structure of the 
xylooligosaccharide specific solute binding protein that mediates high affinity uptake of 
XOS via an ABC transport system within the Bifidobacterium genus is presented.  
 
The ligand specificity of BlXBP 
BlXBP displays no detectable binding activity towards xylose or arabinose, and the 
specificity of the protein was also evident from the lack of detectable binding to various di- 
and oligosaccharides tested. By contrast, BlXBP displayed significant plasticity with 
regard to the size and side chain substitution of xylooligosaccharide being able to 
accommodate undecorated and arabinose decorated xylooligosaccharides with similar 
affinity (Table 1). Notably, AXOS at both the C2 and C3 of the non-reducing end xylosyl 
as in AX2 and AX3(1), respectively, or internally as in AX4 (Table 1). This data is 
consistent with the growth of bifidobacteria on arabinoxylooligosaccrharides and with the 
presence of AXOS specific arabinofuranosidases of mainly GH43 but also GH51 in 
bifidobacteria (38). On the other hand the relatively sharp size preference of  BlXBP for 
DP 3–5 (optimum affinity for DP4) is intriguing as characterized intracellular 
bifidobacterial β-xylosidases of GH8 (reducing end xylanase), GH43 and GH120 do not 
seem to display the same substrate preference. Common to these enzyme families is that 
they display high activity on XOS ligands with DP from 3–6 (17,39). While GH120 and 
GH8 enzymes from bifidobacteria displayer higher activity on longer substrates and are 
essentially inactive on xylobiose,  GH43 enzymes displays high levels of activity on the 
disaccharide, in addition to their activity on longer ligands (17). Thus, additional factors 
such as the competitive niche in the gut appear to have exerted evolutionary pressure to 
select for the ligand preference of the XOS ABC transport system in bifidobacteria (will be 
discussed in more detail below).  
 
Structural, kinetic and thermodynamic aspects of XOS recognition  
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The affinity of BlXBP to its ligands was characterized by large changes in the association 
rate (kon), while changes in the dissociation rate were modest with the exception for X2 
(Table 1, Supplementary Fig. 3). The magnitude of koff reflects the short range interactions 
between the protein and the ligand, while kon is influenced by diffusion and by favorable 
electrostatics when the protein and the ligand are within the encounter complex distance 
(40). The observed changes in koff are in excellent agreement with the determined complex 
structures revealing a binding site accommodating X4. Thus, fewer interactions are 
possible with X2 compared to X3 or X4, rationalizing the 16 fold faster koff compared to 
X4 (Table 1). Ligands longer than X4 will protrude out of the binding site without being 
able to form additional contacts with the protein as compared to X4 (Fig. 5) consistent with 
the almost invariant koff for X4–X6. The arabinoxylated XOS conform largely to the same 
koff trend, with slightly lower values for AX2 and slightly higher values for the larger 
decorated ligands. The more than 20 fold lower kon of X2 as compared to X3 is intriguing 
and may be possibly explained by formation of fewer contacts and possibility to bind in 
more than one binding mode resulting in slower transition from the open to the bound 
conformation of the binding protein (41-43). The estimated stoichiometry from the SPR 
data (Table 2) is similar for X2 and X3, consistent with the binding of a single X2 
molecule in the active site of BlXBP, confirming that the binding of this smaller ligand is 
thermodynamically sufficient to elicit the required conformational change, at the penalty of 
slower kinetics. Interestingly, a similar trend of slower kon governed the affinity to the 
larger ligands X5 and X6. The binding of these ligands would require additional structural 
rearrangements (Fig. 5), which evidently results in slower kon values. Thus the binding 
kinetics modulate the ligand preference of BlXBP for optimal recognition of ligands of DP 
3–4.  
The thermodynamic signature of BlXBP binding to X3 and X4 was similar and revealed an 
enthalpically dominated binding, which is compensated by large entropic penalties. This 
energetic finger print is in excellent agreement with the structural data showing extensive 
protein-ligand interactions involving  a combination of aromatic stacking and a hydrogen 
bonding network including direct and solvent mediated contacts, which contribute to the 
binding enthalpy. The unfavorable entropy is likely to arise from the ordering of water 
molecules in the binding pocket and the loss of conformational freedom of both the ligand 
and the protein side chains and domains that typically possess rotational freedom along the 
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hinge region (44). It was not possible to obtain crystal of BlXBP in the unliganded apo 
form, which is indicative of considerable loss of protein flexibility upon ligand binding. 
Nonetheless, the entropy of ordering the solvent molecules seems to be crucial in the 
entropic off-set of binding, as the blood antigen binding protein from Streptococcus 
pneumonia which does not contain ordered solvent molecules shows a significantly lower 
entropic compensation of the favourable binding enthalpy (ca 10% ΔH as compared to ca 
76% for BlXBP). The energetic fingerprint of BlXBP is similar to the lacto-N-biose 
binding potein from B. longum (37), which also employs ordered solvent molecules to 
mediate a hydrogen bonding network to the bound ligand.  
 
Biological implications of the ligand preference of BlXBP: xylan catabolism in the gut 
Plant cell wall polysaccharides, including arabinoxylan fibres that are abundant in human 
diet, offer members of the gut microbiome an important source of carbon and energy. 
Although xylan metabolism in the colon is not fully understood, it has been suggested that 
species from the Bacteroides and Roseburia genera that possess modular GH10 
endoxylanases are the prevalent xylanotyic taxa (45). This is consistent with the presence 
of at least one gene encoding an extracellular modular GH10 endoxylanase appended to 
one or more putative xylan specific carbohydrate biding modules of CBM4, CBM6 or 
CBM22 (46) or CBM9 (47) in e.g. Roseburia intestinalis and in species of Bacteroides.  
Xylan utlisation in Bacteroides has been shown to be mediated by a specific PULs 
(polysaccharide utilization loci) similar to the SUS (starch utilization system), where 
extracellular modular GH10 enzymes capture the substrate by means of their appended 
CBMs and hydrolyse it to large fragments that are subsequently transported via the SusC 
translocation protein to the periplasm for further degradation to monosaccharides, which 
are taken up by MFS (major facilitator superfamily) transporters (48). Notably, the affinity 
of CBM22 and CBM6 increases with ligand size with highest affinities measured for 
xylohexaose with Kd values typically typically in the low µM range (49). Accordingly, it is 
unlikely that smaller xylan fragments are captured efficiently by the Bacteorides uptake 
system or by Roseburia assuming a similar CBM mediated binding mechanism. It is 
predicted that xylan degradation occurs mainly in the proximal colon (50). Thus it is likely 
that a gradient of increasing concentration of smaller xylooligosaccharides would be 
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formed downstream in the colon, providing a nichè for bacteria like Bifidobaterium 
animalis subsp. lactis with efficient XOS uptake and utilization systems.  
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Legend to Figures 
Fig. 1.Thermrostability of BlXBP analysed by differential scanning calorimetry: Top: 
Reference and base line subtracted thermogram of the unfolding of the apo BlXBP (solid 
line). The complex unfolding transition is best described by a non-two-state model with 
two peaks. The fit to the thermogram (dashed line) is shown as well as the deconvuluted 
transitions. Bottom: Reference and base line subtracted thermogram of the unfolding of the 
BlXBP bound to XOS (solid line).  A non-two-state single peak model is fitted (dotted 
line) to the BlXBP-XOS thermogram (solid line). 
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Fig. 2. Binding kinetics of XOS to BlXBP as analysed by surface plasmon resonance at 25 
°C in in 20 mM Na2HPO4/citrate; 150 mM NaCl; pH 6.5, 0.005% (v/v) P20 surfactant. 
Blank and reference cell corrected sensograms (grey) and one binding site global fits (solid 
black lines) to  five ligand concentrations from 19.5 to 312.5 nM A) xylotetraose (X4), B) 
xylopentaose (X5), C) arabino-xylotriose-1 (AX3(1)), D) arabino-xylotriose-2 (AX3(2)). 
Fig. 3. Isothermal titration calorimetry analysis of BlXBP with X3 and X4. A) The 
thermograms (X3 above X4) and binding isotherms (bottom panel: X3 squares, X4 circles) 
are shown. The analysis is performed at 25 °C and pH 6.5 using 250 µM of each ligand in 
the syringe and 25 µM BlXBP in the cell. 
Fig. 4. Ribbon representation of the overall structure of BlXBP complexed with X4. Two 
globular domains, the smaller N-terminal lobe (Domain 1, brown) on the right, and the 
larger C-terminal lobe (domain 2, green) on the left, are linked by three hinge regions 
(grey). The ligand X4 molecule is shown as a ball-and-stick model numbered from the 
non-reducing end. 
Fig. 5. Comparison of the structures of BlXBP in complex with X3 and X4. Close-up view 
of the sugarbinding site. A: BlXBP complexed with X3. B: BlXBP complexed with X4.   
Fig. 6. Comparison of the binding site of BlXBP in complex with X3 and X4. LigPlot (51) 
representation of binding interactions.  
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 Table 1. Kinetics of xylooligosaccharide binding to BlXBP as measured by 
surface plasmon resonance 
Oligo  kon  koff  Kd  Rmax χ
2
 
 
M
-1
s
-1
 x10
4
 s
-1
 x 10
-2
 M   
 
X2 56.5 ± 1.7 50.25 ± 0.80 9.00 x10
-6
 9.6 ± 0.15 0.11 
X3 1254.0 ± 15.0 12.79 ± 0.10 1.02 x10
-7
 16.23 ± 0.1 0.1 
X4 1019.0 ± 9.1 4.61 ± 0.04 4.53 x10
-8
 18.17 ± 0.06 0.09 
X5 86.1 ± 0.9 5.66 ± 0.05 6.57 x10
-7
 19.17 ± 0.08 0.17 
X6 1.8 ± 0.01 4.42 ± 0.01 2.50 x10
-5
 14.83 ± 0.04 0.19 
    
 
 AX2 650.5 ± 13.4 5.19 ± 0.10 8.10 x10-8 11.77  ± 0.1 0.17 
AX3(1) 1098.7 ± 10.3 7.78 ± 0.04 7.08 x10
-8
 13.93 ± 0.06 0.14 
AX3(2) 1083.0 ± 12.5 8.89 ± 0.07 8.20 x10
-8
 14.2 ± 0.07 0.12 
AX4 90.2 ± 2.0 14.01 ± 0.27 1.55 x10
-6
 10.43 ± 0.07 0.13 
 
 
           
Table 2. Thermodynamic parameters and binding constants obtained by ITC. Binding 
data determined  from SPR and fluorescence spectroscopy measurements are shown 
for comparison 
 
 
ΔG° ΔH° TΔS° Kd n 
 
kJ mol
-1
 kJ mol
-1
 kJ mol
-1
 M x10
-9
 
 
X3
a
 -39.13 -165.5 -126.4 141 0.95 
X4
a
 -39.51 -163.2 -123.7 126 0.83 
X4
b
 -42 -100 -62 45 0.70 
X3
c
 -41.4 ND ND 75 1.13 
X4
c
 -40.7 ND ND 57 1.09 
a
Determined by ITC. 
b
Determined by SPR and the thermodynamics were calculated from the non-linear van´t 
Hoff analysis using the temperature dependence SPR data (Supplementary material Table 
2). 
c
Determined by fluorescence emission spectroscopy. 
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Table 3 Data collection and refinement statistics  
BlXBP  X4 X3  X6 
Wavelength (Å) 0.97935 0.97935 0.97935 
Resolution range (Å)   45.80 - 2.2 (2.3 - 2.2)   45.8 - 2.4 (2.5  - 2.4)     44.5 - 2.6 (2.7  - 2.6) 
Space group P 21 21 2 P 21 21 2  P 1 21 1 
Unit cell 
   68.045 124.049 61.334  
90 90 90 
   68.045 124.049 61.334  
90 90 90 
  67.013 119.882 67.749  
90 95.64 90 
Unique reflections
 α
 27024 (2590) 20785 (1861) 32071 (2570) 
Completeness (%)
α 
99.52 (97.48) 98.76 (90.12) 97.16 (78.50) 
R-meas (%)
α
 5.6 (152.0) 5.9 (150.9) 14.2 (96.0) 
Mean I/σ(I)
 α
 17.65 (2.12) 20.88 (2.24) 8.97 (1.82) 
Wilson B-factor 55.59 62.33 42.65 
R-factor
 β
  0.2072 (0.4323) 0.2668 (0.4372) 0.2080 (0.3016) 
R-free
 β
  0.2576 (0.4453) 0.2902 (0.4558) 0.2607 (0.3479) 
Number of atoms 3110 3002 6004 
  macromolecules 3002 3002 6004 
  Ligands 59 NA NA 
  Water 49 NA 792 
Protein residues 396 396 
 RMS (bonds) 0.007 0.007 0.009 
RMS (angles) 1.3 1.05 1.16 
Ramachandran favored 
(%) 98 98 97 
Ramachandran outliers 
(%) 0 0 0.25 
Clashscore 8.96 6.78 11.77 
Average B-factor 23.3 23.6 25 
    macromolecules 23.6 23.6 25 
    Solvent 13.8 -- -- 
α
 Values in the parenthesis are for the highest resolution shell.
  
β
 Values in the parenthesis are for before refinement.
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7    DISCUSSION 
The present study is part of a larger effort with the goal of providing new insight to the 
beneficial effects of carbohydrates on probiotic bacteria at the molecular level and 
identifying carbohydrate active enzymes and proteins central to probiotic metabolism 
(“Gene discovery and molecular interactions in prebiotics/probiotics systems. Focus on 
carbohydrate prebiotics” (project no. 2101-07-0105)). The project is multi disciplinary and 
involves genome mining for functional units for utilization of non-digestible carbohydrates, 
colon simulator studies [1] and human intervention studies (van Zanten et. al. submitted 
manuscript) combined with protein characterization of carbohydrate active enzymes and 
transcriptome [2, 3] and proteome analysis  of the probiotic bacteria utilizing selected 
carbohydrates in batch single cultures [4]. The crucial points of the concept of probiotics 
and prebiotics are the beneficial effect on the human host and the selective metabolism of 
the probiotic bacteria towards the probiotic compounds [5]. In this study I have focused on 
the latter part involving proteomics and protein characterization. The specific goal for my 
part of this project has been to establish the proteomes of the probiotic bacteria NCFM and 
Bl-04 using 2-DE based proteomics and differential proteome analysis with prebiotic 
carbohydrates to identify the changes in proteome when utilizing potential prebiotic 
carbohydrates. I have further focused on carbohydrates transport systems involved in 
uptake of potential prebiotic carbohydrates, specifically the ABC-transporter associated 
solute binding protein involved in the transport of XOS from Bl-04.      
7.1    REFERENCE PROTEOMES OF NCFM AND BL-04 
The advantage of proteomics compared to genomics is the ability to identify the proteins 
expressed in the cell at a given time, thereby monitoring the physiological state of the 
organism while fermenting potential probiotic carbohydrates. In the present study, the 
detailed reference proteome maps of Lactobacillus acidophilus NCFM and 
Bifidobacterium animalis subsp. lactis Bl-04 was established using two-dimensional gel 
electrophoresis, and have been and will be made public available. For NCFM 507 and 150 
protein identifications were made from the CBB stained 2D-gel representing 275 and 102 
unique proteins (pH 3−7 and pH 6−11). While from the whole cell extract proteome of Bl-
04, 328 unique protein identifications were made from 870 protein identifications (pH 3−7 
and pH 3−10). The purpose of the reference proteomes is to describe the probiotic 
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bacteria’s physiology at the proteome level where proteins represent the actual functional 
molecules required by all life processes in the cell. Reference map serves as a blue print for 
comparative proteomics study to further increase our knowledge on the physiology. From 
the comparison of frequency of unique identifications to total number of identifications in 
the 2 organisms, it is evident that many proteins exist in multiple forms due to protein post-
translational modifications, indicating multiple functions of a protein. The observed 
frequency of unique identifications is similar to other reported bacterial 2-DE reference 
proteomes [6-9]. Why are the proteins in the bacterial cell and specifically in our case the 
enzymes of the carbohrydate metabolism targets for multiple PTM? Regulation of function 
seems to be the most likely explanation. Within this project I have not been able to address 
this question, and gel-free proteomic methods are better suited for this task [10]. Multiple 
functions of one protein species have been reported and dubbed moonlighting proteins [11]. 
Interestingly several proteins involved in carbohydrate metabolism and translation from 
lactobacilli and bifidobacteria have been shown to moonlight in bacteria-host interactions, 
e.g. as adhesins or plasminogen receptors [12-16], and perhaps the PTM are involved in 
regulating these moonlighting functions.   
The distribution of unique identifications into functional categories reveals a similar 
pattern for the two organisms, with the highest number of proteins belonging to 
carbohydrate metabolism, energy conversion and protein synthesis (chapter 2, Fig. 3 and 
chapter 5, Fig. 3). This distribution is also found in other reported bacterial 2-DE reference 
proteomes [6-9]. Noticeably 4.7 and 12.5% of the proteins species identified in the 
reference map for NCFM and Bl-04 respectively were annotated as hypothetical proteins, 
but can no longer be perceived as such. All proteins predicted to be involved in 
carbohydrate metabolism have been identified on the 2DE gels. NCFM is 
homofermentative and uses glycolysis for the utilization of carbohydrates, with lactate as 
the primary end product metabolite. Bl-04 is heterofermentative and uses the bifid shunt 
for utilization of carbohydrates and mixture of acetate, lactate, formate and ethanol are the 
end product metabolites. NCFM produces both enantiomers L-lactate and D-lactate, L-
lactate is readily taken up by the colonic epithelia and used as energy source while D-
lactate is degraded more slowly and is the cause of D-lactic acidosis in some cases [17]. 
The short chain fatty acids from Bl-04 metabolism have anti-inflammatory effects and 
promote defence functions of gut epithelial cells [18-20]. Carbohydrate sources have been 
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shown to play a major role in determining the final end product metabolite in NCFM and 
Bl-04 [21].  
7.2    DIFFERENTIAL PROTEOME ANALYSIS 
7.2.1    NCFM 
Two different carbohydrates, lactitol and raffinose were used for the differential proteome 
analysis. Lactitol is a well established prebiotic with proven beneficial effects [22, 23], 
while raffinose is a potential prebiotic and is a major constituent of diet involving soya 
beans [24].  The 2-DE DIGE experiments with NCFM grown on lactitol and raffinose 
identified the glycoside hydrolases responsible for initiating the break down of these two 
potential prebiotics, namely GH2 β-galactosidase LacLM and GH36 α-galactosidase MelA. 
The hydrolysis product galactose from lactitol and raffinose induced the expression of 
enzymes of the Leloir pathway for galactose metabolism. The glucitol/sorbitol part of 
lactitol was metabolized via a PTS-II component. The sucrose part of raffinose also 
induced the expression of a sucrose-6-phosphate hydrolase, and is the primary enzyme 
involved in the metabolism of sucrose generated from raffinose. Furthermore the various 
changes in the abundance of proteins involved in carbohydrate metabolism were identified. 
Various enzymes involved in CCR mediated regulation in the presence of lactitol were 
identified by DIGE analysis. In low G+C Gram-positive bacteria, PTS protein and HPr are 
the master regulators of carbon flow and metabolism. The phosphorylation and 
dephosphorylation of these proteins control the carbon metabolism via CCR [25, 26]. PTS 
phosphotransferase activity and the phosphoenolpyruvate-to-pyruvate ratio regulates the 
concentrations of metabolites such as fructose-1,6-bis-P, ATP, PPi and Pi, which in turn 
control the HPr kinase activity [26-28]. The key gene products involved in the regulation, 
i.e. catabolite control protein A (CcpA), HPr, HPrK/P and PTS, were consistently highly 
abundant in the NCFM transcriptome, which suggested the regulation to occur at the 
protein rather than the transcriptional level [29]. In Streptococcus sp. transport of lactose 
via lactose permease containing the IIA domain was found to be regulated at the protein 
level by different HPr forms [30]. A similar mechanism is possible in NCFM owing to the 
absence of other transporters for lactose and the presence of a highly homologous lactose 
permease with IIA domain. The cellular concentration of pyruvate kinase, which has 
control over the phosphoenolpyruvate-to-pyruvate ratio, was more abundant, consistent 
with CCR.  
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Lactate dehydrogenase converts the generated pyruvate into lactate, NCFM has two lactate 
dehydrogenase enzymes D-lactate dehydrogenase and L-lactate dehydrogenase. L-lactate is 
the form preferred by the colon epithelia while D-lactate can induce acidosis in the host 
[17]. In the case of lactitol two forms of D-lactate dehydrogenase were found to be 
differentially abundant, with one being up-regulated and the other being down-regulated 
durring growth on lactitol. With growth on raffinose, D-lactate dehydrogenase and L-lactate 
dehydrogenase were found to be differentially abundant with upregulation of L-lactate 
dehydrogenase and downregulation of D-lactate dehydrogenase, indicating a shift from the 
end product enatiomer ratio of lactic acid.  
7.2.2    BL-04 
The established prebiotics galactooligosaccharides, isomaltooligosaccharides (panose and 
isomaltose) and potential prebiotics melibiose, raffinose family oligosaccharides (raffinose 
and stachyose) were used for the differential proteome analysis with Bl-04. The 2D-DIGE 
analysis with GOS, RFO and IMO revealed various proteins involved in the metabolism of 
these carbohydrates. A GH42 β-galactosidase was found to be differentially abundant with 
GOS, and is the primary enzyme in the utilization of β-galactosyl linked oligosaccharides. 
Glycoside hydrolases GH36 α-galactosidase (Balac_1601), GH13_31 oligo-1,6-
glucosidase (Balac_1593) and GH13_18 sucrose phosphorylase (Balac_0138) were found 
to be upregulated during growth on melibiose, raffinose family oligosaccharides and 
isomaltooligosaccharides. In Bl-04 the gene cluster involved in the metabolism of -
galactose linked sugars includes two -galactosidases (Balac_1596 and Balac_1601), 
components of the ABC transporter for sugars, oligo-1-6-glucosidase. The gene cluster is 
similar to the multiple sugar metabolism gene cluster in Gram-positive bacteria capable of 
utilizing melibiose, raffinose and isomalooligosaccharides. The presence and induction of 
oligo-1-6-glucosidase indicates transcriptional regulation and induction by -galactose 
linked sugars and the capability of the gene cluster in Bl-04 to utilize multiple sugars.  
Various proteins of the bifid shunt including L-ribulose-5-phosphate 4-epimerase, 
phosphoketolase, phosphoglucomutase, transketolase, 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase, glyceraldehyde-3-phosphate dehydrogenase, pyruvate kinase, 
formate acetyl transferase, L-2,3-butanedioldehydrogenase/acetoinreductase and L-lactate 
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dehydrogenase were found to be differentially abundant with these prebiotic 
oligosaccharides candidates as carbon source. 
The prebiotic carbohydrate sources have been shown to influence abundance of the 
proteins of the bifid shunt and play a role in the production of end product metabolites. In 
the present study, the differential abundance of isoforms of L-lactate dehydrogenase 2 
involved in the inter conversion of pyruvate to L-Lactate and the bifunctional acetaldehyde-
CoA/alcohol dehydrogenase involved in the inter conversion of acetaldehyde to ethanol 
also suggests changes in the end product metabolites with prebiotic carbohydrates.  
 
7.3    XOS TRANSPORT IN BL-04 
In order to try to understand the selectiveness of XOS towards bifidobacteria the structure 
and biochemical properties of the XOS uptake ABC-transporter associated SBP BlXBP 
was charaterized. BlXBP displayed no detectable binding activity towards xylose or 
arabinose but a relatively sharp size preference for XOS and AXOS with DP 3–5 with an 
optimum affinity for DP4. This observation can perhaps inspire to the production of 
probiotic products containing oligosaccharides with optimal DP for the probiotic strains 
that is targeted.  
The affinity of BlXBP to its ligands was characterized by large changes in the association 
rate (kon), while changes in the dissociation rate were modest with the exception for X2. 
The magnitude of koff reflects the short range interactions between the protein and the 
ligand, while kon is influenced by diffusion and by favorable electrostatics when the protein 
and the ligand are within the encounter complex distance [31]. The trend of a slower kon 
was also observed governing the affinity to the larger ligands X5 and X6. The binding of 
these ligands would require additional structural rearrangements, which results in slower 
kon values. Thus the binding kinetics modulates the ligand preference of BlXBP for optimal 
affinity to ligands of DP 3–4. The thermodynamic signature of BlXBP binding to X3 and 
X4 was similar and revealed an enthalpic dominated binding, which is compensated by 
large entropic penalties. This energetic fingerprint is in excellent agreement with the 
structural data showing extensive protein-ligand interactions involving a combination of 
aromatic stacking and a hydrogen bonding network including direct and solvent mediated 
contacts, which contribute to the binding enthalpy. A similar mode of binding was also 
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observed for Lactose-N-biose SBP from probiotic Bifidobacerium longum [32]. The 
unfavorable entropy is likely to arise from the ordering of water molecules in the binding 
pocket and the loss of conformational freedom of both the ligand and the protein side 
chains and domains that typically possess rotational freedom along the hinge region [33]. 
Previously the binding constants of two other XOS binding SBP have been reported 
Streptomyces thermoviolaceus and Caldanaerobius polysaccharolyticus [34, 35] with high 
affinity towards xylobiose and xylotriose respectively. In the present moment it is unclear, 
what the underlying molecular basis is that determines the difference in ligand preference, 
but further structural analysis may elucidate this. This work contributes to the 
understanding of the molecular mechanism for probiotic selectiveness of probiotic 
carbohydrates.  
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